BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, Huang H, Zhang L, Du C, Zhang Y, Song J, Wang S, Chao Y, Yang Z, Xu J, Chen D, Xiong W, Xu L, Zhou F, Jiang J, Bai C, Zheng J, Song Y. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. 2020;180:934-943. [PMID: 32167524 DOI: 10.1001/jamainternmed.2020.0994] [Cited by in Crossref: 3294] [Cited by in F6Publishing: 3105] [Article Influence: 1647.0] [Reference Citation Analysis]
Number Citing Articles
1 Hu F, Yin G, Chen Y, Song J, Ye M, Liu J, Chen C, Song Y, Tang X, Zhang Y. Corticosteroid, oseltamivir and delayed admission are independent risk factors for prolonged viral shedding in patients with Coronavirus Disease 2019. Clin Respir J 2020;14:1067-75. [PMID: 32750201 DOI: 10.1111/crj.13243] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
2 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
3 Yonas E, Alwi I, Pranata R, Huang I, Lim MA, Yamin M, Nasution SA, Setiati S, Virani SS. Elevated interleukin levels are associated with higher severity and mortality in COVID 19 - A systematic review, meta-analysis, and meta-regression. Diabetes Metab Syndr 2020;14:2219-30. [PMID: 33395783 DOI: 10.1016/j.dsx.2020.11.011] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
4 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
5 Wang LL, Yang JW, Xu JF. Coronavirus (SARS-CoV-2) causes lung inflammation and injury. Clin Microbiol Infect 2021:S1198-743X(21)00674-1. [PMID: 34861410 DOI: 10.1016/j.cmi.2021.11.022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Wang B, Zheng H. From blanket quarantine in Wuhan to distant centralized quarantine in Shijiazhuang: the evolution of China's COVID-19 quarantine approach. Infection 2021;49:765-7. [PMID: 33961272 DOI: 10.1007/s15010-021-01623-8] [Reference Citation Analysis]
7 Pallotto C, Suardi LR, Esperti S, Tarquini R, Grifoni E, Meini S, Valoriani A, Di Martino S, Cei F, Sisti E, Piani F, Botta A, Salomoni E, Baragli F, Blanc P. Increased CD4/CD8 ratio as a risk factor for critical illness in coronavirus disease 2019 (COVID-19): a retrospective multicentre study. Infect Dis (Lond) 2020;52:675-7. [PMID: 32543971 DOI: 10.1080/23744235.2020.1778178] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
8 Khadzhieva MB, Kalinina EV, Larin SS, Sviridova DA, Gracheva AS, Chursinova JV, Stepanov VA, Redkin IV, Avdeikina LS, Rumyantsev AG, Kuzovlev AN, Salnikova LE. TREC/KREC Levels in Young COVID-19 Patients. Diagnostics (Basel) 2021;11:1486. [PMID: 34441420 DOI: 10.3390/diagnostics11081486] [Reference Citation Analysis]
9 Nottmeyer LN, Sera F. Influence of temperature, and of relative and absolute humidity on COVID-19 incidence in England - A multi-city time-series study. Environ Res 2021;196:110977. [PMID: 33684415 DOI: 10.1016/j.envres.2021.110977] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
10 Zhang J, Lan P, Yi J, Yang C, Gong X, Ge H, Xu X, Liu L, Zhou J, Lv F. Secondary bloodstream infection in critically ill patients with COVID-19. J Int Med Res 2021;49:3000605211062783. [PMID: 34898307 DOI: 10.1177/03000605211062783] [Reference Citation Analysis]
11 Wicik Z, Eyileten C, Jakubik D, Simões SN, Martins DC Jr, Pavão R, Siller-Matula JM, Postula M. ACE2 Interaction Networks in COVID-19: A Physiological Framework for Prediction of Outcome in Patients with Cardiovascular Risk Factors. J Clin Med 2020;9:E3743. [PMID: 33233425 DOI: 10.3390/jcm9113743] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
12 Szklanna PB, Altaie H, Comer SP, Cullivan S, Kelliher S, Weiss L, Curran J, Dowling E, O'Reilly KMA, Cotter AG, Marsh B, Gaine S, Power N, Lennon Á, McCullagh B, Ní Áinle F, Kevane B, Maguire PB. Routine Hematological Parameters May Be Predictors of COVID-19 Severity. Front Med (Lausanne) 2021;8:682843. [PMID: 34336889 DOI: 10.3389/fmed.2021.682843] [Reference Citation Analysis]
13 Wang CC, Chao JK, Wang ML, Yang YP, Chien CS, Lai WY, Yang YC, Chang YH, Chou CL, Kao CL. Care for Patients with Stroke During the COVID-19 Pandemic: Physical Therapy and Rehabilitation Suggestions for Preventing Secondary Stroke. J Stroke Cerebrovasc Dis 2020;29:105182. [PMID: 33066878 DOI: 10.1016/j.jstrokecerebrovasdis.2020.105182] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
14 Zhang Y, Coats AJ, Zheng Z, Adamo M, Ambrosio G, Anker SD, Butler J, Xu D, Mao J, Khan MS, Bai L, Mebazaa A, Ponikowski P, Tang Q, Ruschitzka F, Seferovic P, Tschöpe C, Zhang S, Gao C, Zhou S, Senni M, Zhang J, Metra M. Management of heart failure patients with COVID ‐19: a joint position paper of the Chinese Heart Failure Association & National Heart Failure Committee and the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2020;22:941-56. [DOI: 10.1002/ejhf.1915] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 19.0] [Reference Citation Analysis]
15 Guisado-Vasco P, Cano-Megías M, Rodríguez-López M, de-Luna-Boquera IM, Carnevali-Ruiz D; Immunosuppressants Against COVID-19 Working Team. COVID-19 and Metabolic Syndrome: NF-κB Activation. Crossroads. Trends Endocrinol Metab 2020;31:802-3. [PMID: 32972818 DOI: 10.1016/j.tem.2020.08.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
16 Saburi A, Schoepf UJ, Ulversoy KA, Jafari R, Eghbal F, Ghanei M. From Radiological Manifestations to Pulmonary Pathogenesis of COVID-19: A Bench to Bedside Review. Radiol Res Pract. 2020;2020:8825761. [PMID: 33294226 DOI: 10.1155/2020/8825761] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
17 Chernyak BV, Popova EN, Prikhodko AS, Grebenchikov OA, Zinovkina LA, Zinovkin RA. COVID-19 and Oxidative Stress. Biochemistry (Mosc) 2020;85:1543-53. [PMID: 33705292 DOI: 10.1134/S0006297920120068] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 15.0] [Reference Citation Analysis]
18 Liu L, Dong L, Zhang B, Chen X, Song X, Li S, Wei W. Early prediction model for progression and prognosis of severe patients with coronavirus disease 2019. Medicine (Baltimore) 2021;100:e24901. [PMID: 33663123 DOI: 10.1097/MD.0000000000024901] [Reference Citation Analysis]
19 Oyelade T, Alqahtani J, Canciani G. Prognosis of COVID-19 in Patients with Liver and Kidney Diseases: An Early Systematic Review and Meta-Analysis. Trop Med Infect Dis. 2020;5. [PMID: 32429038 DOI: 10.3390/tropicalmed5020080] [Cited by in Crossref: 52] [Cited by in F6Publishing: 41] [Article Influence: 26.0] [Reference Citation Analysis]
20 Tan EH, Sena AG, Prats-Uribe A, You SC, Ahmed WU, Kostka K, Reich C, Duvall SL, Lynch KE, Matheny ME, Duarte-Salles T, Bertolin SF, Hripcsak G, Natarajan K, Falconer T, Spotnitz M, Ostropolets A, Blacketer C, Alshammari TM, Alghoul H, Alser O, Lane JCE, Dawoud DM, Shah K, Yang Y, Zhang L, Areia C, Golozar A, Recalde M, Casajust P, Jonnagaddala J, Subbian V, Vizcaya D, Lai LYH, Nyberg F, Morales DR, Posada JD, Shah NH, Gong M, Vivekanantham A, Abend A, Minty EP, Suchard M, Rijnbeek P, Ryan PB, Prieto-Alhambra D. COVID-19 in patients with autoimmune diseases: characteristics and outcomes in a multinational network of cohorts across three countries. Rheumatology (Oxford) 2021;60:SI37-50. [PMID: 33725121 DOI: 10.1093/rheumatology/keab250] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 7.0] [Reference Citation Analysis]
21 Barbuddhe SB, Rawool DB, Gaonkar PP, Vergis J, Dhama K, Malik SS. Global scenario, public health concerns and mitigation strategies to counter current ongoing SARS-CoV-2 / COVID-19 pandemic. Hum Vaccin Immunother 2020;16:3023-33. [PMID: 33121328 DOI: 10.1080/21645515.2020.1810496] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Pinzón MA, Ortiz S, Holguín H, Betancur JF, Cardona Arango D, Laniado H, Arias Arias C, Muñoz B, Quiceno J, Jaramillo D, Ramirez Z. Dexamethasone vs methylprednisolone high dose for Covid-19 pneumonia. PLoS One 2021;16:e0252057. [PMID: 34033648 DOI: 10.1371/journal.pone.0252057] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
23 Christie MJ, Irving AT, Forster SC, Marsland BJ, Hansbro PM, Hertzog PJ, Nold-Petry CA, Nold MF. Of bats and men: Immunomodulatory treatment options for COVID-19 guided by the immunopathology of SARS-CoV-2 infection. Sci Immunol 2021;6:eabd0205. [PMID: 34533977 DOI: 10.1126/sciimmunol.abd0205] [Reference Citation Analysis]
24 Levy DA, Boey HP, Leff PD. Modified Negative Pressure Enclosure During Tracheostomy in Patients With COVID-19. Ear Nose Throat J 2021;:145561321991319. [PMID: 33530740 DOI: 10.1177/0145561321991319] [Reference Citation Analysis]
25 Bandopadhyay S. We Know the Prognosis but can We Change It? Indian J Crit Care Med 2021;25:835-6. [PMID: 34733016 DOI: 10.5005/jp-journals-10071-23955] [Reference Citation Analysis]
26 [DOI: 10.1101/2020.03.24.20040162] [Cited by in Crossref: 21] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
27 Song JC, Wang G, Zhang W, Zhang Y, Li WQ, Zhou Z; People’s Liberation Army Professional Committee of Critical Care Medicine, Chinese Society on Thrombosis and Haemostasis. Chinese expert consensus on diagnosis and treatment of coagulation dysfunction in COVID-19. Mil Med Res 2020;7:19. [PMID: 32307014 DOI: 10.1186/s40779-020-00247-7] [Cited by in Crossref: 32] [Cited by in F6Publishing: 56] [Article Influence: 16.0] [Reference Citation Analysis]
28 Shafi AMA, Shaikh SA, Shirke MM, Iddawela S, Harky A. Cardiac manifestations in COVID-19 patients-A systematic review. J Card Surg. 2020;35:1988-2008. [PMID: 32652713 DOI: 10.1111/jocs.14808] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 20.5] [Reference Citation Analysis]
29 Tal-Singer R, Crapo JD. COPD at the Time of COVID-19: A COPD Foundation Perspective. Chronic Obstr Pulm Dis 2020;7:73-5. [PMID: 32324976 DOI: 10.15326/jcopdf.7.2.2020.0149] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
30 Chauhan A, Kaur R, Chakrbarti P, Pal A. "Silent Hypoxemia" Leads to Vicious Cycle of Infection, Coagulopathy and Cytokine Storm in COVID-19: Can Prophylactic Oxygen Therapy Prevent It? Indian J Clin Biochem 2021;:1-5. [PMID: 33746377 DOI: 10.1007/s12291-021-00967-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
31 Smith PO, Jin P, Rahman KM. Strategies for drug repurposing against coronavirus targets. Curr Res Pharmacol Drug Discov 2022;3:100072. [PMID: 34901833 DOI: 10.1016/j.crphar.2021.100072] [Reference Citation Analysis]
32 Baidya A, Singh SK, Bajaj S, Zargar AH, Singh P, Das S, Shankar A. Diabetes and COVID-19: A Review. J ASEAN Fed Endocr Soc 2020;35:40-8. [PMID: 33442168 DOI: 10.15605/jafes.035.01.06] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 Vacirca A, Faggioli G, Pini R, Teutonico P, Pilato A, Gargiulo M. Unheralded Lower limb threatening ischemia in a COVID-19 patient. Int J Infect Dis 2020;96:590-2. [PMID: 32447121 DOI: 10.1016/j.ijid.2020.05.060] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
34 Alberti A, Schuelter-Trevisol F, Iser BPM, Traebert E, Freiberger V, Ventura L, Rezin GT, da Silva BB, Meneghetti Dallacosta F, Grigollo L, Dias P, Fin G, De Jesus JA, Pertille F, Rossoni C, Hur Soares B, Nodari Júnior RJ, Comim CM. Obesity in people with diabetes in COVID-19 times: Important considerations and precautions to be taken. World J Clin Cases 2021; 9(20): 5358-5371 [PMID: 34307590 DOI: 10.12998/wjcc.v9.i20.5358] [Reference Citation Analysis]
35 Cafiero C, Re A, Micera A, Palmirotta R, Monaco D, Romano F, Fabrizio C, Di Francia R, Cacciamani A, Surico PL, D'Amato G, Pisconti S. Pharmacogenomics and Pharmacogenetics: In Silico Prediction of Drug Effects in Treatments for Novel Coronavirus SARS-CoV2 Disease. Pharmgenomics Pers Med 2020;13:463-84. [PMID: 33116761 DOI: 10.2147/PGPM.S270069] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Yao Z, Zheng X, Zheng Z, Wu K, Zheng J. Construction and validation of a machine learning-based nomogram: A tool to predict the risk of getting severe coronavirus disease 2019 (COVID-19). Immun Inflamm Dis 2021;9:595-607. [PMID: 33713584 DOI: 10.1002/iid3.421] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
37 Nigro E, Perrotta F, Polito R, D'Agnano V, Scialò F, Bianco A, Daniele A. Metabolic Perturbations and Severe COVID-19 Disease: Implication of Molecular Pathways. Int J Endocrinol 2020;2020:8896536. [PMID: 33312199 DOI: 10.1155/2020/8896536] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
38 Motta JC, Novoa DJ, Gómez CC, Moreno JM, Vargas L, Pérez J, Millán H, Arango ÁI. Prognostic factors in hospitalized patients diagnosed with SARS-CoV-2 infection, Bogotá, Colombia. Biomedica 2020;40:116-30. [PMID: 33152195 DOI: 10.7705/biomedica.5764] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
39 Rauch A, Labreuche J, Lassalle F, Goutay J, Caplan M, Charbonnier L, Rohn A, Jeanpierre E, Dupont A, Duhamel A, Faure K, Lambert M, Kipnis E, Garrigue D, Lenting PJ, Poissy J, Susen S. Coagulation biomarkers are independent predictors of increased oxygen requirements in COVID-19. J Thromb Haemost 2020;18:2942-53. [PMID: 32881304 DOI: 10.1111/jth.15067] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 15.0] [Reference Citation Analysis]
40 Langford BJ, So M, Raybardhan S, Leung V, Westwood D, MacFadden DR, Soucy JR, Daneman N. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clin Microbiol Infect 2020;26:1622-9. [PMID: 32711058 DOI: 10.1016/j.cmi.2020.07.016] [Cited by in Crossref: 250] [Cited by in F6Publishing: 239] [Article Influence: 125.0] [Reference Citation Analysis]
41 Elias P, Poterucha TJ, Jain SS, Sayer G, Raikhelkar J, Fried J, Clerkin K, Griffin J, DeFilippis EM, Gupta A, Lawlor M, Madhavan M, Rosenblum H, Roth ZB, Natarajan K, Hripcsak G, Perotte A, Wan EY, Saluja A, Dizon J, Ehlert F, Morrow JP, Yarmohammadi H, Kumaraiah D, Redfors B, Gavin N, Kirtane A, Rabbani L, Burkhoff D, Moses J, Schwartz A, Leon M, Uriel N. The Prognostic Value of Electrocardiogram at Presentation to Emergency Department in Patients With COVID-19. Mayo Clin Proc 2020;95:2099-109. [PMID: 33012341 DOI: 10.1016/j.mayocp.2020.07.028] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
42 Suzuki Y, Hishiki T, Emi A, Sakaguchi S, Itamura R, Yamamoto R, Matsuzawa T, Shimotohno K, Mizokami M, Nakano T, Yamamoto N. Strong alkaline electrolyzed water efficiently inactivates SARS-CoV-2, other viruses, and Gram-negative bacteria. Biochem Biophys Res Commun 2021;575:36-41. [PMID: 34455219 DOI: 10.1016/j.bbrc.2021.08.048] [Reference Citation Analysis]
43 Caracciolo M, Correale P, Mangano C, Foti G, Falcone C, Macheda S, Cuzzola M, Conte M, Falzea AC, Iuliano E, Morabito A, Caraglia M, Polimeni N, Ferrarelli A, Labate D, Tescione M, Di Renzo L, Chiricolo G, Romano L, De Lorenzo A. Efficacy and Effect of Inhaled Adenosine Treatment in Hospitalized COVID-19 Patients. Front Immunol 2021;12:613070. [PMID: 33815368 DOI: 10.3389/fimmu.2021.613070] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Abdelhafiz AH, Emmerton D, Sinclair AJ. Diabetes in COVID-19 pandemic-prevalence, patient characteristics and adverse outcomes. Int J Clin Pract 2021;75:e14112. [PMID: 33630378 DOI: 10.1111/ijcp.14112] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
45 Miller MM, Meneveau MO, Rochman CM, Schroen AT, Lattimore CM, Gaspard PA, Cubbage RS, Showalter SL. Impact of the COVID-19 pandemic on breast cancer screening volumes and patient screening behaviors. Breast Cancer Res Treat 2021;189:237-46. [PMID: 34032985 DOI: 10.1007/s10549-021-06252-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
46 Cai H, Wang Y, Cai Z, Lin Y, Xu Q. Nutrition intervention in the management of novel coronavirus pneumonia patients. Open Life Sciences 2022;17:243-7. [DOI: 10.1515/biol-2022-0015] [Reference Citation Analysis]
47 [DOI: 10.1101/2020.08.26.20180992] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
48 Meini S, Zanichelli A, Sbrojavacca R, Iuri F, Roberts AT, Suffritti C, Tascini C. Understanding the Pathophysiology of COVID-19: Could the Contact System Be the Key? Front Immunol 2020;11:2014. [PMID: 32849666 DOI: 10.3389/fimmu.2020.02014] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
49 Araújo MPD, Nunes VMA, Costa LA, Souza TA, Torres GV, Nobre TTX. Health conditions of potential risk for severe Covid-19 in institutionalized elderly people. PLoS One 2021;16:e0245432. [PMID: 33444352 DOI: 10.1371/journal.pone.0245432] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
50 Magro F, Rahier JF, Abreu C, MacMahon E, Hart A, van der Woude CJ, Gordon H, Adamina M, Viget N, Vavricka S, Kucharzik T, Leone S, Siegmund B, Danese S, Peyrin-Biroulet L. Inflammatory Bowel Disease Management During the COVID-19 Outbreak: The Ten Do's and Don'ts from the ECCO-COVID Taskforce. J Crohns Colitis. 2020;14:S798-S806. [PMID: 32722754 DOI: 10.1093/ecco-jcc/jjaa160] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 13.5] [Reference Citation Analysis]
51 Mattioli AV, Sciomer S, Cocchi C, Maffei S, Gallina S. Quarantine during COVID-19 outbreak: Changes in diet and physical activity increase the risk of cardiovascular disease. Nutr Metab Cardiovasc Dis 2020;30:1409-17. [PMID: 32571612 DOI: 10.1016/j.numecd.2020.05.020] [Cited by in Crossref: 120] [Cited by in F6Publishing: 106] [Article Influence: 60.0] [Reference Citation Analysis]
52 Romeo FJ, Barbagelata L, Chiabrando JG, Damonte JI, Moras E, Aguilar-Gallardo JS, Lorente-Ros M, Lobo LM, Masson W. The Effect of Colchicine on Mortality, Mechanical Ventilation, and Length of Stay in Patients With COVID-19 Infection: An Updated Systematic Review and Meta-analysis of Randomized Clinical Trials. Am J Ther 2022. [PMID: 35446263 DOI: 10.1097/MJT.0000000000001511] [Reference Citation Analysis]
53 Auld S, Caridi-Scheible M, Blum JM, Robichaux CJ, Kraft CS, Jacob JT, Jabaley CS, Carpenter D, Kaplow R, Hernandez AC, Adelman MW, Martin GS, Coopersmith CM, Murphy DJ. ICU and ventilator mortality among critically ill adults with COVID-19. medRxiv 2020:2020. [PMID: 32511599 DOI: 10.1101/2020.04.23.20076737] [Cited by in Crossref: 20] [Cited by in F6Publishing: 1] [Article Influence: 10.0] [Reference Citation Analysis]
54 González FJ, Miranda FA, Chávez SM, Gajardo AI, Hernández AR, Guiñez DV, Díaz GA, Sarmiento NV, Ihl FE, Cerda MA, Valencia CS, Cornejo RA. Clinical characteristics and in-hospital mortality of patients with COVID-19 in Chile: A prospective cohort study. Int J Clin Pract 2021;:e14919. [PMID: 34564929 DOI: 10.1111/ijcp.14919] [Reference Citation Analysis]
55 Raad M, Gorgis S, Abshire C, Yost M, Dabbagh MF, Chehab O, Aurora L, Patel S, Nona P, Yan J, Singh G, Syrjamaki J, Kaatz S, Parikh S. COVID-19 risk index (CRI): a simple and validated emergency department risk score that predicts mortality and the need for mechanical ventilation. J Thromb Thrombolysis 2021. [PMID: 34554359 DOI: 10.1007/s11239-021-02565-6] [Reference Citation Analysis]
56 Stilhano RS, Costa AJ, Nishino MS, Shams S, Bartolomeo CS, Breithaupt-Faloppa AC, Silva EA, Ramirez AL, Prado CM, Ureshino RP. SARS-CoV-2 and the possible connection to ERs, ACE2, and RAGE: Focus on susceptibility factors. FASEB J 2020;34:14103-19. [PMID: 32965736 DOI: 10.1096/fj.202001394RR] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
57 Rathi H, Burman V, Datta SK, Rana SV, Mirza AA, Saha S, Kumar R, Naithani M. Review on COVID-19 Etiopathogenesis, Clinical Presentation and Treatment Available with Emphasis on ACE2.Indian J Clin Biochem. 2021;1-20. [PMID: 33424145 DOI: 10.1007/s12291-020-00953-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
58 Cadegiani FA. Repurposing existing drugs for COVID-19: an endocrinology perspective. BMC Endocr Disord 2020;20:149. [PMID: 32993622 DOI: 10.1186/s12902-020-00626-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 10.0] [Reference Citation Analysis]
59 Du P, Li D, Wang A, Shen S, Ma Z, Li X. A Systematic Review and Meta-Analysis of Risk Factors Associated with Severity and Death in COVID-19 Patients. Can J Infect Dis Med Microbiol 2021;2021:6660930. [PMID: 33936349 DOI: 10.1155/2021/6660930] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
60 Cabañes-Martínez L, Villadóniga M, González-Rodríguez L, Araque L, Díaz-Cid A, Ruz-Caracuel I, Pian H, Sánchez-Alonso S, Fanjul S, Del Álamo M, Regidor I. Neuromuscular involvement in COVID-19 critically ill patients. Clin Neurophysiol 2020;131:2809-16. [PMID: 33137571 DOI: 10.1016/j.clinph.2020.09.017] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 10.0] [Reference Citation Analysis]
61 Li H, Wu Q, Qin Z, Hou X, Zhang L, Guo J, Li Y, Yang F, Zhang Y, Wu Q, Li L, Chen H. Serum levels of laminin and von Willebrand factor in COVID-19 survivors 6 months after discharge. Int J Infect Dis 2022;115:134-41. [PMID: 34843955 DOI: 10.1016/j.ijid.2021.11.032] [Reference Citation Analysis]
62 Chang C, Mcaleer M, Wong W. Risk and Financial Management of COVID-19 in Business, Economics and Finance. JRFM 2020;13:102. [DOI: 10.3390/jrfm13050102] [Cited by in Crossref: 25] [Cited by in F6Publishing: 8] [Article Influence: 12.5] [Reference Citation Analysis]
63 Keresztesi AA, Perde F, Ghita-Nanu A, Radu CC, Negrea M, Keresztesi G. Post-Mortem Diagnosis and Autopsy Findings in SARS-CoV-2 Infection: Forensic Case Series. Diagnostics (Basel) 2020;10:E1070. [PMID: 33321983 DOI: 10.3390/diagnostics10121070] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
64 Qiu C, Li T, Wei G, Xu J, Yu W, Wu Z, Li D, He Y, Chen T, Zhang J, He X, Hu J, Fang J, Zhang H. Hemorrhage and venous thromboembolism in critically ill patients with COVID-19. SAGE Open Med 2021;9:20503121211020167. [PMID: 34104439 DOI: 10.1177/20503121211020167] [Reference Citation Analysis]
65 Kim EJ, Marrast L, Conigliaro J. COVID-19: Magnifying the Effect of Health Disparities. J Gen Intern Med 2020;35:2441-2. [PMID: 32394141 DOI: 10.1007/s11606-020-05881-4] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 11.5] [Reference Citation Analysis]
66 Yang H, Xu Y, Li Z, Yan L, Wang J, Liao P. The Clinical Implication of Dynamic Hematological Parameters in COVID-19: A Retrospective Study in Chongqing, China. Int J Gen Med 2021;14:4073-80. [PMID: 34354369 DOI: 10.2147/IJGM.S321292] [Reference Citation Analysis]
67 Tsuchida T, Hayakawa M, Kawahara S, Kumano O. Thrombin generation capacity is enhanced by low antithrombin activity and depends on the activity of the related coagulation factors. Thromb J 2022;20:29. [PMID: 35585586 DOI: 10.1186/s12959-022-00388-w] [Reference Citation Analysis]
68 Eibensteiner F, Ritschl V, Ariceta G, Jankauskiene A, Klaus G, Paglialonga F, Edefonti A, Ranchin B, Schmitt CP, Shroff R, Stefanidis CJ, Walle JV, Verrina E, Vondrak K, Zurowska A, Stamm T, Aufricht C;  European Pediatric Dialysis Working Group. Rapid response in the COVID-19 pandemic: a Delphi study from the European Pediatric Dialysis Working Group. Pediatr Nephrol. 2020;35:1669-1678. [PMID: 32418146 DOI: 10.1007/s00467-020-04584-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 5.5] [Reference Citation Analysis]
69 Riveiro-Barciela M, Labrador-Horrillo M, Camps-Relats L, González-Sans D, Ventura-Cots M, Terrones-Peinador M, Nuñez-Conde A, Martínez-Gallo M, Hernández M, Antón A, González A, Pujol-Borrell R, Martínez-Valle F. Simple predictive models identify patients with COVID-19 pneumonia and poor prognosis. PLoS One 2020;15:e0244627. [PMID: 33370397 DOI: 10.1371/journal.pone.0244627] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
70 Albani F, Sepe L, Fusina F, Prezioso C, Baronio M, Caminiti F, Di Maio A, Faggian B, Franceschetti ME, Massari M, Salvaggio M, Natalini G. Thromboprophylaxis with enoxaparin is associated with a lower death rate in patients hospitalized with SARS-CoV-2 infection. A cohort study. EClinicalMedicine 2020;27:100562. [PMID: 33043287 DOI: 10.1016/j.eclinm.2020.100562] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
71 Fakhri S, Nouri Z, Moradi SZ, Farzaei MH. Astaxanthin, COVID-19 and immune response: Focus on oxidative stress, apoptosis and autophagy. Phytother Res 2020;34:2790-2. [PMID: 32754955 DOI: 10.1002/ptr.6797] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 8.5] [Reference Citation Analysis]
72 Del Turco S, Vianello A, Ragusa R, Caselli C, Basta G. COVID-19 and cardiovascular consequences: Is the endothelial dysfunction the hardest challenge? Thromb Res 2020;196:143-51. [PMID: 32871306 DOI: 10.1016/j.thromres.2020.08.039] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 14.0] [Reference Citation Analysis]
73 Bompard F, Monnier H, Saab I, Tordjman M, Abdoul H, Fournier L, Sanchez O, Lorut C, Chassagnon G, Revel MP. Pulmonary embolism in patients with COVID-19 pneumonia. Eur Respir J. 2020;56. [PMID: 32398297 DOI: 10.1183/13993003.01365-2020] [Cited by in Crossref: 144] [Cited by in F6Publishing: 137] [Article Influence: 72.0] [Reference Citation Analysis]
74 Ozkaya E, Taskent I, Somay R, Ocal G, Heybeli C. Acute ischemic events after COVID-19 infection in patients undergoing maintenance hemodialysis. Hemodial Int 2021. [PMID: 34962048 DOI: 10.1111/hdi.12998] [Reference Citation Analysis]
75 Asti E, Lovece A, Bonavina L. Gangrenous cholecystitis during hospitalization for SARS-CoV2 infection. Updates Surg 2020;72:917-9. [PMID: 32458339 DOI: 10.1007/s13304-020-00814-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
76 Baldi E, Primi R, Bendotti S, Currao A, Compagnoni S, Gentile FR, Sechi GM, Mare C, Palo A, Contri E, Ronchi V, Bergamini G, Reali F, Parogni P, Facchin F, Rizzi U, Bussi D, Ruggeri S, Campi S, Centineo P, De Ponti R, Oltrona Visconti L, Savastano S; all the Lombardia CARe researchers. Relationship between out-of-hospital cardiac arrests and COVID-19 during the first and second pandemic wave. The importance of monitoring COVID-19 incidence. PLoS One 2021;16:e0260275. [PMID: 34797840 DOI: 10.1371/journal.pone.0260275] [Reference Citation Analysis]
77 Mei ZW, van Wijk XMR, Pham HP, Marin MJ. Role of von Willebrand Factor in COVID-19 Associated Coagulopathy. J Appl Lab Med 2021:jfab042. [PMID: 33930144 DOI: 10.1093/jalm/jfab042] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
78 Romano CM, Chebabo A, Levi JE. Past, present, and future of COVID-19: a review. Braz J Med Biol Res 2020;53:e10475. [PMID: 32725080 DOI: 10.1590/1414-431x202010475] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
79 Li Z, Wang L, Huang LS, Zhang M, Cai X, Xu F, Wu F, Li H, Huang W, Zhou Q, Yao J, Liang Y, Liu G. Efficient management strategy of COVID-19 patients based on cluster analysis and clinical decision tree classification. Sci Rep 2021;11:9626. [PMID: 33953307 DOI: 10.1038/s41598-021-89187-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
80 Tisminetzky M, Delude C, Hebert T, Carr C, Goldberg RJ, Gurwitz JH. Age, Multiple Chronic Conditions, and COVID-19: A literature review. J Gerontol A Biol Sci Med Sci 2020:glaa320. [PMID: 33367606 DOI: 10.1093/gerona/glaa320] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
81 Davarpanah AH, Asgari R, Moharamzad Y, Mahdavi A, Abrishami A, Nekooghadam S, Sabri A, Zarei E, Khazaei M, Sanei Taheri M. Risk Factors for Poor Outcome in Patients with Severe Viral Pneumonia on Chest CT during the COVID-19 Outbreak: a Perspective from Iran. SN Compr Clin Med 2020;:1-11. [PMID: 32838199 DOI: 10.1007/s42399-020-00445-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
82 Lasbleiz A, Cariou B, Darmon P, Soghomonian A, Ancel P, Boullu S, Houssays M, Romain F, Lagier JC, Boucekine M, Resseguier N, Gourdy P, Pichelin M, Wargny M, Dutour A, Gaborit B. Phenotypic Characteristics and Development of a Hospitalization Prediction Risk Score for Outpatients with Diabetes and COVID-19: The DIABCOVID Study. J Clin Med 2020;9:E3726. [PMID: 33233575 DOI: 10.3390/jcm9113726] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
83 Quinn KL, Fralick M, Zipursky JS, Stall NM. Renin-angiotensin-aldosterone system inhibitors and COVID-19. CMAJ 2020;192:E553-4. [PMID: 32332039 DOI: 10.1503/cmaj.200619] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
84 DeGrado JR, Szumita PM, Schuler BR, Dube KM, Lenox J, Kim EY, Weinhouse GL, Massaro AF. Evaluation of the Efficacy and Safety of Inhaled Epoprostenol and Inhaled Nitric Oxide for Refractory Hypoxemia in Patients With Coronavirus Disease 2019. Crit Care Explor 2020;2:e0259. [PMID: 33134949 DOI: 10.1097/CCE.0000000000000259] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
85 Carretta DM, Silva AM, D'Agostino D, Topi S, Lovero R, Charitos IA, Wegierska AE, Montagnani M, Santacroce L. Cardiac Involvement in COVID-19 Patients: A Contemporary Review. Infect Dis Rep 2021;13:494-517. [PMID: 34206074 DOI: 10.3390/idr13020048] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
86 Stancioiu F, Papadakis GZ, Kteniadakis S, Izotov BN, Coleman MD, Spandidos DA, Tsatsakis A. A dissection of SARS‑CoV2 with clinical implications (Review). Int J Mol Med 2020;46:489-508. [PMID: 32626922 DOI: 10.3892/ijmm.2020.4636] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
87 Batty GD, Deary IJ, Gale CR. Pre-pandemic cognitive function and COVID-19 mortality: prospective cohort study. medRxiv 2021:2021. [PMID: 33564786 DOI: 10.1101/2021.02.07.21251082] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
88 Hashash JG, Jabak S, Francis FF, Regueiro M. Should We Be Screening for SARS-CoV-2 in IBD Patients Before Initiation of Biologic Therapy? Inflamm Bowel Dis. 2021;27:291-294. [PMID: 32619000 DOI: 10.1093/ibd/izaa173] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
89 Martínez-Rubio A, Ascoeta S, Taibi F, Soldevila JG. Coronavirus Disease 2019 and Cardiac Arrhythmias. Eur Cardiol 2020;15:e66. [PMID: 33294034 DOI: 10.15420/ecr.2020.23] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
90 Stojanov A, Malobabic M, Milosevic V, Stojanov J, Vojinovic S, Stanojevic G, Stevic M. Psychological status of patients with relapsing-remitting multiple sclerosis during coronavirus disease-2019 outbreak. Mult Scler Relat Disord 2020;45:102407. [PMID: 32702641 DOI: 10.1016/j.msard.2020.102407] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 12.0] [Reference Citation Analysis]
91 Yousefifard M, Mohamed Ali K, Aghaei A, Zali A, Madani Neishaboori A, Zarghi A, Safari S, Hashemi B, Forouzanfar MM, Hosseini M. Corticosteroids on the Management of Coronavirus Disease 2019 (COVID-19): A Systemic Review and Meta-Analysis. Iran J Public Health 2020;49:1411-21. [PMID: 33083317 DOI: 10.18502/ijph.v49i8.3863] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
92 Kirwan R, McCullough D, Butler T, Perez de Heredia F, Davies IG, Stewart C. Sarcopenia during COVID-19 lockdown restrictions: long-term health effects of short-term muscle loss. Geroscience 2020;42:1547-78. [PMID: 33001410 DOI: 10.1007/s11357-020-00272-3] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 15.5] [Reference Citation Analysis]
93 Fukushima T, Kabata H, Yamamoto R, Suhara T, Uwamino Y, Kondo Y, Masaki K, Kamata H, Nagata H, Homma K, Kaneko Y, Ishii M, Sasaki J, Morisaki H, Hasegawa N, Fukunaga K; Keio Donner Project Team. The real-time reverse transcription-polymerase chain reaction threshold cycle values for severe acute respiratory syndrome coronavirus 2 predict the prognosis of coronavirus disease 2019 pneumonia. Respir Investig 2021;59:360-3. [PMID: 33582075 DOI: 10.1016/j.resinv.2020.12.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
94 Lai Q, Spoletini G, Bianco G, Graceffa D, Agnes S, Rossi M, Lerut J. SARS-CoV2 and immunosuppression: A double-edged sword. Transpl Infect Dis 2020;22:e13404. [PMID: 32639598 DOI: 10.1111/tid.13404] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
95 Putman M, Chock YPE, Tam H, Kim AHJ, Sattui SE, Berenbaum F, Danila MI, Korsten P, Sanchez-Alvarez C, Sparks JA, Coates LC, Palmerlee C, Peirce A, Jayatilleke A, Johnson SR, Kilian A, Liew J, Prokop LJ, Murad MH, Grainger R, Wallace ZS, Duarte-García A; COVID-19 Global Rheumatology Alliance. Antirheumatic Disease Therapies for the Treatment of COVID-19: A Systematic Review and Meta-Analysis. Arthritis Rheumatol 2021;73:36-47. [PMID: 32741139 DOI: 10.1002/art.41469] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 12.0] [Reference Citation Analysis]
96 Cheng Y, Luo R, Wang X, Wang K, Zhang N, Zhang M, Wang Z, Dong L, Li J, Zeng R, Yao Y, Ge S, Xu G. The Incidence, Risk Factors, and Prognosis of Acute Kidney Injury in Adult Patients with Coronavirus Disease 2019. Clin J Am Soc Nephrol 2020;15:1394-402. [PMID: 32963018 DOI: 10.2215/CJN.04650420] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 12.5] [Reference Citation Analysis]
97 Baldi E, Sechi GM, Mare C, Canevari F, Brancaglione A, Primi R, Klersy C, Palo A, Contri E, Ronchi V, Beretta G, Reali F, Parogni P, Facchin F, Rizzi U, Bussi D, Ruggeri S, Oltrona Visconti L, Savastano S; Lombardia CARe researchers. COVID-19 kills at home: the close relationship between the epidemic and the increase of out-of-hospital cardiac arrests. Eur Heart J 2020;41:3045-54. [PMID: 32562486 DOI: 10.1093/eurheartj/ehaa508] [Cited by in Crossref: 87] [Cited by in F6Publishing: 70] [Article Influence: 43.5] [Reference Citation Analysis]
98 Khalid A, Ali Jaffar M, Khan T, Abbas Lail R, Ali S, Aktas G, Waris A, Javaid A, Ijaz N, Muhammad N. Hematological and biochemical parameters as diagnostic and prognostic markers in SARS-COV-2 infected patients of Pakistan: a retrospective comparative analysis. Hematology 2021;26:529-42. [PMID: 34334100 DOI: 10.1080/16078454.2021.1950898] [Reference Citation Analysis]
99 Viana-Llamas MC, Arroyo-Espliguero R, Silva-Obregón JA, Uribe-Heredia G, Núñez-Gil I, García-Magallón B, Torán-Martínez CG, Castillo-Sandoval A, Díaz-Caraballo E, Rodríguez-Guinea I, Domínguez-López J. Hypoalbuminemia on admission in COVID-19 infection: An early predictor of mortality and adverse events. A retrospective observational study. Med Clin (Engl Ed) 2021;156:428-36. [PMID: 33969222 DOI: 10.1016/j.medcle.2020.12.015] [Reference Citation Analysis]
100 Miyake S, Higurashi T, Jono T, Akimoto T, Ogawa F, Oi Y, Tanaka K, Hara Y, Kobayashi N, Kato H, Yamashiro T, Utsunomiya D, Nakajima A, Yamamoto T, Maeda S, Kaneko T, Takeuchi I. Real-world evaluation of a computed tomography-first triage strategy for suspected Coronavirus disease 2019 in outpatients in Japan: An observational cohort study. Medicine (Baltimore) 2021;100:e26161. [PMID: 34087874 DOI: 10.1097/MD.0000000000026161] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
101 Webb BJ, Peltan ID, Jensen P, Hoda D, Hunter B, Silver A, Starr N, Buckel W, Grisel N, Hummel E, Snow G, Morris D, Stenehjem E, Srivastava R, Brown SM. Clinical criteria for COVID-19-associated hyperinflammatory syndrome: a cohort study. Lancet Rheumatol 2020;2:e754-63. [PMID: 33015645 DOI: 10.1016/S2665-9913(20)30343-X] [Cited by in Crossref: 83] [Cited by in F6Publishing: 48] [Article Influence: 41.5] [Reference Citation Analysis]
102 Correale P, Caracciolo M, Bilotta F, Conte M, Cuzzola M, Falcone C, Mangano C, Falzea AC, Iuliano E, Morabito A, Foti G, Armentano A, Caraglia M, De Lorenzo A, Sitkovsky M, Macheda S. Therapeutic effects of adenosine in high flow 21% oxygen aereosol in patients with Covid19-pneumonia. PLoS One 2020;15:e0239692. [PMID: 33031409 DOI: 10.1371/journal.pone.0239692] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
103 Dayaramani C, De Leon J, Reiss AB. Cardiovascular Disease Complicating COVID-19 in the Elderly. Medicina (Kaunas) 2021;57:833. [PMID: 34441038 DOI: 10.3390/medicina57080833] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
104 Zhang X, Yang X, Jiao H, Liu X. Coagulopathy in patients with COVID-19: a systematic review and meta-analysis. Aging (Albany NY) 2020;12:24535-51. [PMID: 33229625 DOI: 10.18632/aging.104138] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
105 Vogel F, Reincke M. Endocrine risk factors for COVID-19: Endogenous and exogenous glucocorticoid excess. Rev Endocr Metab Disord 2021. [PMID: 34241765 DOI: 10.1007/s11154-021-09670-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
106 Fouladseresht H, Ghamar Talepoor A, Eskandari N, Norouzian M, Ghezelbash B, Beyranvand MR, Nejadghaderi SA, Carson-chahhoud K, Kolahi A, Safiri S. Potential Immune Indicators for Predicting the Prognosis of COVID-19 and Trauma: Similarities and Disparities. Front Immunol 2022;12:785946. [DOI: 10.3389/fimmu.2021.785946] [Reference Citation Analysis]
107 Zuazua-Gonzalez A, Collazo-Lorduy T, Coello-Casariego G, Collazo-Lorduy A, Leon-Soriano E, Torralba-Moron A, Onrubia-Parra T, Gomez-Martin-Zarco JM, Echarri-SanMartin R, Ripolles-Melchor J, Martinez-De-la-Gandara A, Domingo-Carrasco C. Surgical Tracheostomies in COVID-19 Patients: Indications, Technique, and Results in a Second-Level Spanish Hospital. OTO Open 2020;4:2473974X20957636. [PMID: 32974425 DOI: 10.1177/2473974X20957636] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
108 Damiati LA, Bahlas S, Aljohaney A, Bawazir Y, Mustafa M, Denetiu I, Pushparaj PN. Implications of SARS-CoV-2 infection on the clinical, hematological, and inflammatory parameters in COVID-19 patients: A retrospective cross-sectional study. J Infect Public Health 2022;15:214-21. [PMID: 35007842 DOI: 10.1016/j.jiph.2021.12.013] [Reference Citation Analysis]
109 Ahmed A, Alderazi SA, Aslam R, Barkat B, Barker BL, Bhat R, Cassidy S, Crowley LE, Dosanjh DP, Ebrahim H, Elndari N, Gardiner C, Gogokhia A, Grudzinska FS, Gurung MT, Hughes T, Ismail I, Iredale N, Irshad S, Johnson S, Kavanagh D, Knight T, Livesey A, Lugg ST, Marathe M, Mcdougall A, Nawaz W, Nettleton K, O’flynn L, Okoth K, Parekh D, Perry R, Pudney EJ, Sadiq A, Soge O, Soloman R, Soltan M, Strecker M, Thein OS, Thickett D, Thomas A, Thornton R. Utility of severity assessment tools in COVID-19 pneumonia: a multicentre observational study. Clin Med 2022;22:63-70. [DOI: 10.7861/clinmed.2020-1107] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
110 Coyle J, Igbinomwanhia E, Sanchez-Nadales A, Danciu S, Chu C, Shah N. A Recovered Case of COVID-19 Myocarditis and ARDS Treated With Corticosteroids, Tocilizumab, and Experimental AT-001. JACC Case Rep 2020;2:1331-6. [PMID: 32368755 DOI: 10.1016/j.jaccas.2020.04.025] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 20.0] [Reference Citation Analysis]
111 Hazbun ME, Faust AC, Ortegon AL, Sheperd LA, Weinstein GL, Doebele RL, Weinmeister KD, Liddell AM, Feldman M. The Combination of Tocilizumab and Methylprednisolone Along With Initial Lung Recruitment Strategy in Coronavirus Disease 2019 Patients Requiring Mechanical Ventilation: A Series of 21 Consecutive Cases. Crit Care Explor 2020;2:e0145. [PMID: 32696008 DOI: 10.1097/CCE.0000000000000145] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
112 Albani F, Fusina F, Granato E, Capotosto C, Ceracchi C, Gargaruti R, Santangelo G, Schiavone L, Taranto MS, Tosati C, Vavassori E, Natalini G. Corticosteroid treatment has no effect on hospital mortality in COVID-19 patients. Sci Rep 2021;11:1015. [PMID: 33441909 DOI: 10.1038/s41598-020-80654-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
113 Alam S, Bhuiyan FR, Emon TH, Hasan M. Prospects of nutritional interventions in the care of COVID-19 patients. Heliyon 2021;7:e06285. [PMID: 33615017 DOI: 10.1016/j.heliyon.2021.e06285] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
114 Manivannan M, Jogalekar MP, Kavitha MS, Maran BAV, Gangadaran P. A mini-review on the effects of COVID-19 on younger individuals. Exp Biol Med (Maywood) 2021;246:293-7. [PMID: 33210552 DOI: 10.1177/1535370220975118] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
115 Boyarsky BJ, Massie AB, Love AD, Werbel WA, Durand CM, Avery RK, Jackson KR, Kernodle AB, Thomas AG, Ronin M, Altrich M, Niles P, Trahan C, Hewlett J, Segev DL, Garonzik-Wang JM. Early Experiences With COVID-19 Testing in Transplantation. Transplant Direct 2020;6:e572. [PMID: 32766427 DOI: 10.1097/TXD.0000000000001024] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
116 Cultrera R, Barozzi A, Libanore M, Marangoni E, Pora R, Quarta B, Spadaro S, Ragazzi R, Marra A, Segala D, Volta CA. Co-Infections in Critically Ill Patients with or without COVID-19: A Comparison of Clinical Microbial Culture Findings. Int J Environ Res Public Health 2021;18:4358. [PMID: 33923992 DOI: 10.3390/ijerph18084358] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
117 Rodríguez-Molinero A, Pérez-López C, Gálvez-Barrón C, Miñarro A, Rodríguez Gullello EA, Collado Pérez I, Milà Ràfols N, Mónaco EE, Hidalgo García A, Añaños Carrasco G, Chamero Pastilla A; en representación del grupo de investigadores para la COVID-19 del Consorci Sanitari de l’Alt Penedès i Garraf (CSAPG). [Association between high-dose steroid therapy, respiratory function, and time to discharge in patients with COVID-19: Cohort study]. Med Clin (Barc) 2021;156:7-12. [PMID: 33129511 DOI: 10.1016/j.medcli.2020.08.003] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
118 Wang H, Saha AK, Sun X, Kon ND, Ferrario CM, Groban L. Atrial appendage angiotensin-converting enzyme-2, aging and cardiac surgical patients: a platform for understanding aging-related coronavirus disease-2019 vulnerabilities. Curr Opin Anaesthesiol 2021;34:187-98. [PMID: 33606395 DOI: 10.1097/ACO.0000000000000965] [Reference Citation Analysis]
119 Trejo-Gabriel-Galán JM. Stroke as a complication and prognostic factor of COVID-19. Neurologia (Engl Ed) 2020;35:318-22. [PMID: 32493597 DOI: 10.1016/j.nrl.2020.04.015] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 9.0] [Reference Citation Analysis]
120 Curtis JR, Kross EK, Stapleton RD. The Importance of Addressing Advance Care Planning and Decisions About Do-Not-Resuscitate Orders During Novel Coronavirus 2019 (COVID-19). JAMA 2020;323:1771-2. [PMID: 32219360 DOI: 10.1001/jama.2020.4894] [Cited by in Crossref: 105] [Cited by in F6Publishing: 141] [Article Influence: 52.5] [Reference Citation Analysis]
121 Yang SC, Tsai YF, Pan YL, Hwang TL. Understanding the role of neutrophils in acute respiratory distress syndrome. Biomed J 2020:S2319-4170(20)30149-9. [PMID: 33087299 DOI: 10.1016/j.bj.2020.09.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
122 Mitsumura T, Okamoto T, Shirai T, Iijima Y, Sakakibara R, Honda T, Ishizuka M, Aiboshi J, Tateishi T, Tamaoka M, Shigemitsu H, Arai H, Otomo Y, Tohda S, Anzai T, Takahashi K, Yasuda S, Miyazaki Y. Predictors associated with clinical improvement of SARS-CoV-2 pneumonia. J Infect Chemother 2021;27:857-63. [PMID: 33676842 DOI: 10.1016/j.jiac.2021.02.012] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
123 Alswaidi FM, Assiri AM, Alhaqbani HH, Alalawi MM. Characteristics and outcome of COVID-19 cases in Saudi Arabia: Review of six-months of data (March-August 2020). Saudi Pharm J 2021;29:682-91. [PMID: 34400862 DOI: 10.1016/j.jsps.2021.04.030] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
124 Sandkovsky U, Colley P, Sam T, Modrykamien AM, Berhe M. The dynamic treatment of SARS-CoV-2 disease. Proc (Bayl Univ Med Cent) 2020;33:572-9. [PMID: 33100531 DOI: 10.1080/08998280.2020.1780086] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
125 Fathi M, Vakili K, Sayehmiri F, Mohamadkhani A, Hajiesmaeili M, Rezaei-Tavirani M, Eilami O. The prognostic value of comorbidity for the severity of COVID-19: A systematic review and meta-analysis study. PLoS One 2021;16:e0246190. [PMID: 33592019 DOI: 10.1371/journal.pone.0246190] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
126 Morris DS. Polarization, partisanship, and pandemic: The relationship between county-level support for Donald Trump and the spread of Covid-19 during the spring and summer of 2020. Soc Sci Q 2021;102:2412-31. [PMID: 34908615 DOI: 10.1111/ssqu.13053] [Reference Citation Analysis]
127 Kassam N, Aghan E, Aziz O, Mbithe H, Hameed K, Shah R, Surani S, Orwa J, Somji S. Factors Associated with Mortality Among Hospitalized Adults with COVID-19 Pneumonia at a Private Tertiary Hospital in Tanzania: A Retrospective Cohort Study. Int J Gen Med 2021;14:5431-40. [PMID: 34526810 DOI: 10.2147/IJGM.S330580] [Reference Citation Analysis]
128 Tang XD, Ji TT, Dong JR, Feng H, Chen FQ, Chen X, Zhao HY, Chen DK, Ma WT. Pathogenesis and Treatment of Cytokine Storm Induced by Infectious Diseases. Int J Mol Sci 2021;22:13009. [PMID: 34884813 DOI: 10.3390/ijms222313009] [Reference Citation Analysis]
129 Singh V, Upadhyay P, Reddy J, Granger J. SARS-CoV-2 respiratory co-infections: Incidence of viral and bacterial co-pathogens. Int J Infect Dis 2021;105:617-20. [PMID: 33640570 DOI: 10.1016/j.ijid.2021.02.087] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
130 Fernandez-Montero JV, Soriano V, Barreiro P, de Mendoza C, Artacho MÁ. Coronavirus and other airborne agents with pandemic potential. Curr Opin Environ Sci Health 2020;17:41-8. [PMID: 32995685 DOI: 10.1016/j.coesh.2020.09.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
131 Johnson RM, Vinetz JM. Dexamethasone in the management of covid -19. BMJ. [DOI: 10.1136/bmj.m2648] [Cited by in Crossref: 84] [Cited by in F6Publishing: 83] [Article Influence: 42.0] [Reference Citation Analysis]
132 Vagapova ER, Lebedev TD, Prassolov VS. Viral fibrotic scoring and drug screen based on MAPK activity uncovers EGFR as a key regulator of COVID-19 fibrosis. Sci Rep 2021;11:11234. [PMID: 34045585 DOI: 10.1038/s41598-021-90701-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
133 Merzon E, Green I, Shpigelman M, Vinker S, Raz I, Golan-Cohen A, Eldor R. Haemoglobin A1c is a predictor of COVID-19 severity in patients with diabetes. Diabetes Metab Res Rev 2021;37:e3398. [PMID: 32852883 DOI: 10.1002/dmrr.3398] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
134 Bustos P, Tambley C, Acevedo A, Andrade W, Leal G, Vidal D, Roldán F, Fasce R, Ramírez E. Quantitative detection of SARS-CoV-2 RNA in nasopharyngeal samples from infected patients with mild disease. J Med Virol 2021;93:2439-45. [PMID: 33368332 DOI: 10.1002/jmv.26761] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
135 Rebelos E, Moriconi D, Virdis A, Taddei S, Foschi D, Nannipieri M. Letter to the Editor: Importance of metabolic health in the era of COVID-19. Metabolism 2020;108:154247. [PMID: 32333939 DOI: 10.1016/j.metabol.2020.154247] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 8.5] [Reference Citation Analysis]
136 Uranga A, Villanueva A, Lafuente I, González N, Legarreta MJ, Aguirre U, Pablo España P, Quintana JM, García-Gutiérrez S; el grupo de trabajo COVID-19-Osakidetza. [Risk factors for clinical deterioration in patients admitted for COVID-19: a case-control study]. Rev Clin Esp 2021. [PMID: 34054133 DOI: 10.1016/j.rce.2021.04.007] [Reference Citation Analysis]
137 Elamari S, Motaib I, Zbiri S, Elaidaoui K, Chadli A, Elkettani C. Characteristics and outcomes of diabetic patients infected by the SARS-CoV-2. Pan Afr Med J 2020;37:32. [PMID: 33209159 DOI: 10.11604/pamj.2020.37.32.25192] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
138 Ebinger JE, Lan R, Sun N, Wu M, Joung S, Botwin GJ, Botting P, Al-Amili D, Aronow H, Beekley J, Coleman B, Contreras S, Cozen W, Davis J, Debbas P, Diaz J, Driver M, Fert-Bober J, Gu Q, Heath M, Herrera E, Hoang A, Hussain SK, Huynh C, Kim L, Kittleson M, Liu Y, Lloyd J, Luong E, Malladi B, Merchant A, Merin N, Mujukian A, Nguyen N, Nguyen TT, Pozdnyakova V, Rashid M, Raedschelders K, Reckamp KL, Rhoades K, Sternbach S, Vallejo R, White S, Tompkins R, Wong M, Arditi M, Figueiredo JC, Van Eyk JE, Miles PB, Chavira C, Shane R, Sobhani K, Melmed GY, McGovern DPB, Braun JG, Cheng S, Minissian MB. Symptomology following mRNA vaccination against SARS-CoV-2. Prev Med 2021;153:106860. [PMID: 34687733 DOI: 10.1016/j.ypmed.2021.106860] [Reference Citation Analysis]
139 Reina G, Iglesias D, Samorì P, Bianco A. Graphene: A Disruptive Opportunity for COVID-19 and Future Pandemics? Adv Mater 2021;33:e2007847. [PMID: 33538037 DOI: 10.1002/adma.202007847] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 15.0] [Reference Citation Analysis]
140 Ripon RK, Mim SS, Puente AE, Hossain S, Babor MMH, Sohan SA, Islam N. COVID-19: psychological effects on a COVID-19 quarantined population in Bangladesh. Heliyon 2020;6:e05481. [PMID: 33200105 DOI: 10.1016/j.heliyon.2020.e05481] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
141 Cheng P, Zhu H, Witteles RM, Wu JC, Quertermous T, Wu SM, Rhee JW. Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty. Curr Cardiol Rep 2020;22:34. [PMID: 32350632 DOI: 10.1007/s11886-020-01293-2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 12.5] [Reference Citation Analysis]
142 Khan MS, Shahid I, Anker SD, Solomon SD, Vardeny O, Michos ED, Fonarow GC, Butler J. Cardiovascular implications of COVID-19 versus influenza infection: a review. BMC Med 2020;18:403. [PMID: 33334360 DOI: 10.1186/s12916-020-01816-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
143 Ting M, Suzuki JB. SARS-CoV-2: Overview and Its Impact on Oral Health. Biomedicines 2021;9:1690. [PMID: 34829919 DOI: 10.3390/biomedicines9111690] [Reference Citation Analysis]
144 Chen F, Hao L, Zhu S, Yang X, Shi W, Zheng K, Wang T, Chen H. Potential Adverse Effects of Dexamethasone Therapy on COVID-19 Patients: Review and Recommendations. Infect Dis Ther 2021. [PMID: 34296386 DOI: 10.1007/s40121-021-00500-z] [Reference Citation Analysis]
145 Sañudo B, Seixas A, Gloeckl R, Rittweger J, Rawer R, Taiar R, van der Zee EA, van Heuvelen MJG, Lacerda AC, Sartorio A, Bemben M, Cochrane D, Furness T, de Sá-Caputo D, Bernardo-Filho M. Potential Application of Whole Body Vibration Exercise For Improving The Clinical Conditions of COVID-19 Infected Individuals: A Narrative Review From the World Association of Vibration Exercise Experts (WAVex) Panel. Int J Environ Res Public Health 2020;17:E3650. [PMID: 32455961 DOI: 10.3390/ijerph17103650] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
146 Bonam SR, Kaveri SV, Sakuntabhai A, Gilardin L, Bayry J. Adjunct Immunotherapies for the Management of Severely Ill COVID-19 Patients. Cell Rep Med. 2020;1:100016. [PMID: 32562483 DOI: 10.1016/j.xcrm.2020.100016] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 27.0] [Reference Citation Analysis]
147 Hensley MK, Prescott HC. Caring for the Critically Ill Patient with COVID-19. Clinics in Chest Medicine 2022. [DOI: 10.1016/j.ccm.2022.04.006] [Reference Citation Analysis]
148 Rudin RS, Perez S, Rodriguez JA, Sousa J, Plombon S, Arcia A, Foer D, Bates DW, Dalal AK. User-centered design of a scalable, electronic health record-integrated remote symptom monitoring intervention for patients with asthma and providers in primary care. J Am Med Inform Assoc 2021;28:2433-44. [PMID: 34406413 DOI: 10.1093/jamia/ocab157] [Reference Citation Analysis]
149 Henry BM, Lippi G. Poor survival with extracorporeal membrane oxygenation in acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19): Pooled analysis of early reports. J Crit Care 2020;58:27-8. [PMID: 32279018 DOI: 10.1016/j.jcrc.2020.03.011] [Cited by in Crossref: 90] [Cited by in F6Publishing: 82] [Article Influence: 45.0] [Reference Citation Analysis]
150 Brown R, McKelvey MC, Ryan S, Creane S, Linden D, Kidney JC, McAuley DF, Taggart CC, Weldon S. The Impact of Aging in Acute Respiratory Distress Syndrome: A Clinical and Mechanistic Overview.Front Med (Lausanne). 2020;7:589553. [PMID: 33195353 DOI: 10.3389/fmed.2020.589553] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
151 Aisyah DN, Mayadewi CA, Igusti G, Manikam L, Adisasmito W, Kozlakidis Z. Laboratory Readiness and Response for SARS-Cov-2 in Indonesia. Front Public Health 2021;9:705031. [PMID: 34350153 DOI: 10.3389/fpubh.2021.705031] [Reference Citation Analysis]
152 Kim H, Hong H, Yoon SH. Diagnostic Performance of CT and Reverse Transcriptase Polymerase Chain Reaction for Coronavirus Disease 2019: A Meta-Analysis. Radiology 2020;296:E145-55. [PMID: 32301646 DOI: 10.1148/radiol.2020201343] [Cited by in Crossref: 240] [Cited by in F6Publishing: 226] [Article Influence: 120.0] [Reference Citation Analysis]
153 Bairwa M, Kumar R, Ajmal M, Bahurupi Y, Kant R. Predictors of critical illness and mortality based on symptoms and initial physical examination for patients with SARS-CoV-2: A retrospective cohort study. J Infect Public Health 2021;14:1028-34. [PMID: 34153728 DOI: 10.1016/j.jiph.2021.06.010] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
154 Palanisamy K, Rubavathy SME, Prakash M, Thilagavathi R, Hosseini-zare MS, Selvam C. Antiviral activities of natural compounds and ionic liquids to inhibit the Mpro of SARS-CoV-2: a computational approach. RSC Adv 2022;12:3687-95. [DOI: 10.1039/d1ra08604a] [Reference Citation Analysis]
155 Guan X, Zhang B, Fu M, Li M, Yuan X, Zhu Y, Peng J, Guo H, Lu Y. Clinical and inflammatory features based machine learning model for fatal risk prediction of hospitalized COVID-19 patients: results from a retrospective cohort study. Ann Med 2021;53:257-66. [PMID: 33410720 DOI: 10.1080/07853890.2020.1868564] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 11.0] [Reference Citation Analysis]
156 Lascarrou JB, Gaultier A, Soumagne T, Serck N, Sauneuf B, Piagnerelli M, Ly A, Lejeune F, Lefebvre L, Hraiech S, Horlait G, Higny J, D'hondt A, Gaudry S, Courcelle R, Carbutti G, Blonz G, Ottavy G, Aissaoui N, Vinsonneau C, Vandenbunder B, Textoris J, Szychowiak P, Grimaldi D; COVADIS study group. Identifying Clinical Phenotypes in Moderate to Severe Acute Respiratory Distress Syndrome Related to COVID-19: The COVADIS Study. Front Med (Lausanne) 2021;8:632933. [PMID: 33777977 DOI: 10.3389/fmed.2021.632933] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
157 Violi F, Pastori D, Cangemi R, Pignatelli P, Loffredo L. Hypercoagulation and Antithrombotic Treatment in Coronavirus 2019: A New Challenge. Thromb Haemost 2020;120:949-56. [PMID: 32349133 DOI: 10.1055/s-0040-1710317] [Cited by in Crossref: 105] [Cited by in F6Publishing: 91] [Article Influence: 52.5] [Reference Citation Analysis]
158 Task Force for the management of COVID-19 of the European Society of Cardiology . ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up. Cardiovasc Res 2021:cvab343. [PMID: 34864876 DOI: 10.1093/cvr/cvab343] [Reference Citation Analysis]
159 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
160 Ma S, Lai X, Chen Z, Tu S, Qin K. Clinical characteristics of critically ill patients co-infected with SARS-CoV-2 and the influenza virus in Wuhan, China. Int J Infect Dis 2020;96:683-7. [PMID: 32470606 DOI: 10.1016/j.ijid.2020.05.068] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 17.5] [Reference Citation Analysis]
161 Bellos I, Tavernaraki K, Stefanidis K, Michalopoulou O, Lourida G, Korompoki E, Thanou I, Thanos L, Pefanis A, Argyraki A. Chest CT severity score and radiological patterns as predictors of disease severity, ICU admission, and viral positivity in COVID-19 patients. Respir Investig 2021;59:436-45. [PMID: 33820751 DOI: 10.1016/j.resinv.2021.02.008] [Reference Citation Analysis]
162 Cheung S, Quiwa JC, Pillai A, Onwu C, Tharayil ZJ, Gupta R. Superior Mesenteric Artery Thrombosis and Acute Intestinal Ischemia as a Consequence of COVID-19 Infection. Am J Case Rep 2020;21:e925753. [PMID: 32724028 DOI: 10.12659/AJCR.925753] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 12.0] [Reference Citation Analysis]
163 Cheng L, Li H, Li L, Liu C, Yan S, Chen H, Li Y. Ferritin in the coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis. J Clin Lab Anal 2020;34:e23618. [PMID: 33078400 DOI: 10.1002/jcla.23618] [Cited by in Crossref: 39] [Cited by in F6Publishing: 43] [Article Influence: 19.5] [Reference Citation Analysis]
164 Shanbehzadeh M, Kazemi-Arpanahi H, Mazhab-Jafari K, Haghiri H. Coronavirus disease 2019 (COVID-19) surveillance system: Development of COVID-19 minimum data set and interoperable reporting framework. J Educ Health Promot. 2020;9:203. [PMID: 33062736 DOI: 10.4103/jehp.jehp_456_20] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
165 Perikleous E, Tsalkidis A, Bush A, Paraskakis E. Coronavirus global pandemic: An overview of current findings among pediatric patients. Pediatr Pulmonol 2020;55:3252-67. [PMID: 32965785 DOI: 10.1002/ppul.25087] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
166 Zong Z, Wei Y, Ren J, Zhang L, Zhou F. The intersection of COVID-19 and cancer: signaling pathways and treatment implications. Mol Cancer 2021;20:76. [PMID: 34001144 DOI: 10.1186/s12943-021-01363-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
167 Dessie ZG, Zewotir T. Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients. BMC Infect Dis 2021;21:855. [PMID: 34418980 DOI: 10.1186/s12879-021-06536-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
168 Lewis TC, Adhikari S, Tatapudi V, Holub M, Kunichoff D, Troxel AB, Montgomery RA, Sterman DH. A Propensity-Matched Cohort Study of Tocilizumab in Patients With Coronavirus Disease 2019. Crit Care Explor 2020;2:e0283. [PMID: 33225307 DOI: 10.1097/CCE.0000000000000283] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
169 Brandão SCS, Godoi ETAM, Ramos JOX, de Melo LMMP, Sarinho ESC. Severe COVID-19: understanding the role of immunity, endothelium, and coagulation in clinical practice. J Vasc Bras 2020;19:e20200131. [PMID: 34211530 DOI: 10.1590/1677-5449.200131] [Reference Citation Analysis]
170 Somasekar J, Pavan Kumar Visulaization P, Sharma A, Ramesh G. Machine Learning and Image Analysis Applications in the Fight against COVID-19 Pandemic: Datasets, Research Directions, Challenges and Opportunities. Mater Today Proc 2020. [PMID: 32983909 DOI: 10.1016/j.matpr.2020.09.352] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
171 Batty GD, Gaye B, Gale CR, Hamer M, Lassale C. Explaining ethnic disparities in COVID-19 mortality: population-based, prospective cohort study. medRxiv 2021:2021. [PMID: 33564795 DOI: 10.1101/2021.02.07.21251079] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
172 Pinninti SG, Pati S, Poole C, Latting M, Seleme MC, Yarbrough A, Arora N, Britt WJ, Boppana S. Virological Characteristics of Hospitalized Children With SARS-CoV-2 Infection. Pediatrics 2021;147:e2020037812. [PMID: 33622794 DOI: 10.1542/peds.2020-037812] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
173 Farne H, Kumar K, Ritchie AI, Finney LJ, Johnston SL, Singanayagam A. Repurposing Existing Drugs for the Treatment of COVID-19. Ann Am Thorac Soc 2020;17:1186-94. [PMID: 32692580 DOI: 10.1513/AnnalsATS.202005-566FR] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
174 Gude-Sampedro F, Fernández-Merino C, Ferreiro L, Lado-Baleato Ó, Espasandín-Domínguez J, Hervada X, Cadarso CM, Valdés L. Development and validation of a prognostic model based on comorbidities to predict COVID-19 severity: a population-based study. Int J Epidemiol 2021;50:64-74. [PMID: 33349845 DOI: 10.1093/ije/dyaa209] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
175 Hanchard J, Capó-Vélez CM, Deusch K, Lidington D, Bolz SS. Stabilizing Cellular Barriers: Raising the Shields Against COVID-19. Front Endocrinol (Lausanne) 2020;11:583006. [PMID: 33101215 DOI: 10.3389/fendo.2020.583006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
176 Menichelli D, Di Rocco A, Del Sole F, Pignatelli P, Vestri A, Violi F, Pastori D. Serum albumin, clotting activation and COVID-19 severity: a systematic review and meta-regression analysis of 4579 patients. Ital J Emerg Med 2021;10. [DOI: 10.23736/s2532-1285.21.00078-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
177 Shaw RJ, Bradbury C, Abrams ST, Wang G, Toh CH. COVID-19 and immunothrombosis: emerging understanding and clinical management. Br J Haematol 2021;194:518-29. [PMID: 34114204 DOI: 10.1111/bjh.17664] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
178 Beydoğan E, Yürük Atasoy P. The relationship between CRP at admission and thorax CT findings in patients diagnosed with COVID-19. Int J Clin Pract 2021;:e14962. [PMID: 34624163 DOI: 10.1111/ijcp.14962] [Reference Citation Analysis]
179 Pérez-Belmonte LM, López-Carmona MD, Quevedo-Marín JL, Ricci M, Martín-Carmona J, Sanz-Cánovas J, López-Sampalo A, Martín-Escalante MD, Bernal-López MR, Gómez-Huelgas R. Differences between Clinical Protocols for the Treatment of Coronavirus Disease 2019 (COVID-19) in Andalusia, Spain. Int J Environ Res Public Health 2020;17:E6845. [PMID: 32961675 DOI: 10.3390/ijerph17186845] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
180 Li Q, Cao Y, Chen L, Wu D, Yu J, Wang H, He W, Chen L, Dong F, Chen W, Chen W, Li L, Ran Q, Liu Q, Ren W, Gao F, Chen Z, Gale RP, Hu Y. Hematological features of persons with COVID-19. Leukemia 2020;34:2163-72. [PMID: 32528042 DOI: 10.1038/s41375-020-0910-1] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 18.5] [Reference Citation Analysis]
181 Hu K, Lin L, Liang Y, Shao X, Hu Z, Luo H, Lei M. COVID-19: risk factors for severe cases of the Delta variant. Aging (Albany NY) 2021;13:23459-70. [PMID: 34710058 DOI: 10.18632/aging.203655] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
182 Iturricastillo G, Ávalos Pérez-Urría E, Couñago F, Landete P. Scientific evidence in the COVID-19 treatment: A comprehensive review. World J Virol 2021; 10(5): 217-228 [PMID: 34631473 DOI: 10.5501/wjv.v10.i5.217] [Reference Citation Analysis]
183 Yang L, Han Y, Jaffré F, Nilsson-Payant BE, Bram Y, Wang P, Zhu J, Zhang T, Redmond D, Houghton S, Uhl S, Borczuk A, Huang Y, Richardson C, Chandar V, Acklin JA, Lim JK, Chen Z, Xiang J, Ho DD, tenOever BR, Schwartz RE, Evans T, Chen S. An Immuno-Cardiac Model for Macrophage-Mediated Inflammation in COVID-19 Hearts. Circ Res 2021;129:33-46. [PMID: 33853355 DOI: 10.1161/CIRCRESAHA.121.319060] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
184 Fu L, Li XY, Fei J, Xiang Y, Xiang HX, Li MD, Liu FF, Li Y, Zhao H, Xu DX. Myocardial Injury at Early Stage and Its Association With the Risk of Death in COVID-19 Patients: A Hospital-Based Retrospective Cohort Study. Front Cardiovasc Med 2020;7:590688. [PMID: 33195480 DOI: 10.3389/fcvm.2020.590688] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
185 Alberici F, Affatato S, Moratto D, Mescia F, Delbarba E, Guerini A, Tedesco M, Burbelo PD, Zani R, Castagna I, Gallico A, Tonoli M, Venturini M, Roccaro AM, Giacomelli M, Cohen JI, Giustini V, Dobbs K, Su HC, Fiorini C, Quaresima V, Viola FB, Vizzardi V, Gaggiotti M, Bossini N, Gaggia P, Badolato R, Notarangelo LD, Chiarini M, Scolari F. SARS-CoV-2 infection in dialysis and kidney transplant patients: immunological and serological response. J Nephrol. [DOI: 10.1007/s40620-021-01214-8] [Reference Citation Analysis]
186 Wan J, Wang X, Su S, Zhang Y, Jin Y, Shi Y, Wu K, Liang J. Digestive symptoms and liver injury in patients with coronavirus disease 2019 (COVID-19): A systematic review with meta-analysis. JGH Open 2020;4:1047-58. [PMID: 33319036 DOI: 10.1002/jgh3.12428] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
187 Vitale RJ, Valtis YK, McDonell ME, Palermo NE, Fisher NDL. Euglycemic Diabetic Ketoacidosis with COVID-19 Infection in Patients with Type 2 Diabetes taking SGLT2 Inhibitors. Clin Case Rep. 2020;In press. [PMID: 33521255 DOI: 10.1016/j.aace.2020.11.019] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
188 Napoli R. Diabetes and Covid-19: An interplay difficult to dissect. Diabetes Metab Res Rev 2021;37:e3387. [PMID: 32818297 DOI: 10.1002/dmrr.3387] [Reference Citation Analysis]
189 Piano C, Di Stasio E, Primiano G, Janiri D, Luigetti M, Frisullo G, Vollono C, Lucchini M, Brunetti V, Monforte M, Guglielmi V, Della Marca G, Evoli A, Marra C, Mirabella M, Quaranta D, Ricci E, Servidei S, Silvestri G, Bellavia S, Bortolani S, Bove F, Di Iorio R, Di Paolantonio A, Genovese D, Ialongo T, Lo Monaco MR, Marotta J, Patanella AK, Perna A, Petracca M, Presicce G, Riso V, Rollo E, Romano A, Romozzi M, Sancricca C, Scala I, Spagni G, Solito M, Tricoli L, Zinzi P, Calabresi P, Bentivoglio AR. An Italian Neurology Outpatient Clinic Facing SARS-CoV-2 Pandemic: Data From 2,167 Patients. Front Neurol 2020;11:564. [PMID: 32574249 DOI: 10.3389/fneur.2020.00564] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
190 Mahale N, Rajhans P, Godavarthy P, Narasimhan VL, Oak G, Marreddy S, Bedekar A, Dhundi U, Pawar HS, Akole P, Pawar B, Bhurke B, Chavan S, Prayag P, Purandare B, Dalvi P, Telbhare V, Marudwar P, Diwane D, Shahane M, Prayag A, Gugale S, Bhor S, Jog S. A Retrospective Observational Study of Hypoxic COVID-19 Patients Treated with Immunomodulatory Drugs in a Tertiary Care Hospital. Indian J Crit Care Med 2020;24:1020-7. [PMID: 33384506 DOI: 10.5005/jp-journals-10071-23599] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
191 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
192 Moreno A, Vargas C, Azocar F, Villarroel F, Cofré M, Oppliger H, Ríos F, Raijmakers M, Silva-Ayarza I, Beltrán C, Zamora F. Steroids and mortality in non-critically ill COVID-19 patients: a propensity score-weighted study in a Chilean cohort. Int J Infect Dis 2021;112:124-9. [PMID: 34547488 DOI: 10.1016/j.ijid.2021.09.038] [Reference Citation Analysis]
193 Bartoli A, Gabrielli F, Alicandro T, Nascimbeni F, Andreone P. COVID-19 treatment options: a difficult journey between failed attempts and experimental drugs. Intern Emerg Med 2021;16:281-308. [PMID: 33398609 DOI: 10.1007/s11739-020-02569-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 11.0] [Reference Citation Analysis]
194 Verdecchia P, Cavallini C, Spanevello A, Angeli F. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection. Eur J Intern Med. 2020;76:14-20. [PMID: 32336612 DOI: 10.1016/j.ejim.2020.04.037] [Cited by in Crossref: 450] [Cited by in F6Publishing: 407] [Article Influence: 225.0] [Reference Citation Analysis]
195 Pourbagheri-Sigaroodi A, Bashash D, Fateh F, Abolghasemi H. Laboratory findings in COVID-19 diagnosis and prognosis. Clin Chim Acta 2020;510:475-82. [PMID: 32798514 DOI: 10.1016/j.cca.2020.08.019] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 15.5] [Reference Citation Analysis]
196 Palmer S, Cunniffe N, Donnelly R. COVID-19 hospitalization rates rise exponentially with age, inversely proportional to thymic T-cell production. J R Soc Interface 2021;18:20200982. [PMID: 33726544 DOI: 10.1098/rsif.2020.0982] [Reference Citation Analysis]
197 Lafaurie M, Martin-Blondel G, Delobel P, Charpentier S, Sommet A, Moulis G. Outcome of patients hospitalized for COVID-19 and exposure to angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in France: results of the ACE-CoV study. Fundam Clin Pharmacol 2021;35:194-203. [PMID: 33111329 DOI: 10.1111/fcp.12613] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
198 Lazzeri C, Bonizzoli M, Batacchi S, Di Valvasone S, Chiostri M, Peris A. The prognostic role of hyperglycemia and glucose variability in covid-related acute respiratory distress Syndrome. Diabetes Res Clin Pract 2021;175:108789. [PMID: 33812902 DOI: 10.1016/j.diabres.2021.108789] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
199 Peyrony O, Marbeuf-Gueye C, Truong V, Giroud M, Rivière C, Khenissi K, Legay L, Simonetta M, Elezi A, Principe A, Taboulet P, Ogereau C, Tourdjman M, Ellouze S, Fontaine JP. Accuracy of Emergency Department Clinical Findings for Diagnosis of Coronavirus Disease 2019. Ann Emerg Med 2020;76:405-12. [PMID: 32563600 DOI: 10.1016/j.annemergmed.2020.05.022] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 15.0] [Reference Citation Analysis]
200 Fan S, Zhen Q, Chen C, Wang W, Wu Q, Ma H, Zhang C, Zhang L, Lu B, Ge H, Yong L, Li B, Yu Y, Chen W, Mao Y, Qu G, Su L, Wang A, Ding Z, Li H, Zhang J, Wang Y, Gao Y, Xu X, Zhu Z, Chen J, Zhang L, Liang H, Wu S, Huang M, Xia Q, Li P, Sun Y, Liang C, Wei W, Liu Q, Sun L. Clinical efficacy of low-dose emetine for patients with COVID-19: a real-world study. J BioX Res 2021;4:53-9. [PMID: 34254034 DOI: 10.1097/JBR.0000000000000076] [Reference Citation Analysis]
201 Nusshag C, Morath C, Speer C, Kaelble F, Zeier M, Boxberger M, Schulze-Schleithoff E, Fiedler MO, Weigand MA, Merle U. Plasma Exchange in Patients With Severe Coronavirus Disease 2019: A Single-Center Experience. Crit Care Explor 2021;3:e0517. [PMID: 34476404 DOI: 10.1097/CCE.0000000000000517] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
202 Bost P, De Sanctis F, Canè S, Ugel S, Donadello K, Castellucci M, Eyal D, Fiore A, Anselmi C, Barouni RM, Trovato R, Caligola S, Lamolinara A, Iezzi M, Facciotti F, Mazzariol A, Gibellini D, De Nardo P, Tacconelli E, Gottin L, Polati E, Schwikowski B, Amit I, Bronte V. Deciphering the state of immune silence in fatal COVID-19 patients. Nat Commun 2021;12:1428. [PMID: 33674591 DOI: 10.1038/s41467-021-21702-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 10.0] [Reference Citation Analysis]
203 Mick E, Kamm J, Pisco AO, Ratnasiri K, Babik JM, Calfee CS, Castañeda G, DeRisi JL, Detweiler AM, Hao S, Kangelaris KN, Kumar GR, Li LM, Mann SA, Neff N, Prasad PA, Serpa PH, Shah SJ, Spottiswoode N, Tan M, Christenson SA, Kistler A, Langelier C. Upper airway gene expression differentiates COVID-19 from other acute respiratory illnesses and reveals suppression of innate immune responses by SARS-CoV-2. medRxiv 2020:2020. [PMID: 32511476 DOI: 10.1101/2020.05.18.20105171] [Cited by in Crossref: 24] [Cited by in F6Publishing: 1] [Article Influence: 12.0] [Reference Citation Analysis]
204 Pan F, Yang L, Liang B, Ye T, Li L, Li L, Liu D, Wang J, Hesketh RL, Zheng C. Chest CT Patterns from Diagnosis to 1 Year of Follow-up in COVID-19. Radiology 2021;:211199. [PMID: 34609153 DOI: 10.1148/radiol.2021211199] [Reference Citation Analysis]
205 Mulchandani R, Lyngdoh T, Kakkar AK. Deciphering the COVID-19 cytokine storm: Systematic review and meta-analysis. Eur J Clin Invest 2021;51:e13429. [PMID: 33058143 DOI: 10.1111/eci.13429] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 13.0] [Reference Citation Analysis]
206 Tsaplin S, Schastlivtsev I, Zhuravlev S, Barinov V, Lobastov K, Caprini JA. The original and modified Caprini score equally predicts venous thromboembolism in COVID-19 patients. J Vasc Surg Venous Lymphat Disord 2021:S2213-333X(21)00105-0. [PMID: 33744497 DOI: 10.1016/j.jvsv.2021.02.018] [Reference Citation Analysis]
207 Ferreira-Santos D, Maranhão P, Monteiro-Soares M; COVIDcids. Identifying common baseline clinical features of COVID-19: a scoping review. BMJ Open 2020;10:e041079. [PMID: 32938604 DOI: 10.1136/bmjopen-2020-041079] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
208 Naeem KB, Hachim MY, Hachim IY, Chkhis A, Quadros R, Hannawi H, Al Salmi I, Alokaily F, Hannawi S. Acute cardiac injury is associated with adverse outcomes, including mortality in COVID-19 patients. A single-center experience. Saudi Med J 2020;41:1204-10. [PMID: 33130840 DOI: 10.15537/smj.2020.11.25466] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
209 Freund Y, Drogrey M, Miró Ò, Marra A, Féral-Pierssens AL, Penaloza A, Hernandez BAL, Beaune S, Gorlicki J, Vaittinada Ayar P, Truchot J, Pena B, Aguirre A, Fémy F, Javaud N, Chauvin A, Chouihed T, Montassier E, Claret PG, Occelli C, Roussel M, Brigant F, Ellouze S, Le Borgne P, Laribi S, Simon T, Lucidarme O, Cachanado M, Bloom B; IMPROVING EMERGENCY CARE FHU Collaborators. Association Between Pulmonary Embolism and COVID-19 in Emergency Department Patients Undergoing Computed Tomography Pulmonary Angiogram: The PEPCOV International Retrospective Study. Acad Emerg Med 2020;27:811-20. [PMID: 32734624 DOI: 10.1111/acem.14096] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 19.0] [Reference Citation Analysis]
210 Roig-Marín N, Roig-Rico P. Elderly Hospitalized for COVID-19 and Fever: A Retrospective Cohort Study. Exp Aging Res 2021;:1-8. [PMID: 34583614 DOI: 10.1080/0361073X.2021.1973824] [Reference Citation Analysis]
211 Baguma S, Okot C, Alema NO, Apiyo P, Layet P, Acullu D, Oloya JN, Ochula D, Atim P, Olwedo PO, Okot SG, Oyat FWD, Oola J, Ikoona EN, Aloyo J, Kitara DL. Factors Associated With Mortality Among the COVID-19 Patients Treated at Gulu Regional Referral Hospital: A Retrospective Study. Front Public Health 2022;10:841906. [DOI: 10.3389/fpubh.2022.841906] [Reference Citation Analysis]
212 Giacalone A, Rocco G, Ruberti E. Physical Health and Psychosocial Considerations During the Coronavirus Disease 2019 Outbreak. Psychosomatics 2020;61:851-2. [PMID: 32861431 DOI: 10.1016/j.psym.2020.07.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
213 Tian J, Yuan X, Xiao J, Zhong Q, Yang C, Liu B, Cai Y, Lu Z, Wang J, Wang Y, Liu S, Cheng B, Wang J, Zhang M, Wang L, Niu S, Yao Z, Deng X, Zhou F, Wei W, Li Q, Chen X, Chen W, Yang Q, Wu S, Fan J, Shu B, Hu Z, Wang S, Yang XP, Liu W, Miao X, Wang Z. Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort study. Lancet Oncol 2020;21:893-903. [PMID: 32479790 DOI: 10.1016/S1470-2045(20)30309-0] [Cited by in Crossref: 174] [Cited by in F6Publishing: 133] [Article Influence: 87.0] [Reference Citation Analysis]
214 Jacob G, Aharon A, Brenner B. COVID-19-Associated Hyper-Fibrinolysis: Mechanism and Implementations. Front Physiol 2020;11:596057. [PMID: 33391014 DOI: 10.3389/fphys.2020.596057] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
215 Zhang P, Wang M, Wang Y, Wang Y, Li T, Zeng J, Wang L, Li C, Gong Y. Risk factors associated with the progression of COVID-19 in elderly diabetes patients. Diabetes Res Clin Pract 2021;171:108550. [PMID: 33232760 DOI: 10.1016/j.diabres.2020.108550] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
216 Sharma JB, Sharma E, Sharma S, Singh J. Recommendations for prenatal, intrapartum, and postpartum care during COVID-19 pandemic in India. Am J Reprod Immunol 2020;84:e13336. [PMID: 32877014 DOI: 10.1111/aji.13336] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
217 Baazaoui N, Iqbal K. COVID-19 and Neurodegenerative Diseases: Prion-Like Spread and Long-Term Consequences. JAD 2022. [DOI: 10.3233/jad-220105] [Reference Citation Analysis]
218 Jaiswal S, Kumar M, Mandeep, Sunita, Singh Y, Shukla P. Systems Biology Approaches for Therapeutics Development Against COVID-19. Front Cell Infect Microbiol 2020;10:560240. [PMID: 33194800 DOI: 10.3389/fcimb.2020.560240] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
219 Gralnek IM, Hassan C, Beilenhoff U, Antonelli G, Ebigbo A, Pellisè M, Arvanitakis M, Bhandari P, Bisschops R, Van Hooft JE, Kaminski MF, Triantafyllou K, Webster G, Pohl H, Dunkley I, Fehrke B, Gazic M, Gjergek T, Maasen S, Waagenes W, de Pater M, Ponchon T, Siersema PD, Messmann H, Dinis-ribeiro M. ESGE and ESGENA Position Statement on gastrointestinal endoscopy and the COVID-19 pandemic. Endoscopy 2020;52:483-90. [DOI: 10.1055/a-1155-6229] [Cited by in Crossref: 145] [Cited by in F6Publishing: 147] [Article Influence: 72.5] [Reference Citation Analysis]
220 Sena K, Furue K, Setoguchi F, Noguchi K. Altered expression of SARS-CoV-2 entry and processing genes by Porphyromonas gingivalis-derived lipopolysaccharide, inflammatory cytokines and prostaglandin E2 in human gingival fibroblasts. Arch Oral Biol 2021;129:105201. [PMID: 34174588 DOI: 10.1016/j.archoralbio.2021.105201] [Reference Citation Analysis]
221 Huang I, Pranata R, Lim MA, Oehadian A, Alisjahbana B. C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis. Ther Adv Respir Dis 2020;14:1753466620937175. [PMID: 32615866 DOI: 10.1177/1753466620937175] [Cited by in Crossref: 110] [Cited by in F6Publishing: 107] [Article Influence: 55.0] [Reference Citation Analysis]
222 López-Medrano F, Pérez-Jacoiste Asín MA, Fernández-Ruiz M, Carretero O, Lalueza A, Maestro de la Calle G, Caro JM, de la Calle C, Catalán M, García-García R, Martínez-López J, Origüen J, Ripoll M, San Juan R, Trujillo H, Sevillano Á, Gutiérrez E, de Miguel B, Aguilar F, Gómez C, Silva JT, García-Ruiz de Morales D, Saro-Buendía M, Marrero-Sánchez Á, Chiara-Graciani G, Bueno H, Paz-Artal E, Lumbreras C, Pablos JL, Aguado JM; H12O Immunomodulation Therapy for COVID-19 Group. Combination therapy with tocilizumab and corticosteroids for aged patients with severe COVID-19 pneumonia: A single-center retrospective study. Int J Infect Dis 2021;105:487-94. [PMID: 33647515 DOI: 10.1016/j.ijid.2021.02.099] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
223 Khoshkam Z, Aftabi Y, Stenvinkel P, Paige Lawrence B, Rezaei MH, Ichihara G, Fereidouni S. Recovery scenario and immunity in COVID-19 disease: A new strategy to predict the potential of reinfection. J Adv Res 2021;31:49-60. [PMID: 33520309 DOI: 10.1016/j.jare.2020.12.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
224 Farhang-Sardroodi S, Korosec CS, Gholami S, Craig M, Moyles IR, Ghaemi MS, Ooi HK, Heffernan JM. Analysis of Host Immunological Response of Adenovirus-Based COVID-19 Vaccines. Vaccines (Basel) 2021;9:861. [PMID: 34451985 DOI: 10.3390/vaccines9080861] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
225 Zou L, Dai L, Zhang X, Zhang Z, Zhang Z. Hydroxychloroquine and chloroquine: a potential and controversial treatment for COVID-19. Arch Pharm Res 2020;43:765-72. [PMID: 32740801 DOI: 10.1007/s12272-020-01258-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 9.5] [Reference Citation Analysis]
226 Kumari P, Rawat K, Saha L. Pipeline Pharmacological Therapies in Clinical Trial for COVID-19 Pandemic: a Recent Update. Curr Pharmacol Rep 2020;:1-13. [PMID: 32837854 DOI: 10.1007/s40495-020-00226-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
227 Keene AB, Admon AJ, Brenner SK, Gupta S, Lazarous D, Leaf DE, Gershengorn HB; STOP-COVID Investigators. Association of Surge Conditions with Mortality Among Critically Ill Patients with COVID-19. J Intensive Care Med 2021;:8850666211067509. [PMID: 34939474 DOI: 10.1177/08850666211067509] [Reference Citation Analysis]
228 de Oliveira JCP, Araujo WJB, Belczak SQ, Erzinger FL, de Oliveira LMP, Marques MA, Sarquis LM, Gutfilen B. Limb ischemia in patients with COVID-19. J Vasc Bras 2021;20:e20210004. [PMID: 34211543 DOI: 10.1590/1677-5449.210004] [Reference Citation Analysis]
229 Sherren PB, Ostermann M, Agarwal S, Meadows CIS, Ioannou N, Camporota L. COVID-19-related organ dysfunction and management strategies on the intensive care unit: a narrative review. Br J Anaesth 2020;125:912-25. [PMID: 32988604 DOI: 10.1016/j.bja.2020.08.050] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
230 Mussap M. Clinical Laboratory Test Unit Homogeneity—an Urgent Need. JAMA Intern Med 2020;180:1715. [DOI: 10.1001/jamainternmed.2020.3532] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
231 Sottile PD, Albers D, DeWitt PE, Russell S, Stroh JN, Kao DP, Adrian B, Levine ME, Mooney R, Larchick L, Kutner JS, Wynia MK, Glasheen JJ, Bennett TD. Real-Time Electronic Health Record Mortality Prediction During the COVID-19 Pandemic: A Prospective Cohort Study. medRxiv 2021:2021. [PMID: 33469601 DOI: 10.1101/2021.01.14.21249793] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
232 Zhu H, Rhee JW, Cheng P, Waliany S, Chang A, Witteles RM, Maecker H, Davis MM, Nguyen PK, Wu SM. Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response. Curr Cardiol Rep 2020;22:32. [PMID: 32318865 DOI: 10.1007/s11886-020-01292-3] [Cited by in Crossref: 79] [Cited by in F6Publishing: 82] [Article Influence: 39.5] [Reference Citation Analysis]
233 Mussini C, Cozzi-Lepri A, Menozzi M, Meschiari M, Franceschini E, Rogati C, Cuomo G, Bedini A, Iadisernia V, Volpi S, Milic J, Tonelli R, Brugioni L, Pietrangelo A, Girardis M, Cossarizza A, Clini E, Guaraldi G; Modena Covid-19 Working Group (MoCo19)., Office of information and communication technologies of Policlinico di Modena. Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediator. Clin Microbiol Infect 2021;27:1137-44. [PMID: 33359539 DOI: 10.1016/j.cmi.2020.12.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
234 Luo L, Liang W, Pang J, Xu G, Chen Y, Guo X, Wang X, Zhao Y, Lai Y, Liu Y, Li B, Su B, Zhang S, Baniyash M, Shen L, Chen L, Ling Y, Wang Y, Liang Q, Lu H, Zhang Z, Wang F. Dynamics of TCR repertoire and T cell function in COVID-19 convalescent individuals. Cell Discov 2021;7:89. [PMID: 34580278 DOI: 10.1038/s41421-021-00321-x] [Reference Citation Analysis]
235 Dziedzic A, Tanasiewicz M, Tysiąc-Miśta M. Dental Care Provision during Coronavirus Disease 2019 (COVID-19) Pandemic: The Importance of Continuous Support for Vulnerable Patients. Medicina (Kaunas) 2020;56:E294. [PMID: 32545630 DOI: 10.3390/medicina56060294] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
236 Etkind SN, Bone AE, Lovell N, Cripps RL, Harding R, Higginson IJ, Sleeman KE. The Role and Response of Palliative Care and Hospice Services in Epidemics and Pandemics: A Rapid Review to Inform Practice During the COVID-19 Pandemic. J Pain Symptom Manage 2020;60:e31-40. [PMID: 32278097 DOI: 10.1016/j.jpainsymman.2020.03.029] [Cited by in Crossref: 102] [Cited by in F6Publishing: 82] [Article Influence: 51.0] [Reference Citation Analysis]
237 Samuel LJ, Gaskin DJ, Trujillo AJ, Szanton SL, Samuel A, Slade E. Race, ethnicity, poverty and the social determinants of the coronavirus divide: U.S. county-level disparities and risk factors. BMC Public Health 2021;21:1250. [PMID: 34187414 DOI: 10.1186/s12889-021-11205-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
238 Mohanka MR, Mahan LD, Joerns J, Lawrence A, Bollineni S, Kaza V, La Hoz RM, Kershaw CD, Terada LS, Torres F, Banga A. Clinical characteristics, management practices, and outcomes among lung transplant patients with COVID-19. J Heart Lung Transplant 2021:S1053-2498(21)02317-2. [PMID: 34172387 DOI: 10.1016/j.healun.2021.05.003] [Reference Citation Analysis]
239 Alhumaid S, Al Mutair A, Al Alawi Z, Alshawi AM, Alomran SA, Almuhanna MS, Almuslim AA, Bu Shafia AH, Alotaibi AM, Ahmed GY, Rabaan AA, Al-Tawfiq JA, Al-Omari A. Coinfections with Bacteria, Fungi, and Respiratory Viruses in Patients with SARS-CoV-2: A Systematic Review and Meta-Analysis. Pathogens 2021;10:809. [PMID: 34202114 DOI: 10.3390/pathogens10070809] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
240 Rosca A, Balcaen T, Lanoix J, Michaud A, Moyet J, Marcq I, Schmit J, Bloch F, Deschasse G. Mortality risk and antibiotic use for COVID-19 in hospitalized patients over 80. Biomedicine & Pharmacotherapy 2022;146:112481. [DOI: 10.1016/j.biopha.2021.112481] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
241 Arastehfar A, Carvalho A, van de Veerdonk FL, Jenks JD, Koehler P, Krause R, Cornely OA, S Perlin D, Lass-Flörl C, Hoenigl M. COVID-19 Associated Pulmonary Aspergillosis (CAPA)-From Immunology to Treatment. J Fungi (Basel) 2020;6:E91. [PMID: 32599813 DOI: 10.3390/jof6020091] [Cited by in Crossref: 83] [Cited by in F6Publishing: 74] [Article Influence: 41.5] [Reference Citation Analysis]
242 Juneja D, Savio RD, Srinivasan S, Pandit RA, Ramasubban S, Reddy PK, Singh M, Gopal PB, Chaudhry D, Govil D, Dixit S, Samavedam S. Basic Critical Care for Management of COVID-19 Patients: Position Paper of Indian Society of Critical Care Medicine, Part-I. Indian J Crit Care Med 2020;24:S244-53. [PMID: 33354048 DOI: 10.5005/jp-journals-10071-23601] [Reference Citation Analysis]
243 Elahi R, Karami P, Heidary AH, Esmaeilzadeh A. An updated overview of recent advances, challenges, and clinical considerations of IL-6 signaling blockade in severe coronavirus disease 2019 (COVID-19). International Immunopharmacology 2022;105:108536. [DOI: 10.1016/j.intimp.2022.108536] [Reference Citation Analysis]
244 Dobesh PP, Trujillo TC. Coagulopathy, Venous Thromboembolism, and Anticoagulation in Patients with COVID-19. Pharmacotherapy 2020;40:1130-51. [PMID: 33006163 DOI: 10.1002/phar.2465] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 11.0] [Reference Citation Analysis]
245 Bian Y, Le Y, Du H, Chen J, Zhang P, He Z, Wang Y, Yu S, Fang Y, Yu G, Ling J, Feng Y, Wei S, Huang J, Xiao L, Zheng Y, Yu Z, Li S. Efficacy and Safety of Anticoagulation Treatment in COVID-19 Patient Subgroups Identified by Clinical-Based Stratification and Unsupervised Machine Learning: A Matched Cohort Study. Front Med (Lausanne) 2021;8:786414. [PMID: 35004751 DOI: 10.3389/fmed.2021.786414] [Reference Citation Analysis]
246 Asiri AA, Alguwaihes AM, Jammah AA, Alfadda AA, Al-Sofiani ME. Assessment of the Effectiveness of a Protocol to Manage Dexamethasone-Induced Hyperglycemia Among Hospitalized Patients With COVID-19. Endocr Pract 2021:S1530-891X(21)01154-X. [PMID: 34358694 DOI: 10.1016/j.eprac.2021.07.016] [Reference Citation Analysis]
247 Chidambaram V, Tun NL, Haque WZ, Majella MG, Sivakumar RK, Kumar A, Hsu AT, Ishak IA, Nur AA, Ayeh SK, Salia EL, Zil-E-Ali A, Saeed MA, Sarena APB, Seth B, Ahmadzada M, Haque EF, Neupane P, Wang KH, Pu TM, Ali SMH, Arshad MA, Wang L, Baksh S, Karakousis PC, Galiatsatos P. Factors associated with disease severity and mortality among patients with COVID-19: A systematic review and meta-analysis.PLoS One. 2020;15:e0241541. [PMID: 33206661 DOI: 10.1371/journal.pone.0241541] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 13.5] [Reference Citation Analysis]
248 Mavraganis G, Aivalioti E, Chatzidou S, Patras R, Paraskevaidis I, Kanakakis I, Stamatelopoulos K, Dimopoulos MA. Cardiac arrest and drug-related cardiac toxicity in the Covid-19 era. Epidemiology, pathophysiology and management. Food Chem Toxicol 2020;145:111742. [PMID: 32916218 DOI: 10.1016/j.fct.2020.111742] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
249 Blanch-Ruiz MA, Ortega-Luna R, Gómez-García G, Martínez-Cuesta MÁ, Álvarez Á. Role of Neutrophil Extracellular Traps in COVID-19 Progression: An Insight for Effective Treatment. Biomedicines 2021;10:31. [PMID: 35052711 DOI: 10.3390/biomedicines10010031] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
250 Hranjec T, Estreicher M, Rogers B, Kohler L, Solomon R, Hennessy S, Cibulas M, Hurst D, Hegazy M, Lee J, Perez D, Doctor N, Kiffin C, Pigneri D, LaGuardia H, Shaw K, Arenas J, Rosenthal A, Katz RS, Sawyer RG, Pepe PE. Integral Use of Thromboelastography With Platelet Mapping to Guide Appropriate Treatment, Avoid Complications, and Improve Survival of Patients With Coronavirus Disease 2019-Related Coagulopathy. Crit Care Explor 2020;2:e0287. [PMID: 33381763 DOI: 10.1097/CCE.0000000000000287] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
251 Kim EJ, Coppa K, Hirsch JS, Abrahams S, Johnson J, Lesser M, Davidson KW, Conigliaro J; Northwell Health COVID-19 Research Consortium., Northwell Health COVID-19 Research Consortium. Examination of patient characteristics and hydroxychloroquine use based on the US Food and Drug Administration's recommendation: a cross-sectional analysis in New York. BMJ Open 2021;11:e042965. [PMID: 33558355 DOI: 10.1136/bmjopen-2020-042965] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
252 Filbin MR, Mehta A, Schneider AM, Kays KR, Guess JR, Gentili M, Fenyves BG, Charland NC, Gonye ALK, Gushterova I, Khanna HK, LaSalle TJ, Lavin-Parsons KM, Lilly BM, Lodenstein CL, Manakongtreecheep K, Margolin JD, McKaig BN, Rojas-Lopez M, Russo BC, Sharma N, Tantivit J, Thomas MF, Gerszten RE, Heimberg GS, Hoover PJ, Lieb DJ, Lin B, Ngo D, Pelka K, Reyes M, Smillie CS, Waghray A, Wood TE, Zajac AS, Jennings LL, Grundberg I, Bhattacharyya RP, Parry BA, Villani AC, Sade-Feldman M, Hacohen N, Goldberg MB. Plasma proteomics reveals tissue-specific cell death and mediators of cell-cell interactions in severe COVID-19 patients. bioRxiv 2020:2020. [PMID: 33173871 DOI: 10.1101/2020.11.02.365536] [Cited by in Crossref: 25] [Cited by in F6Publishing: 6] [Article Influence: 12.5] [Reference Citation Analysis]
253 Potere N, Valeriani E, Candeloro M, Tana M, Porreca E, Abbate A, Spoto S, Rutjes AWS, Di Nisio M. Acute complications and mortality in hospitalized patients with coronavirus disease 2019: a systematic review and meta-analysis. Crit Care 2020;24:389. [PMID: 32616077 DOI: 10.1186/s13054-020-03022-1] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 28.0] [Reference Citation Analysis]
254 Widyasari N, Basuki H, Wahjuni CU. Associated Risk of Death from Covid-19 Infection in Patients with Hypertensive Co-Morbidities. JBE 2021;9:130. [DOI: 10.20473/jbe.v9i22021.130-139] [Reference Citation Analysis]
255 Liang H, Zheng L, Xia H, Tang J. SARS-CoV-2 infection in China-Before the pandemic. PLoS Negl Trop Dis 2020;14:e0008472. [PMID: 32760070 DOI: 10.1371/journal.pntd.0008472] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
256 Pinna G, Sanfilippo L, Bassareo PP, Fanos V, Marcialis MA. COVID-19 and Comorbidities: Is Inflammation the Underlying Condition in Children? A Narrative Review. Curr Pediatr Rev 2021;17:38-44. [PMID: 33183207 DOI: 10.2174/1573396316666201112093920] [Reference Citation Analysis]
257 Battaglini D, Robba C, Fedele A, Trancǎ S, Sukkar SG, Di Pilato V, Bassetti M, Giacobbe DR, Vena A, Patroniti N, Ball L, Brunetti I, Torres Martí A, Rocco PRM, Pelosi P. The Role of Dysbiosis in Critically Ill Patients With COVID-19 and Acute Respiratory Distress Syndrome. Front Med (Lausanne) 2021;8:671714. [PMID: 34150807 DOI: 10.3389/fmed.2021.671714] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
258 Plesa M, Gaudet M, Mogas A, Jalaleddine N, Halayko A, Al Heialy S, Hamid Q. Vitamin D3 Attenuates Viral-Induced Inflammation and Fibrotic Responses in Bronchial Smooth Muscle Cells. Front Immunol 2021;12:715848. [PMID: 34512638 DOI: 10.3389/fimmu.2021.715848] [Reference Citation Analysis]
259 Değerli E, Derin S, Oruç K, Şengül Samancı N, Bedir Ş, Çelik E, Şentürk Öztaş N, Alkan G, Demirelli FH, Demirci NS. The demographic characteristics, prognosis, and relationship with cancer subtypes of hospitalized COVID-19 patients with malignancy: A single-center experience. J Med Virol 2021;93:5839-45. [PMID: 34081337 DOI: 10.1002/jmv.27123] [Reference Citation Analysis]
260 Mikhaleva LM, Cherniaev AL, Samsonova MV, Zayratyants OV, Kakturskiy LV, Vasyukova OA, Birukov AE, Kontorshchikov AS, Sorokina AV, Sinelnikov MY. Pathological Features in 100 Deceased Patients With COVID-19 in Correlation With Clinical and Laboratory Data. Pathol Oncol Res 2021;27:1609900. [PMID: 34421396 DOI: 10.3389/pore.2021.1609900] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
261 El-Sharkawi D, Iyengar S. Haematological cancers and the risk of severe COVID-19: Exploration and critical evaluation of the evidence to date. Br J Haematol 2020;190:336-45. [PMID: 32559308 DOI: 10.1111/bjh.16956] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
262 Saha A, Ahsan MM, Quader TU, Shohan MUS, Naher S, Dutta P, Akash AS, Mehedi HMH, Chowdhury AAU, Karim H, Rahman T, Parvin A. Characteristics, management and outcomes of critically ill COVID-19 patients admitted to ICU in hospitals in Bangladesh: a retrospective study. J Prev Med Hyg 2021;62:E33-45. [PMID: 34322614 DOI: 10.15167/2421-4248/jpmh2021.62.1.1838] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
263 Saad Menezes MC, Santinelli Pestana DV, Ferreira JC, Ribeiro de Carvalho CR, Felix MC, Marcilio IO, da Silva KR, Junior VC, Marchini JF, Alencar JC, Gomez LMG, Mauá DD, Souza HP; Emergency USP COVID-19 Group, HCFMUSP COVID-19 Study Group. Distinct Outcomes in COVID-19 Patients with Positive or Negative RT-PCR Test. Viruses 2022;14:175. [DOI: 10.3390/v14020175] [Reference Citation Analysis]
264 Martinez E, Redding D. Osteopathic Response to the COVID-19 Pandemic. J Am Osteopath Assoc 2020. [PMID: 32658249 DOI: 10.7556/jaoa.2020.081] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
265 Antunes DE, Goulart IMB, Goulart LR. Will cases of leprosy reaction increase with COVID-19 infection? PLoS Negl Trop Dis 2020;14:e0008460. [PMID: 32678816 DOI: 10.1371/journal.pntd.0008460] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
266 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
267 Martínez-López J, Mateos MV, Encinas C, Sureda A, Hernández-Rivas JÁ, Lopez de la Guía A, Conde D, Krsnik I, Prieto E, Riaza Grau R, Gironella M, Blanchard MJ, Caminos N, Fernández de Larrea C, Senin MA, Escalante F, de la Puerta JE, Giménez E, Martínez-Barranco P, Mateos JJ, Casado LF, Bladé J, Lahuerta JJ, de la Cruz J, San-Miguel J. Multiple myeloma and SARS-CoV-2 infection: clinical characteristics and prognostic factors of inpatient mortality. Blood Cancer J 2020;10:103. [PMID: 33077708 DOI: 10.1038/s41408-020-00372-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 6.5] [Reference Citation Analysis]
268 Qiu P, Zhou Y, Wang F, Wang H, Zhang M, Pan X, Zhao Q, Liu J. Clinical characteristics, laboratory outcome characteristics, comorbidities, and complications of related COVID-19 deceased: a systematic review and meta-analysis. Aging Clin Exp Res 2020;32:1869-78. [PMID: 32734576 DOI: 10.1007/s40520-020-01664-3] [Cited by in Crossref: 51] [Cited by in F6Publishing: 39] [Article Influence: 25.5] [Reference Citation Analysis]
269 Afshar Y, Gaw SL, Flaherman VJ, Chambers BD, Krakow D, Berghella V, Shamshirsaz AA, Boatin AA, Aldrovandi G, Greiner A, Riley L, Boscardin WJ, Jamieson DJ, Jacoby VL; Pregnancy CoRonavIrus Outcomes RegIsTrY (PRIORITY) Study. Clinical Presentation of Coronavirus Disease 2019 (COVID-19) in Pregnant and Recently Pregnant People. Obstet Gynecol 2020;136:1117-25. [PMID: 33027186 DOI: 10.1097/AOG.0000000000004178] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 11.0] [Reference Citation Analysis]
270 Hazeldine J, Lord JM. Immunesenescence: A Predisposing Risk Factor for the Development of COVID-19? Front Immunol 2020;11:573662. [PMID: 33123152 DOI: 10.3389/fimmu.2020.573662] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
271 Bosso M, Thanaraj TA, Abu-Farha M, Alanbaei M, Abubaker J, Al-Mulla F. The Two Faces of ACE2: The Role of ACE2 Receptor and Its Polymorphisms in Hypertension and COVID-19. Mol Ther Methods Clin Dev 2020;18:321-7. [PMID: 32665962 DOI: 10.1016/j.omtm.2020.06.017] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 19.5] [Reference Citation Analysis]
272 Coman V, Vodnar DC. Gut microbiota and old age: Modulating factors and interventions for healthy longevity. Exp Gerontol 2020;141:111095. [PMID: 32979504 DOI: 10.1016/j.exger.2020.111095] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
273 Lingappan K, Karmouty-Quintana H, Davies J, Akkanti B, Harting MT. Understanding the age divide in COVID-19: why are children overwhelmingly spared? Am J Physiol Lung Cell Mol Physiol. 2020;319:L39-L44. [PMID: 32491949 DOI: 10.1152/ajplung.00183.2020] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 17.5] [Reference Citation Analysis]
274 Marron RM, Zheng M, Fernandez Romero G, Zhao H, Patel R, Leopold I, Thomas A, Standiford T, Kumaran M, Patlakh N, Stewart J, Criner GJ; and the Temple University COVID-19 Research Group. Impact of Chronic Obstructive Pulmonary Disease and Emphysema on Outcomes of Hospitalized Patients with Coronavirus Disease 2019 Pneumonia. Chronic Obstr Pulm Dis 2021;8:255-68. [PMID: 33780602 DOI: 10.15326/jcopdf.2020.0200] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
275 Brandão Neto RA, Marchini JF, Marino LO, Alencar JCG, Lazar Neto F, Ribeiro S, Salvetti FV, Rahhal H, Gomez Gomez LM, Bueno CG, Faria CC, da Cunha VP, Padrão E, Velasco IT, de Souza HP; Emergencia USP Covid group. Mortality and other outcomes of patients with coronavirus disease pneumonia admitted to the emergency department: A prospective observational Brazilian study. PLoS One 2021;16:e0244532. [PMID: 33411707 DOI: 10.1371/journal.pone.0244532] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
276 Lage SL, Rocco JM, Laidlaw E, Rupert A, Galindo F, Kellogg A, Kumar P, Poon R, Wortmann GW, Lisco A, Manion M, Sereti I. Activation of Complement Components on Circulating Blood Monocytes From COVID-19 Patients. Front Immunol 2022;13:815833. [DOI: 10.3389/fimmu.2022.815833] [Reference Citation Analysis]
277 Eloffy MG, El-sherif DM, Abouzid M, Elkodous MA, El-nakhas HS, Sadek RF, Ghorab MA, Al-anazi A, El-sayyad GS. Proposed approaches for coronaviruses elimination from wastewater: Membrane techniques and nanotechnology solutions. Nanotechnology Reviews 2022;11:1-25. [DOI: 10.1515/ntrev-2022-0001] [Reference Citation Analysis]
278 Al-Horani RA. Potential Therapeutic Roles for Direct Factor Xa Inhibitors in Coronavirus Infections. Am J Cardiovasc Drugs 2020;20:525-33. [PMID: 32918208 DOI: 10.1007/s40256-020-00438-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
279 Gallego P, Ruperti-Repilado FJ, Schwerzmann M. Adults with congenital heart disease during the coronavirus disease 2019 (COVID-19) pandemic: are they at risk? Rev Esp Cardiol (Engl Ed) 2020;73:795-8. [PMID: 32660909 DOI: 10.1016/j.rec.2020.06.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
280 Aryana IGPS, Setiati S, Paulus IB, Daniella D. Appropriate Timing and Type of Physical Training in Patients with COVID-19 for Muscle Health and Quality of Life: A Systematic Review. J Nutr Metab 2022;2022:6119593. [PMID: 35663367 DOI: 10.1155/2022/6119593] [Reference Citation Analysis]
281 Chaudhry F, Jageka C, Levy PD, Cerghet M, Lisak RP. Review of the COVID-19 Risk in Multiple Sclerosis. J Cell Immunol 2021;3:68-77. [PMID: 33959727 DOI: 10.33696/immunology.3.080] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
282 Sommer P, Lukovic E, Fagley E, Long D, Sobol J, Heller K, Moitra V, Pauldine R, O'Connor M, Shahul S, Nunnally M, Tung A. Initial Clinical Impressions of the Critical Care of COVID-19 Patients in Seattle, New York City, and Chicago. Anesth Analg. 2020;. [PMID: 32221172 DOI: 10.1213/ane.0000000000004830] [Cited by in Crossref: 29] [Cited by in F6Publishing: 14] [Article Influence: 14.5] [Reference Citation Analysis]
283 Tseng HT, Wu XC, Huang CY, Shih CM, Lin YW, Lin FY. The Impact of SARS-CoV-2 Infection, and Application of Immunosuppressive Agents in Kidney Transplant Recipients Suffering from COVID-19. Pharmaceuticals (Basel) 2021;14:1054. [PMID: 34681278 DOI: 10.3390/ph14101054] [Reference Citation Analysis]
284 MacKenzie EL, Hareza DA, Collison MW, Czapar AE, Kraft AK, Waxse BJ, Friedman EE, Ridgway JP. Clinical characteristics of hospitalized patients with false-negative severe acute respiratory coronavirus virus 2 (SARS-CoV-2) test results. Infect Control Hosp Epidemiol 2021;:1-7. [PMID: 33867000 DOI: 10.1017/ice.2021.146] [Reference Citation Analysis]
285 Scuto M, Trovato Salinaro A, Caligiuri I, Ontario ML, Greco V, Sciuto N, Crea R, Calabrese EJ, Rizzolio F, Canzonieri V, Calabrese V. Redox modulation of vitagenes via plant polyphenols and vitamin D: Novel insights for chemoprevention and therapeutic interventions based on organoid technology. Mech Ageing Dev 2021;199:111551. [PMID: 34358533 DOI: 10.1016/j.mad.2021.111551] [Reference Citation Analysis]
286 Kang N, Alrashed MA, Place EM, Nguyen PT, Perona SJ, Erstad BL. Clinical outcomes of concomitant use of enteral and intravenous sedatives and analgesics in mechanically ventilated patients with COVID-19. Am J Health Syst Pharm 2021:zxab385. [PMID: 34597357 DOI: 10.1093/ajhp/zxab385] [Reference Citation Analysis]
287 Hollenberg MD, Epstein M. The innate immune response, microenvironment proteinases, and the COVID-19 pandemic: pathophysiologic mechanisms and emerging therapeutic targets. Kidney International Supplements 2022;12:48-62. [DOI: 10.1016/j.kisu.2021.12.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
288 Verma AA, Hora T, Jung HY, Fralick M, Malecki SL, Lapointe-Shaw L, Weinerman A, Tang T, Kwan JL, Liu JJ, Rawal S, Chan TCY, Cheung AM, Rosella LC, Ghassemi M, Herridge M, Mamdani M, Razak F. Characteristics and outcomes of hospital admissions for COVID-19 and influenza in the Toronto area. CMAJ 2021;193:E410-8. [PMID: 33568436 DOI: 10.1503/cmaj.202795] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
289 [DOI: 10.1101/2020.05.13.20101345] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
290 Nguyen Y, Corre F, Honsel V, Curac S, Zarrouk V, Burtz CP, Weiss E, Moyer JD, Gauss T, Grégory J, Bert F, Trichet C, Peoc'h K, Vilgrain V, Rebours V, Fantin B, Galy A. A nomogram to predict the risk of unfavourable outcome in COVID-19: a retrospective cohort of 279 hospitalized patients in Paris area. Ann Med 2020;52:367-75. [PMID: 32723107 DOI: 10.1080/07853890.2020.1803499] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
291 Zhang M, Bai X, Cao W, Ji J, Wang L, Yang Y, Yang H. The Influence of Corticosteroids, Immunosuppressants and Biologics on Patients With Inflammatory Bowel Diseases, Psoriasis and Rheumatic Diseases in the Era of COVID-19: A Review of Current Evidence. Front Immunol 2021;12:677957. [PMID: 34335579 DOI: 10.3389/fimmu.2021.677957] [Reference Citation Analysis]
292 Zhou S, Chen C, Hu Y, Lv W, Ai T, Xia L. Chest CT imaging features and severity scores as biomarkers for prognostic prediction in patients with COVID-19. Ann Transl Med. 2020;8:1449. [PMID: 33313194 DOI: 10.21037/atm-20-3421] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
293 Cui R, Zhu Y, Wang Y, Chen XH, Li Q, Dai SM, Tong Q. Tocilizumab in the treatment of coronavirus disease 2019 pneumonia: real-world data from a case series. Future Virol 2021. [PMID: 34055031 DOI: 10.2217/fvl-2020-0410] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
294 Acar HC, Can G, Karaali R, Börekçi Ş, Balkan İİ, Gemicioğlu B, Konukoğlu D, Erginöz E, Erdoğan MS, Tabak F. An easy-to-use nomogram for predicting in-hospital mortality risk in COVID-19: a retrospective cohort study in a university hospital. BMC Infect Dis 2021;21:148. [PMID: 33546639 DOI: 10.1186/s12879-021-05845-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
295 Chen G, Su W, Yang J, Luo D, Xia P, Jia W, Li X, Wang C, Lang S, Meng Q, Zhang Y, Ke Y, Fan A, Yang S, Zheng Y, Fan X, Qiao J, Lian F, Wei L, Tong X. Chinese herbal medicine reduces mortality in patients with severe and critical Coronavirus disease 2019: a retrospective cohort study. Front Med 2020;14:752-9. [PMID: 32926320 DOI: 10.1007/s11684-020-0813-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
296 Favà A, Cucchiari D, Montero N, Toapanta N, Centellas FJ, Vila-Santandreu A, Coloma A, Meneghini M, Manonelles A, Sellarés J, Torres I, Gelpi R, Lorenzo I, Ventura-Aguiar P, Cofan F, Torregrosa JV, Perelló M, Facundo C, Seron D, Oppenheimer F, Bestard O, Cruzado JM, Moreso F, Melilli E. Clinical characteristics and risk factors for severe COVID-19 in hospitalized kidney transplant recipients: A multicentric cohort study. Am J Transplant 2020;20:3030-41. [PMID: 32777153 DOI: 10.1111/ajt.16246] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 23.0] [Reference Citation Analysis]
297 Xie J, Covassin N, Fan Z, Singh P, Gao W, Li G, Kara T, Somers VK. Association Between Hypoxemia and Mortality in Patients With COVID-19. Mayo Clin Proc 2020;95:1138-47. [PMID: 32376101 DOI: 10.1016/j.mayocp.2020.04.006] [Cited by in Crossref: 170] [Cited by in F6Publishing: 147] [Article Influence: 85.0] [Reference Citation Analysis]
298 Fratta Pasini AM, Stranieri C, Cominacini L, Mozzini C. Potential Role of Antioxidant and Anti-Inflammatory Therapies to Prevent Severe SARS-Cov-2 Complications. Antioxidants (Basel) 2021;10:272. [PMID: 33578849 DOI: 10.3390/antiox10020272] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
299 Lu S, Zhou Q, Huang L, Shi Q, Zhao S, Wang Z, Li W, Tang Y, Ma Y, Luo X, Fukuoka T, Ahn HS, Lee MS, Luo Z, Liu E, Chen Y, Zhou C, Peng D. Effectiveness and safety of glucocorticoids to treat COVID-19: a rapid review and meta-analysis. Ann Transl Med 2020;8:627. [PMID: 32566564 DOI: 10.21037/atm-20-3307] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 12.5] [Reference Citation Analysis]
300 Biswas M, Sawajan N, Rungrotmongkol T, Sanachai K, Ershadian M, Sukasem C. Pharmacogenetics and Precision Medicine Approaches for the Improvement of COVID-19 Therapies. Front Pharmacol 2022;13:835136. [DOI: 10.3389/fphar.2022.835136] [Reference Citation Analysis]
301 Syed SM, Gardner J, Roll G, Webber A, Mehta N, Shoji J, Adelmann D, Niemann C, Braun HJ, Mello A, Yao F, Posselt A, Kang SM, Hirose R, Roberts J, Feng S, Ascher N, Stock P, Freise C. COVID-19 and Abdominal Transplant: A Stepwise Approach to Practice During Pandemic Conditions. Transplantation 2020;104:2215-20. [PMID: 32639408 DOI: 10.1097/TP.0000000000003387] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
302 Shabalin IG, Czub MP, Majorek KA, Brzezinski D, Grabowski M, Cooper DR, Panasiuk M, Chruszcz M, Minor W. Molecular determinants of vascular transport of dexamethasone in COVID-19 therapy. bioRxiv 2020:2020. [PMID: 32743572 DOI: 10.1101/2020.07.21.212704] [Reference Citation Analysis]
303 Zhao J, Zhu M, Su X, Huang M, Yang Y, Huang J, Songshi N, Cao Q, Gu Q, Li J, Li J, Zhao W, Shi B, Shi Y. Clinical features and risk factors for severe-critically ill COVID-19 adult patients in Jiangsu, China: A multiple-centered, retrospective study. Medicine (Baltimore) 2021;100:e24332. [PMID: 33592878 DOI: 10.1097/MD.0000000000024332] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
304 Piechotta V, Chai KL, Valk SJ, Doree C, Monsef I, Wood EM, Lamikanra A, Kimber C, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev 2020;7:CD013600. [PMID: 32648959 DOI: 10.1002/14651858.CD013600.pub2] [Cited by in Crossref: 41] [Cited by in F6Publishing: 51] [Article Influence: 20.5] [Reference Citation Analysis]
305 Guo Z, Sun L, Li B, Tian R, Zhang X, Zhang Z, Clifford SP, Liu Y, Huang J, Li X. Anticoagulation Management in Severe Coronavirus Disease 2019 Patients on Extracorporeal Membrane Oxygenation. J Cardiothorac Vasc Anesth 2021;35:389-97. [PMID: 32994131 DOI: 10.1053/j.jvca.2020.08.067] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
306 Yuksel A, Karadogan D, Gurkan CG, Akyil FT, Toreyin ZN, Marim F, Arikan H, Eyuboglu TS, Emiralioglu N, Serifoglu I, Develi E, Celik S, Sertcelik UO, Gursoy TR, Elversli MF, Oncel A, Er B, Firincioglulari A, Gunaydin FE, Ozakinci H, Ozcelik N, Esendagli D, Aydin A, Kose N, Ercelik M, Gulhan PY, Yildiz E, Irmak I, Kara BY, Gurz S, Karakas FG, Akgun M. Unclear Issues Regarding COVID-19. Eurasian J Med 2020;52:191-6. [PMID: 32612430 DOI: 10.5152/eurasianjmed.2020.20092] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
307 Callejas Rubio JL, Luna Del Castillo JD, de la Hera Fernández J, Guirao Arrabal E, Colmenero Ruiz M, Ortego Centeno N. Effectiveness of corticoid pulses in patients with cytokine storm syndrome induced by SARS-CoV-2 infection. Med Clin (Engl Ed) 2020;155:159-61. [PMID: 32835105 DOI: 10.1016/j.medcle.2020.07.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
308 Lentz S, Roginski MA, Montrief T, Ramzy M, Gottlieb M, Long B. Initial emergency department mechanical ventilation strategies for COVID-19 hypoxemic respiratory failure and ARDS. Am J Emerg Med 2020;38:2194-202. [PMID: 33071092 DOI: 10.1016/j.ajem.2020.06.082] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
309 Piepenbrink MS, Park JG, Oladunni FS, Deshpande A, Basu M, Sarkar S, Loos A, Woo J, Lovalenti P, Sloan D, Ye C, Chiem K, Bates CW, Burch RE, Erdmann NB, Goepfert PA, Truong VL, Walter MR, Martinez-Sobrido L, Kobie JJ. Therapeutic activity of an inhaled potent SARS-CoV-2 neutralizing human monoclonal antibody in hamsters. Cell Rep Med 2021;2:100218. [PMID: 33649747 DOI: 10.1016/j.xcrm.2021.100218] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
310 Singh A, Bhardwaj A, Ravichandran N, Malhotra M. Surviving COVID-19 and multiple complications post total laryngectomy. BMJ Case Rep 2021;14:e244277. [PMID: 34321272 DOI: 10.1136/bcr-2021-244277] [Reference Citation Analysis]
311 Liu J, Liu Z, Jiang W, Wang J, Zhu M, Song J, Wang X, Su Y, Xiang G, Ye M, Li J, Zhang Y, Shen Q, Li Z, Yao D, Song Y, Yu K, Luo Z, Ye L. Clinical predictors of COVID-19 disease progression and death: Analysis of 214 hospitalised patients from Wuhan, China. Clin Respir J 2021;15:293-309. [PMID: 33090710 DOI: 10.1111/crj.13296] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
312 Ge C, He Y. In Silico Prediction of Molecular Targets of Astragaloside IV for Alleviation of COVID-19 Hyperinflammation by Systems Network Pharmacology and Bioinformatic Gene Expression Analysis. Front Pharmacol 2020;11:556984. [PMID: 33041797 DOI: 10.3389/fphar.2020.556984] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
313 Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J, Li Q, Jiang C, Zhou Y, Liu S, Ye C, Zhang P, Xing Y, Guo H, Tang W. Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis. J Infect. 2020;81:e16-e25. [PMID: 32335169 DOI: 10.1016/j.jinf.2020.04.021] [Cited by in Crossref: 714] [Cited by in F6Publishing: 659] [Article Influence: 357.0] [Reference Citation Analysis]
314 Alwaqfi NR, Ibrahim KS. COVID-19: an update and cardiac involvement. J Cardiothorac Surg 2020;15:239. [PMID: 32907637 DOI: 10.1186/s13019-020-01299-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
315 Chad T, Sampson C. Prone positioning in conscious patients on medical wards: A review of the evidence and its relevance to patients with COVID-19 infection. Clin Med (Lond) 2020;20:e97-e103. [PMID: 32503800 DOI: 10.7861/clinmed.2020-0179] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
316 Diem L, Fregolente-Gomes L, Warncke JD, Hammer H, Friedli C, Kamber N, Jung S, Bigi S, Funke-Chambour M, Chan A, Bassetti CL, Salmen A, Hoepner R. Fatigue in Post-COVID-19 Syndrome: Clinical Phenomenology, Comorbidities and Association With Initial Course of COVID-19. J Cent Nerv Syst Dis 2022;14:11795735221102727. [PMID: 35633835 DOI: 10.1177/11795735221102727] [Reference Citation Analysis]
317 Espinosa-solano M, Gonzalez-vergara D, Ferrer-galvan M, Asensio-cruz MI, Lomas JM, Roca-oporto C, Navarro-amuedo MD, Paniagua-garcia M, Sotomayor C, Espinosa N, Garcia-gutierrez M, Molina Gil-bermejo J, Aguilar-guisado M, Poyato M, Praena-segovia J, Palomo A, Borrero-rodriguez M, Cordero E, Caballero-eraso C, Jara-palomares L. Repeated Pulses of Methyl-Prednisolone in Adults Hospitalized With COVID-19 Pneumonia and Acute Respiratory Distress Syndrome: A Preliminary Before–After Study (CortiCOVID Study). Open Respiratory Archives 2021;3:100086. [DOI: 10.1016/j.opresp.2021.100086] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
318 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
319 Lalueza A, Lora-Tamayo J, Maestro-de la Calle G, Folgueira D, Arrieta E, de Miguel-Campo B, Díaz-Simón R, Lora D, de la Calle C, Mancheño-Losa M, Marchán-López Á, García-Reyne A, Fernández-Ruiz M, Sayas-Catalán J, Serrano A, Cueto-Felgueroso C, San Juan R, García-García R, Catalán M, Villena V, Aguado JM, Lumbreras C; COVID+12 group. A predictive score at admission for respiratory failure among hospitalized patients with confirmed 2019 Coronavirus Disease: a simple tool for a complex problem. Intern Emerg Med 2021. [PMID: 33914228 DOI: 10.1007/s11739-021-02748-2] [Reference Citation Analysis]
320 Astore C, Zhou H, Jacob J, Skolnick J. Prediction of severe adverse events, modes of action and drug treatments for COVID-19's complications. Sci Rep 2021;11:20864. [PMID: 34675303 DOI: 10.1038/s41598-021-00368-6] [Reference Citation Analysis]
321 Klouda CB, Stone WL. Oxidative Stress, Proton Fluxes, and Chloroquine/Hydroxychloroquine Treatment for COVID-19. Antioxidants (Basel) 2020;9:E894. [PMID: 32967165 DOI: 10.3390/antiox9090894] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
322 Wang Z, Chen J, Zhu C, Liu L, Qi T, Shen Y, Zhang Y, Xu L, Li T, Qian Z, Steinhart CR, Lu H. Thymosin Alpha-1 Has no Beneficial Effect on Restoring CD4+ and CD8+ T Lymphocyte Counts in COVID-19 Patients. Front Immunol 2021;12:568789. [PMID: 34149679 DOI: 10.3389/fimmu.2021.568789] [Reference Citation Analysis]
323 Recio-Vivas AM, Font-Jiménez I, Mansilla-Domínguez JM, Belzunegui-Eraso A, Díaz-Pérez D, Lorenzo-Allegue L, Peña-Otero D. Fear and Attitude towards SARS-CoV-2 (COVID-19) Infection in Spanish Population during the Period of Confinement. Int J Environ Res Public Health 2022;19:834. [PMID: 35055656 DOI: 10.3390/ijerph19020834] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
324 Zeng F, Huang Y, Guo Y, Yin M, Chen X, Xiao L, Deng G. Association of inflammatory markers with the severity of COVID-19: A meta-analysis. Int J Infect Dis 2020;96:467-74. [PMID: 32425643 DOI: 10.1016/j.ijid.2020.05.055] [Cited by in Crossref: 137] [Cited by in F6Publishing: 120] [Article Influence: 68.5] [Reference Citation Analysis]
325 Elizalde González JJ. SARS-CoV-2 y COVID-19. Una revisión de la pandemia. Medicina Crítica 2020;33:53-67. [DOI: 10.35366/93281] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
326 Ji P, Chen J, Golding A, Nikolov NP, Saluja B, Ren YR, Sahajwalla CG. Immunomodulatory Therapeutic Proteins in COVID-19: Current Clinical Development and Clinical Pharmacology Considerations. J Clin Pharmacol 2020;60:1275-93. [PMID: 32779201 DOI: 10.1002/jcph.1729] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
327 Yang N, Tian K, Jin M, Zhang X, Zhang F, Shi X, Wang X, Niu S, Shi J, Hu K, Liu K, Peng P, Wang Y, Zhang H, Tian J. Sudden death of COVID-19 patients in Wuhan, China: A retrospective cohort study. J Glob Health 2021;11:05006. [PMID: 33828847 DOI: 10.7189/jogh.11.05006] [Reference Citation Analysis]
328 Fraser DD, Cepinskas G, Slessarev M, Martin C, Daley M, Miller MR, O'Gorman DB, Gill SE, Patterson EK, Dos Santos CC. Inflammation Profiling of Critically Ill Coronavirus Disease 2019 Patients. Crit Care Explor 2020;2:e0144. [PMID: 32696007 DOI: 10.1097/CCE.0000000000000144] [Cited by in Crossref: 31] [Cited by in F6Publishing: 21] [Article Influence: 15.5] [Reference Citation Analysis]
329 Gude F, Riveiro V, Rodríguez-Núñez N, Ricoy J, Lado-Baleato Ó, Lourido T, Rábade C, Lama A, Casal A, Abelleira-París R, Ferreiro L, Suárez-Antelo J, Toubes ME, Pou C, Taboada-Muñiz M, Calle-Velles F, Mayán-Conesa P, Del Molino MLP, Galbán-Rodríguez C, Álvarez-Escudero J, Beceiro-Abad C, Molinos-Castro S, Agra-Vázquez N, Pazo-Núñez M, Páez-Guillán E, Varela-García P, Martínez-Rey C, Pernas-Pardavila H, Domínguez-Santalla MJ, Vidal-Vázquez M, Marques-Afonso AT, González-Quintela A, González-Juanatey JR, Pose A, Valdés L. Development and validation of a clinical score to estimate progression to severe or critical state in COVID-19 pneumonia hospitalized patients. Sci Rep 2020;10:19794. [PMID: 33188225 DOI: 10.1038/s41598-020-75651-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
330 Azzi Y, Bartash R, Scalea J, Loarte-Campos P, Akalin E. COVID-19 and Solid Organ Transplantation: A Review Article. Transplantation 2021;105:37-55. [PMID: 33148977 DOI: 10.1097/TP.0000000000003523] [Cited by in Crossref: 34] [Cited by in F6Publishing: 21] [Article Influence: 34.0] [Reference Citation Analysis]
331 Barrett JS. Risk assessment of therapeutic agents under consideration to treat COVID-19 in paediatric patients and pregnant women. Br J Clin Pharmacol 2021;87:3462-80. [PMID: 33125791 DOI: 10.1111/bcp.14630] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
332 Chauvelot L, Bitker L, Dhelft F, Mezidi M, Orkisz M, Davila Serrano E, Penarrubia L, Yonis H, Chabert P, Folliet L, David G, Provoost J, Lecam P, Boussel L, Richard JC. Quantitative-analysis of computed tomography in COVID-19 and non COVID-19 ARDS patients: A case-control study. J Crit Care 2020;60:169-76. [PMID: 32854088 DOI: 10.1016/j.jcrc.2020.08.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
333 Costa JA, Silveira JA, Santos SCMD, Nogueira PP. Cardiovascular Implications in Patients Infected with Covid-19 and the Importance of Social Isolation to Reduce Dissemination of the Disease. Arq Bras Cardiol 2020;114:834-8. [PMID: 32491075 DOI: 10.36660/abc.20200243] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
334 Hussain A, do Vale Moreira NC. Letter to the editor in response to article: "Clinical considerations for patients with diabetes in times of COVID-19 epidemic (Gupta et al.). Diabetes Metab Syndr 2020;14:363. [PMID: 32325393 DOI: 10.1016/j.dsx.2020.04.022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
335 Sano T, Matsumoto S, Ikeda T, Kuroda S, Kitai T, Yonetsu T, Kohsaka S, Torii S, Node K, Matsue Y. New-Onset Atrial Fibrillation in Patients With Coronavirus Disease 2019 (COVID-19) and Cardiovascular Disease - Insights From the CLAVIS-COVID Registry. Circ J 2022. [PMID: 35082216 DOI: 10.1253/circj.CJ-21-0911] [Reference Citation Analysis]
336 Nashiry A, Sarmin Sumi S, Islam S, Quinn JMW, Moni MA. Bioinformatics and system biology approach to identify the influences of COVID-19 on cardiovascular and hypertensive comorbidities. Brief Bioinform 2021;22:1387-401. [PMID: 33458761 DOI: 10.1093/bib/bbaa426] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
337 Elnoby AS. Clinical Consideration of Glucocorticoids in COVID-19. J Pharm Pract 2021;34:181-2. [PMID: 33455524 DOI: 10.1177/0897190020987124] [Reference Citation Analysis]
338 Tapaskar N, Colon Hidalgo D, Koo G, Shingada K, Rao S, Rodriguez R, Alcantar D, Espinoza Barrera D, Lee R, Rameshkumar N, Amine M, Rodrigues S, Giron F, Chaugule A, Rech MA. Sedation Usage in COVID-19 Acute Respiratory Distress Syndrome: A Multicenter Study. Ann Pharmacother 2022;56:117-23. [PMID: 34075807 DOI: 10.1177/10600280211021925] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
339 Sobral MFF, Roazzi A, da Penha Sobral AIG, de Oliveira BRB, Duarte GB, da Silva JF, Nogueira RMTBL. A retrospective cohort study of 238,000 COVID-19 hospitalizations and deaths in Brazil. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-07538-0] [Reference Citation Analysis]
340 Miller-Handley H, Luckett K, Govil A. Treatment Options for Coronavirus Disease 2019 in Patients With Reduced or Absent Kidney Function. Adv Chronic Kidney Dis 2020;27:434-41. [PMID: 33308510 DOI: 10.1053/j.ackd.2020.09.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
341 Ribeiro TDS, Stechi G, Castro PCD, Viana AL. Comunicação em saúde sobre COVID-19 e Diabetes Mellitus em mídias sociais: verdadeiro e falso. Esc Anna Nery 2022;26:e20210358. [DOI: 10.1590/2177-9465-ean-2021-0358] [Reference Citation Analysis]
342 Luo YH, Chiu HY, Weng CS, Chen YM. Overview of coronavirus disease 2019: Treatment updates and advances. J Chin Med Assoc 2020;83:805-8. [PMID: 32520770 DOI: 10.1097/JCMA.0000000000000367] [Cited by in Crossref: 5] [Article Influence: 2.5] [Reference Citation Analysis]
343 Kichloo A, Kumar A, Amir R, Aljadah M, Farooqi N, Albosta M, Singh J, Jamal S, El-Amir Z, Kichloo A, Lone N. Utilization of extracorporeal membrane oxygenation during the COVID-19 pandemic. World J Crit Care Med 2021; 10(1): 1-11 [PMID: 33505868 DOI: 10.5492/wjccm.v10.i1.1] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
344 Dorjee K, Kim H, Bonomo E, Dolma R. Prevalence and predictors of death and severe disease in patients hospitalized due to COVID-19: A comprehensive systematic review and meta-analysis of 77 studies and 38,000 patients. PLoS One 2020;15:e0243191. [PMID: 33284825 DOI: 10.1371/journal.pone.0243191] [Cited by in Crossref: 30] [Cited by in F6Publishing: 37] [Article Influence: 15.0] [Reference Citation Analysis]
345 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
346 Pourabdollah Toutkaboni M, Askari E, Khalili N, Tabarsi P, Jamaati H, Velayati AA, Dorudinia A, Rezaei M, Nadji SA, Mohamadnia A, Khalili N. Demographics, laboratory parameters and outcomes of 1061 patients with coronavirus disease 2019: a report from Tehran, Iran. New Microbes New Infect 2020;38:100777. [PMID: 33042553 DOI: 10.1016/j.nmni.2020.100777] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
347 Sahni S, Gupta G, Sarda R, Pandey S, Pandey RM, Sinha S. Impact of metabolic and cardiovascular disease on COVID-19 mortality: A systematic review and meta-analysis. Diabetes Metab Syndr 2021;15:102308. [PMID: 34673359 DOI: 10.1016/j.dsx.2021.102308] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
348 Coll E, Fernández-Ruiz M, Sánchez-Álvarez JE, Martínez-Fernández JR, Crespo M, Gayoso J, Bada-Bosch T, Oppenheimer F, Moreso F, López-Oliva MO, Melilli E, Rodríguez-Ferrero ML, Bravo C, Burgos E, Facundo C, Lorenzo I, Yañez Í, Galeano C, Roca A, Cabello M, Gómez-Bueno M, García-Cosío M, Graus J, Lladó L, de Pablo A, Loinaz C, Aguado B, Hernández D, Domínguez-Gil B; Spanish Group for the Study of COVID-19 in Transplant Recipients. COVID-19 in transplant recipients: The Spanish experience. Am J Transplant 2021;21:1825-37. [PMID: 33098200 DOI: 10.1111/ajt.16369] [Cited by in Crossref: 79] [Cited by in F6Publishing: 64] [Article Influence: 39.5] [Reference Citation Analysis]
349 Brown LB, Spinelli MA, Gandhi M. The interplay between HIV and COVID-19: summary of the data and responses to date. Curr Opin HIV AIDS 2021;16:63-73. [PMID: 33186229 DOI: 10.1097/COH.0000000000000659] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 14.0] [Reference Citation Analysis]
350 Lee E, Krajewski A, Clarke C, O'Sullivan D, Herbst T, Lee S. Arterial and venous thromboembolic complications of COVID-19 detected by CT angiogram and venous duplex ultrasound. Emerg Radiol 2021;28:469-76. [PMID: 33428043 DOI: 10.1007/s10140-020-01884-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
351 Bailey CJ, Gwilt M. Diabetes, Metformin and the Clinical Course of Covid-19: Outcomes, Mechanisms and Suggestions on the Therapeutic Use of Metformin. Front Pharmacol 2022;13:784459. [PMID: 35370738 DOI: 10.3389/fphar.2022.784459] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
352 Chopra A, Chieng HC, Austin A, Tiwari A, Mehta S, Nautiyal A, Al-Tarbsheh AH, Jain E, Feustel PJ, Shkolnik B, Jaitovich A. Corticosteroid Administration Is Associated With Improved Outcome in Patients With Severe Acute Respiratory Syndrome Coronavirus 2-Related Acute Respiratory Distress Syndrome. Crit Care Explor 2020;2:e0143. [PMID: 32696006 DOI: 10.1097/CCE.0000000000000143] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
353 Rubin DT, Abreu MT, Rai V, Siegel CA;  International Organization for the Study of Inflammatory Bowel Disease. Management of Patients With Crohn's Disease and Ulcerative Colitis During the Coronavirus Disease-2019 Pandemic: Results of an International Meeting. Gastroenterology. 2020;159:6-13.e6. [PMID: 32272113 DOI: 10.1053/j.gastro.2020.04.002] [Cited by in Crossref: 91] [Cited by in F6Publishing: 97] [Article Influence: 45.5] [Reference Citation Analysis]
354 Tan W, Aboulhosn J. The cardiovascular burden of coronavirus disease 2019 (COVID-19) with a focus on congenital heart disease. Int J Cardiol 2020;309:70-7. [PMID: 32248966 DOI: 10.1016/j.ijcard.2020.03.063] [Cited by in Crossref: 126] [Cited by in F6Publishing: 106] [Article Influence: 63.0] [Reference Citation Analysis]
355 Pustahija T, Ristić M, Medić S, Vuković V, Štrbac M, Rajčević S, Patić A, Petrović V. Epidemiological characteristics of COVID-19 travel-associated cases in Vojvodina, Serbia, during 2020. PLoS One 2021;16:e0261840. [PMID: 34941947 DOI: 10.1371/journal.pone.0261840] [Reference Citation Analysis]
356 Fernandez J, Gratacos-Ginès J, Olivas P, Costa M, Nieto S, Mateo D, Sánchez MB, Aguilar F, Bassegoda O, Ruiz P, Caballol B, Pocurull A, Llach J, Mustieles MJ, Cid J, Reverter E, Toapanta ND, Hernández-Tejero M, Martínez JA, Claria J, Fernández C, Mensa J, Arroyo V, Castro P, Lozano M; Covid Clinic Critical Care (CCCC) Group. Plasma Exchange: An Effective Rescue Therapy in Critically Ill Patients With Coronavirus Disease 2019 Infection. Crit Care Med 2020;48:e1350-5. [PMID: 32833695 DOI: 10.1097/CCM.0000000000004613] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 5.5] [Reference Citation Analysis]
357 Costa LMAD, Nunes RAB, Scudeler TL. Cardiopulmonary Resuscitation in Prone Position. International Journal of Cardiovascular Sciences 2021. [DOI: 10.36660/ijcs.20200091] [Reference Citation Analysis]
358 Imam Z, Odish F, Gill I, O'Connor D, Armstrong J, Vanood A, Ibironke O, Hanna A, Ranski A, Halalau A. Older age and comorbidity are independent mortality predictors in a large cohort of 1305 COVID-19 patients in Michigan, United States. J Intern Med 2020;288:469-76. [PMID: 32498135 DOI: 10.1111/joim.13119] [Cited by in Crossref: 113] [Cited by in F6Publishing: 98] [Article Influence: 56.5] [Reference Citation Analysis]
359 Niedźwiedzka-Rystwej P, Majchrzak A, Kurkowska S, Małkowska P, Sierawska O, Hrynkiewicz R, Parczewski M. Immune Signature of COVID-19: In-Depth Reasons and Consequences of the Cytokine Storm. Int J Mol Sci 2022;23:4545. [PMID: 35562935 DOI: 10.3390/ijms23094545] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
360 Tortonese S, Scriabine I, Anjou L, Loens C, Michon A, Benabdelhak M, Ouali S, Morin G, Laifi M, Dobosziewicz H, Guillet M, Dekeyser M, Luong Nguyen LB, Grünenwald A, Dang J, Desbuissons G, Becquemont L, Snanoudj R, Legendre C, Hebibi H, Lefèvre E, Beaudreuil S, Zaidan M; AP-HP/Universities/Inserm COVID-19 research collaboration. COVID-19 in Patients on Maintenance Dialysis in the Paris Region. Kidney Int Rep 2020;5:1535-44. [PMID: 32838082 DOI: 10.1016/j.ekir.2020.07.016] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
361 Liu W, Guan WJ, Zhong NS. Strategies and Advances in Combating COVID-19 in China. Engineering (Beijing) 2020;6:1076-84. [PMID: 33078078 DOI: 10.1016/j.eng.2020.10.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
362 Vrillon A, Hourregue C, Azuar J, Grosset L, Boutelier A, Tan S, Roger M, Mourman V, Mouly S, Sène D, François V, Dumurgier J, Paquet C; for LRB COVID Group. COVID-19 in Older Adults: A Series of 76 Patients Aged 85 Years and Older with COVID-19. J Am Geriatr Soc 2020;68:2735-43. [PMID: 33045106 DOI: 10.1111/jgs.16894] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
363 Ogen Y. Response to the commentary by Alexandra A. Chudnovsky on 'Assessing nitrogen dioxide (NO 2 ) levels as a contributing factor to coronavirus (COVID-19) fatality'. Sci Total Environ 2020;740:139239. [PMID: 32402464 DOI: 10.1016/j.scitotenv.2020.139239] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
364 de Lucena TMC, da Silva Santos AF, de Lima BR, de Albuquerque Borborema ME, de Azevêdo Silva J. Mechanism of inflammatory response in associated comorbidities in COVID-19. Diabetes Metab Syndr 2020;14:597-600. [PMID: 32417709 DOI: 10.1016/j.dsx.2020.05.025] [Cited by in Crossref: 56] [Cited by in F6Publishing: 42] [Article Influence: 28.0] [Reference Citation Analysis]
365 Balaz D, Wikman-Jorgensen PE, Galvañ VG, Rubio-Rivas M, de Miguel Campo B, López MN, Caleya JFL, Huelgas RG, Fontán PMP, Bailón MM, Fernández-Garcés M, Cruz AF, García GMG, Rhyman N, Corral-Gudino L, Rodríguez-Mancheño AL, De La Chica MN, García AT, Alcalá JN, Jiménez PD, Trallero LER, Casanova PC, Núñez-Cortés JM, Casas-Rojo JM, On Behalf Of The Semi-Covid-Network. Evolution of the Use of Corticosteroids for the Treatment of Hospitalised COVID-19 Patients in Spain between March and November 2020: SEMI-COVID National Registry. J Clin Med 2021;10:4610. [PMID: 34640628 DOI: 10.3390/jcm10194610] [Reference Citation Analysis]
366 Baracy M Jr, Afzal F, Szpunar SM, Tremp M, Grace K, Liovas M, Aslam MF. Coronavirus disease 2019 (COVID-19) and the risk of hypertensive disorders of pregnancy: a retrospective cohort study. Hypertens Pregnancy 2021;40:226-35. [PMID: 34428127 DOI: 10.1080/10641955.2021.1965621] [Reference Citation Analysis]
367 Korsunov V, Georgiyants M, Skoryk V. CENTRAL HEMODYNAMICS AND OXYGEN TRANSPORT IN PATIENTS WITH ACUTE RESPIRATORY DISTRESS SYNDROME CAUSED BY COVID-19 AND THEIR IMPACT ON THE COURSE AND OUTCOMES OF THE DISEASE. Eureka: HS 2021. [DOI: 10.21303/2504-5679.2021.001622] [Reference Citation Analysis]
368 Masola V, Greco N, Gambaro G, Franchi M, Onisto M. Heparanase as active player in endothelial glycocalyx remodeling. Matrix Biol Plus 2022;13:100097. [PMID: 35036899 DOI: 10.1016/j.mbplus.2021.100097] [Reference Citation Analysis]
369 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
370 Allez M, Fleshner P, Gearry R, Lakatos PL, Rubin DT. Care of the Patient With IBD Requiring Hospitalisation During the COVID-19 Pandemic. J Crohns Colitis. 2020;14:S774-S779. [PMID: 32722757 DOI: 10.1093/ecco-jcc/jjaa150] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
371 Avdeev SN, Yaroshetskiy AI, Tsareva NA, Merzhoeva ZM, Trushenko NV, Nekludova GV, Chikina SY. Noninvasive ventilation for acute hypoxemic respiratory failure in patients with COVID-19. Am J Emerg Med 2021;39:154-7. [PMID: 33067061 DOI: 10.1016/j.ajem.2020.09.075] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
372 Gubernatorova EO, Gorshkova EA, Polinova AI, Drutskaya MS. IL-6: Relevance for immunopathology of SARS-CoV-2.Cytokine Growth Factor Rev. 2020;53:13-24. [PMID: 32475759 DOI: 10.1016/j.cytogfr.2020.05.009] [Cited by in Crossref: 89] [Cited by in F6Publishing: 80] [Article Influence: 44.5] [Reference Citation Analysis]
373 Aleva FE, van Mourik L, Broeders MEAC, Paling AJ, de Jager CPC. COVID-19 in critically ill patients in North Brabant, the Netherlands: Patient characteristics and outcomes. J Crit Care 2020;60:111-5. [PMID: 32799179 DOI: 10.1016/j.jcrc.2020.08.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
374 Singh R, Sarsaiya S, Singh TA, Singh T, Pandey LK, Pandey PK, Khare N, Sobin F, Sikarwar R, Gupta MK. Corona Virus (COVID-19) Symptoms Prevention and Treatment: A Short Review. J Drug Delivery Ther 2021;11:118-20. [DOI: 10.22270/jddt.v11i2-s.4644] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
375 O'Meara L, Turner C, Coitinho DC, Oenema S. Consumer experiences of food environments during the Covid-19 pandemic: Global insights from a rapid online survey of individuals from 119 countries. Glob Food Sec 2022;32:100594. [PMID: 34812406 DOI: 10.1016/j.gfs.2021.100594] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
376 Can Ö, Bilek G, Sahan S. Risk factors for infection and mortality among hemodialysis patients during COVID-19 pandemic. Int Urol Nephrol 2021. [PMID: 34227016 DOI: 10.1007/s11255-021-02926-3] [Reference Citation Analysis]
377 Lodge MDS, Abeygunaratne T, Alderson H, Ali I, Brown N, Chrysochou C, Donne R, Erekosima I, Evans P, Flanagan E, Gray S, Green D, Hegarty J, Hyde A, Kalra PA, Lamerton E, Lewis D, Middleton R, New D, Nipah R, O'Donoghue D, O'Riordan E, Poulikakos D, Rainone F, Raman M, Ritchie J, Sinha S, Wood G, Tollitt J. Safely reducing haemodialysis frequency during the COVID-19 pandemic. BMC Nephrol 2020;21:532. [PMID: 33287730 DOI: 10.1186/s12882-020-02172-2] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
378 Jęśkowiak I, Wiatrak B, Grosman-Dziewiszek P, Szeląg A. The Incidence and Severity of Post-Vaccination Reactions after Vaccination against COVID-19. Vaccines (Basel) 2021;9:502. [PMID: 34067955 DOI: 10.3390/vaccines9050502] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
379 Firstenberg MS, Libby M, Roberts R, Petersen C, Hanna J. Complete pulmonary recovery after COVID-19 infection requiring extracorporeal membrane oxygenation: A case report. Int J Crit Illn Inj Sci 2020;10:155-7. [PMID: 33409133 DOI: 10.4103/IJCIIS.IJCIIS_132_20] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
380 McElvaney OJ, McEvoy NL, McElvaney OF, Carroll TP, Murphy MP, Dunlea DM, Ní Choileáin O, Clarke J, O'Connor E, Hogan G, Ryan D, Sulaiman I, Gunaratnam C, Branagan P, O'Brien ME, Morgan RK, Costello RW, Hurley K, Walsh S, de Barra E, McNally C, McConkey S, Boland F, Galvin S, Kiernan F, O'Rourke J, Dwyer R, Power M, Geoghegan P, Larkin C, O'Leary RA, Freeman J, Gaffney A, Marsh B, Curley GF, McElvaney NG. Characterization of the Inflammatory Response to Severe COVID-19 Illness. Am J Respir Crit Care Med 2020;202:812-21. [PMID: 32584597 DOI: 10.1164/rccm.202005-1583OC] [Cited by in Crossref: 123] [Cited by in F6Publishing: 105] [Article Influence: 61.5] [Reference Citation Analysis]
381 Dalamaga M, Karampela I, Mantzoros CS. Commentary: Phosphodiesterase 4 inhibitors as potential adjunct treatment targeting the cytokine storm in COVID-19. Metabolism 2020;109:154282. [PMID: 32497535 DOI: 10.1016/j.metabol.2020.154282] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 11.5] [Reference Citation Analysis]
382 Cummings MJ, Baldwin MR, Abrams D, Jacobson SD, Meyer BJ, Balough EM, Aaron JG, Claassen J, Rabbani LE, Hastie J, Hochman BR, Salazar-Schicchi J, Yip NH, Brodie D, O'Donnell MR. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet 2020;395:1763-70. [PMID: 32442528 DOI: 10.1016/S0140-6736(20)31189-2] [Cited by in Crossref: 846] [Cited by in F6Publishing: 551] [Article Influence: 423.0] [Reference Citation Analysis]
383 d'Annunzio G, Maffeis C, Cherubini V, Rabbone I, Scaramuzza A, Schiaffini R, Minuto N, Piccolo G, Maghnie M. Caring for children and adolescents with type 1 diabetes mellitus: Italian Society for Pediatric Endocrinology and Diabetology (ISPED) statements during COVID-19 pandemia. Diabetes Res Clin Pract 2020;168:108372. [PMID: 32827594 DOI: 10.1016/j.diabres.2020.108372] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
384 Mascolo S, Carleo MA, Contieri M, Izzo S, Perna A, De Luca A, Esposito V. SARS-CoV-2 and inflammatory responses: From mechanisms to the potential therapeutic use of intravenous immunoglobulin. J Med Virol 2021;93:2654-61. [PMID: 33150961 DOI: 10.1002/jmv.26651] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
385 Ruch Y, Kaeuffer C, Ohana M, Labani A, Fabacher T, Bilbault P, Kepka S, Solis M, Greigert V, Lefebvre N, Hansmann Y, Danion F. CT lung lesions as predictors of early death or ICU admission in COVID-19 patients. Clin Microbiol Infect 2020;26:1417.e5-8. [PMID: 32717417 DOI: 10.1016/j.cmi.2020.07.030] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
386 Skalny AV, Rink L, Ajsuvakova OP, Aschner M, Gritsenko VA, Alekseenko SI, Svistunov AA, Petrakis D, Spandidos DA, Aaseth J, Tsatsakis A, Tinkov AA. Zinc and respiratory tract infections: Perspectives for COVID‑19 (Review). Int J Mol Med 2020;46:17-26. [PMID: 32319538 DOI: 10.3892/ijmm.2020.4575] [Cited by in Crossref: 76] [Cited by in F6Publishing: 117] [Article Influence: 38.0] [Reference Citation Analysis]
387 Fiorillo A, Sampogna G, Giallonardo V, Del Vecchio V, Luciano M, Albert U, Carmassi C, Carrà G, Cirulli F, Dell'Osso B, Nanni MG, Pompili M, Sani G, Tortorella A, Volpe U. Effects of the lockdown on the mental health of the general population during the COVID-19 pandemic in Italy: Results from the COMET collaborative network. Eur Psychiatry 2020;63:e87. [PMID: 32981568 DOI: 10.1192/j.eurpsy.2020.89] [Cited by in Crossref: 41] [Cited by in F6Publishing: 29] [Article Influence: 20.5] [Reference Citation Analysis]
388 Al Mutair A, Alhumaid S, Alhuqbani WN, Zaidi ARZ, Alkoraisi S, Al-Subaie MF, AlHindi AM, Abogosh AK, Alrasheed AK, Alsharafi AA, Alhuqbani MN, Alhowar NA, Salih S, Alhedaithy MA, Al-Tawfiq JA, Al-Shammari H, Abdulqawi R, Ismail AF, Hamdan N, Saad F, Olhaye FA, Eltahir TA, Rabaan AA, Al-Omari A. Clinical, epidemiological, and laboratory characteristics of mild-to-moderate COVID-19 patients in Saudi Arabia: an observational cohort study. Eur J Med Res 2020;25:61. [PMID: 33239068 DOI: 10.1186/s40001-020-00462-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 7.5] [Reference Citation Analysis]
389 Cortés-Tellés A, López-Romero S, Mancilla-Ceballos R, Ortíz-Farías DL, Núñez-Caamal N, Figueroa-Hurtado E. Risk Factors for Mortality in Hospitalized Patients with COVID-19: An Overview in a Mexican Population. Tuberc Respir Dis (Seoul) 2020;83:S46-54. [PMID: 33121231 DOI: 10.4046/trd.2020.0095] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
390 Alavi Darazam I, Hatami F, Mahdi Rabiei M, Amin Pourhoseingholi M, Shabani M, Shokouhi S, Mardani M, Moradi O, Javandoust Gharehbagh F, Mirtalaee N, Negahban H, Amirdosara M, Zangi M, Hajiesmaeili M, Kazempour M, Shafigh N. An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a in severe COVID-19: The COVIFERON II randomized controlled trial. Int Immunopharmacol 2021;99:107916. [PMID: 34224994 DOI: 10.1016/j.intimp.2021.107916] [Reference Citation Analysis]
391 Koschmieder S, Jost E, Cornelissen C, Müller T, Schulze-Hagen M, Bickenbach J, Marx G, Kleines M, Marx N, Brümmendorf TH, Dreher M. Favorable COVID-19 course despite significant comorbidities in a ruxolitinib-treated patient with primary myelofibrosis. Eur J Haematol 2020;105:655-8. [PMID: 32593209 DOI: 10.1111/ejh.13480] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
392 Iglesias JI, Vassallo AV, Sullivan JB, Elbaga Y, Patel VV, Patel N, Ayad L, Benson P, Pittiglio M, Gobran E, Clark A, Khan W, Damalas K, Mohan R, Singh SP. Retrospective analysis of anti-inflammatory therapies during the first wave of COVID-19 at a community hospital. World J Crit Care Med 2021; 10(5): 244-259 [PMID: 34616660 DOI: 10.5492/wjccm.v10.i5.244] [Reference Citation Analysis]
393 Brogna B, Bignardi E, Brogna C, Volpe M, Lombardi G, Rosa A, Gagliardi G, Capasso PFM, Gravino E, Maio F, Pane F, Picariello V, Buono M, Colucci L, Musto LA. A Pictorial Review of the Role of Imaging in the Detection, Management, Histopathological Correlations, and Complications of COVID-19 Pneumonia. Diagnostics (Basel) 2021;11:437. [PMID: 33806423 DOI: 10.3390/diagnostics11030437] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
394 Zhou S, Mi S, Luo S, Wang Y, Ren B, Cai L, Wu M. Risk Factors for Mortality in 220 Patients With COVID-19 in Wuhan, China: A Single-Center, Retrospective Study. Ear Nose Throat J 2021;100:140S-7S. [PMID: 33155834 DOI: 10.1177/0145561320972608] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
395 Dong Y, Dai T, Liu J, Zhang L, Zhou F. Coronavirus in Continuous Flux: From SARS-CoV to SARS-CoV-2. Adv Sci (Weinh) 2020;7:2001474. [PMID: 32837848 DOI: 10.1002/advs.202001474] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
396 Mornese Pinna S, Lupia T, Scabini S, Vita D, De Benedetto I, Gaviraghi A, Colasanto I, Varese A, Cattel F, De Rosa FG, Corcione S. Monoclonal antibodies for the treatment of COVID-19 patients: An umbrella to overcome the storm? Int Immunopharmacol 2021;101:108200. [PMID: 34607231 DOI: 10.1016/j.intimp.2021.108200] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
397 Ghanei M. It is time to consider an anti-inflammatory therapy based on the pathophysiology of COVID-19 infection during the right time window? Arch Med Sci 2021;17:546-50. [PMID: 33747291 DOI: 10.5114/aoms/130647] [Reference Citation Analysis]
398 Al-Zaidan L, Mestiri S, Raza A, Merhi M, Inchakalody VP, Fernandes Q, Taib N, Uddin S, Dermime S. The expression of hACE2 receptor protein and its involvement in SARS-CoV-2 entry, pathogenesis, and its application as potential therapeutic target. Tumour Biol 2021;43:177-96. [PMID: 34420993 DOI: 10.3233/TUB-200084] [Reference Citation Analysis]
399 Gemelli Against COVID-19 Post-Acute Care Study Group. Post-COVID-19 global health strategies: the need for an interdisciplinary approach. Aging Clin Exp Res 2020;32:1613-20. [PMID: 32529595 DOI: 10.1007/s40520-020-01616-x] [Cited by in Crossref: 82] [Cited by in F6Publishing: 55] [Article Influence: 41.0] [Reference Citation Analysis]
400 Chan EY. Moral foundations underlying behavioral compliance during the COVID-19 pandemic. Pers Individ Dif 2021;171:110463. [PMID: 33106715 DOI: 10.1016/j.paid.2020.110463] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
401 Ikeda S, Misumi T, Izumi S, Sakamoto K, Nishimura N, Ro S, Fukunaga K, Okamori S, Tachikawa N, Miyata N, Shinkai M, Shinoda M, Miyazaki Y, Iijima Y, Izumo T, Inomata M, Okamoto M, Yamaguchi T, Iwabuchi K, Masuda M, Takoi H, Oyamada Y, Fujitani S, Mineshita M, Ishii H, Nakagawa A, Yamaguchi N, Hibino M, Tsushima K, Nagai T, Ishikawa S, Ishikawa N, Kondoh Y, Yamazaki Y, Gocho K, Nishizawa T, Tsuzuku A, Yagi K, Shindo Y, Takeda Y, Yamanaka T, Ogura T. Corticosteroids for hospitalized patients with mild to critically-ill COVID-19: a multicenter, retrospective, propensity score-matched study. Sci Rep 2021;11:10727. [PMID: 34021229 DOI: 10.1038/s41598-021-90246-y] [Reference Citation Analysis]
402 Karras A, Livrozet M, Lazareth H, Benichou N, Hulot JS, Fayol A, Chauvet S, Jannot AS, Penet MA, Diehl JL, Godier A, Sanchez O, Mirault T, Thervet E, Pallet N. Proteinuria and Clinical Outcomes in Hospitalized COVID-19 Patients: A Retrospective Single-Center Study. Clin J Am Soc Nephrol 2021:CJN. [PMID: 33661756 DOI: 10.2215/CJN.09130620] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
403 Amgalan A, Othman M. Hemostatic laboratory derangements in COVID-19 with a focus on platelet count. Platelets 2020;31:740-5. [DOI: 10.1080/09537104.2020.1768523] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 9.5] [Reference Citation Analysis]
404 [DOI: 10.1101/2020.04.29.20084533] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
405 Semczuk-Kaczmarek K, Rys-Czaporowska A, Sierdzinski J, Kaczmarek LD, Szymanski FM, Platek AE. Association between air pollution and COVID-19 mortality and morbidity. Intern Emerg Med 2021. [PMID: 34637085 DOI: 10.1007/s11739-021-02834-5] [Reference Citation Analysis]
406 Kumar S, Mehta S, Sarangdhar N, Ray A, Sinha S, Wig N. Management of COVID-19 from the pulmonologist's perspective: a narrative review. Expert Rev Respir Med 2021;15:519-35. [PMID: 33211553 DOI: 10.1080/17476348.2021.1853529] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
407 Stessel B, Vanvuchelen C, Bruckers L, Geebelen L, Callebaut I, Vandenbrande J, Pellens B, Van Tornout M, Ory JP, van Halem K, Messiaen P, Herbots L, Ramaekers D, Dubois J. Impact of implementation of an individualised thromboprophylaxis protocol in critically ill ICU patients with COVID-19: A longitudinal controlled before-after study. Thromb Res 2020;194:209-15. [PMID: 32788120 DOI: 10.1016/j.thromres.2020.07.038] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 9.5] [Reference Citation Analysis]
408 Thakkar S, Arora S, Kumar A, Jaswaney R, Faisaluddin M, Ammad Ud Din M, Shariff M, Barssoum K, Patel HP, Nirav A, Jani C, Patel K, Savani S, DeSimone C, Mulpuru S, Deshmukh A. A Systematic Review of the Cardiovascular Manifestations and Outcomes in the Setting of Coronavirus-19 Disease. Clin Med Insights Cardiol 2020;14:1179546820977196. [PMID: 33312009 DOI: 10.1177/1179546820977196] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
409 Barrantes FJ. While We Wait for a Vaccine Against SARS-CoV-2, Why Not Think About Available Drugs? Front Physiol 2020;11:820. [PMID: 32719619 DOI: 10.3389/fphys.2020.00820] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
410 Gandini O, Criniti A, Ballesio L, Giglio S, Galardo G, Gianni W, Santoro L, Angeloni A, Lubrano C. Serum Ferritin is an independent risk factor for Acute Respiratory Distress Syndrome in COVID-19. J Infect 2020;81:979-97. [PMID: 32946917 DOI: 10.1016/j.jinf.2020.09.006] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
411 Zaim S, Chong JH, Sankaranarayanan V, Harky A. COVID-19 and Multiorgan Response. Curr Probl Cardiol 2020;45:100618. [PMID: 32439197 DOI: 10.1016/j.cpcardiol.2020.100618] [Cited by in Crossref: 286] [Cited by in F6Publishing: 268] [Article Influence: 143.0] [Reference Citation Analysis]
412 de Andrade CLT, Pereira CCA, Martins M, Lima SML, Portela MC. COVID-19 hospitalizations in Brazil's Unified Health System (SUS). PLoS One 2020;15:e0243126. [PMID: 33301479 DOI: 10.1371/journal.pone.0243126] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
413 Elahi S. Hematopoietic responses to SARS-CoV-2 infection. Cell Mol Life Sci 2022;79. [DOI: 10.1007/s00018-022-04220-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
414 Zucker J, Gomez-Simmonds A, Purpura LJ, Shoucri S, LaSota E, Morley NE, Sovic BW, Castellon MA, Theodore DA, Bartram LL, Miko BA, Scherer ML, Meyers KA, Turner WC, Kelly M, Pavlicova M, Basaraba CN, Baldwin MR, Brodie D, Burkart KM, Bathon J, Uhlemann AC, Yin MT, Castor D, Sobieszczyk ME. Supervised Machine Learning Approach to Identify Early Predictors of Poor Outcome in Patients with COVID-19 Presenting to a Large Quaternary Care Hospital in New York City. J Clin Med 2021;10:3523. [PMID: 34441819 DOI: 10.3390/jcm10163523] [Reference Citation Analysis]
415 Davis J, Leff R, Patel A, Venkatesan S. Mortality of critical care interventions in the COVID-19: A systematic review. World J Meta-Anal 2021; 9(1): 64-73 [DOI: 10.13105/wjma.v9.i1.64] [Reference Citation Analysis]
416 Zhang R, Liu Y, Zhang B, Wu C, Zhou J, Zhang Y, Yang W, Li Z, Shi S. Coagulopathy is associated with multiple organ damage and prognosis of COVID-19. EXCLI J 2021;20:174-91. [PMID: 33564286 DOI: 10.17179/excli2020-2853] [Reference Citation Analysis]
417 Tahir Huyut M, Huyut Z, İlkbahar F, Mertoğlu C. What is the impact and efficacy of routine immunological, biochemical and hematological biomarkers as predictors of COVID-19 mortality? International Immunopharmacology 2022;105:108542. [DOI: 10.1016/j.intimp.2022.108542] [Reference Citation Analysis]
418 Sitanggang JS, Siregar KB, Sitanggang HH, Sprinse Vinolina N. Prevalence and characteristics of cancer patients with COVID-19: a meta-analysis study. F1000Res 2021;10:975. [DOI: 10.12688/f1000research.53539.1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
419 Cecchetti G, Vabanesi M, Chieffo R, Fanelli G, Minicucci F, Agosta F, Tresoldi M, Zangrillo A, Filippi M. Cerebral involvement in COVID-19 is associated with metabolic and coagulation derangements: an EEG study. J Neurol 2020;267:3130-4. [PMID: 32556572 DOI: 10.1007/s00415-020-09958-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
420 Liu Z, Shi F, Liu JX, Liu JQ, Li J, Wang Q, Wang H, Gao CL, Li JM, Zhao DF. Clinical Efficacy of Corticosteroids in the Early Stages of Deterioration in COVID-19 Pneumonia. Infect Drug Resist 2021;14:2667-74. [PMID: 34285519 DOI: 10.2147/IDR.S314938] [Reference Citation Analysis]
421 Nasonov EL. IMMUNOPATHOLOGY AND IMMUNOPHARMACOTHERAPY OF CORONAVIRUS DISEASE 2019 (COVID-19): FOCUS ON INTERLEUKIN 6. Naučno-praktičeskaâ revmatologiâ 2020;58:245-61. [DOI: 10.14412/1995-4484-2020-245-261] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
422 Overmyer KA, Shishkova E, Miller IJ, Balnis J, Bernstein MN, Peters-Clarke TM, Meyer JG, Quan Q, Muehlbauer LK, Trujillo EA, He Y, Chopra A, Chieng HC, Tiwari A, Judson MA, Paulson B, Brademan DR, Zhu Y, Serrano LR, Linke V, Drake LA, Adam AP, Schwartz BS, Singer HA, Swanson S, Mosher DF, Stewart R, Coon JJ, Jaitovich A. Large-Scale Multi-omic Analysis of COVID-19 Severity. Cell Syst 2021;12:23-40.e7. [PMID: 33096026 DOI: 10.1016/j.cels.2020.10.003] [Cited by in Crossref: 90] [Cited by in F6Publishing: 93] [Article Influence: 45.0] [Reference Citation Analysis]
423 Jarkovsky J, Benesova K, Cerny V, Razova J, Kala P, Dolina J, Majek O, Sebestova S, Bezdekova M, Melicharova H, Snajdrova L, Dusek L, Parenica J. Covidogram as a simple tool for predicting severe course of COVID-19: population-based study. BMJ Open 2021;11:e045442. [PMID: 33622955 DOI: 10.1136/bmjopen-2020-045442] [Reference Citation Analysis]
424 Shang Y, Pan C, Yang X, Zhong M, Shang X, Wu Z, Yu Z, Zhang W, Zhong Q, Zheng X, Sang L, Jiang L, Zhang J, Xiong W, Liu J, Chen D. Management of critically ill patients with COVID-19 in ICU: statement from front-line intensive care experts in Wuhan, China. Ann Intensive Care 2020;10:73. [PMID: 32506258 DOI: 10.1186/s13613-020-00689-1] [Cited by in Crossref: 54] [Cited by in F6Publishing: 41] [Article Influence: 27.0] [Reference Citation Analysis]
425 Brance ML, Cóccaro NM, Casalongue AN, Durán A, Brun LR. Extensive progressive heterotopic ossification post-Covid-19 in a man. Bone 2022;155:116287. [PMID: 34896358 DOI: 10.1016/j.bone.2021.116287] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
426 Pang L, Liu Y, Shen M, Ye J, Chen R, Lan Z, Wu Z, Guo Y, Zhang P. Influence of aging on deterioration of patients with COVID-19. Aging (Albany NY) 2020;12:26248-62. [PMID: 33232272 DOI: 10.18632/aging.202136] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
427 Beni ZN, Beni AN, Samani FR, Dayani MA, Beni FN, Radmehr H, Noorshargh P. Multivariable analysis of clinical and laboratory data manifestations predicting severity and mortality risk in patients with Coronavirus disease 2019 in the mountainous west of Iran: a retrospective single-center study. Asian Biomedicine 2022;16:31-42. [DOI: 10.2478/abm-2022-0005] [Reference Citation Analysis]
428 Ho KS, Howell D, Rogers L, Narasimhan B, Verma H, Steiger D. The relationship between asthma, eosinophilia, and outcomes in coronavirus disease 2019 infection. Ann Allergy Asthma Immunol 2021;127:42-8. [PMID: 33647451 DOI: 10.1016/j.anai.2021.02.021] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
429 López-Reyes R, Oscullo G, Jiménez D, Cano I, García-Ortega A. Thrombotic Risk and Covid-19: Review of Current Evidence for a Better Diagnostic and Therapeutic Approach. Arch Bronconeumol 2021;57 Suppl 1:55-64. [PMID: 32950309 DOI: 10.1016/j.arbres.2020.07.033] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
430 Li C, Jiang J, Wang F, Zhou N, Veronese G, Moslehi JJ, Ammirati E, Wang DW. Longitudinal correlation of biomarkers of cardiac injury, inflammation, and coagulation to outcome in hospitalized COVID-19 patients. J Mol Cell Cardiol 2020;147:74-87. [PMID: 32827510 DOI: 10.1016/j.yjmcc.2020.08.008] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 11.0] [Reference Citation Analysis]
431 Shi C, Wang L, Ye J, Gu Z, Wang S, Xia J, Xie Y, Li Q, Xu R, Lin N. Predictors of mortality in patients with coronavirus disease 2019: a systematic review and meta-analysis. BMC Infect Dis 2021;21:663. [PMID: 34238232 DOI: 10.1186/s12879-021-06369-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
432 Monzani A, Tagliaferri F, Bellone S, Genoni G, Rabbone I. A Global Overview of COVID-19 Research in the Pediatric Field: Bibliometric Review. JMIR Pediatr Parent 2021;4:e24791. [PMID: 34081597 DOI: 10.2196/24791] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
433 Cori L, Curzio O, Adorni F, Prinelli F, Noale M, Trevisan C, Fortunato L, Giacomelli A, Bianchi F. Fear of COVID-19 for Individuals and Family Members: Indications from the National Cross-Sectional Study of the EPICOVID19 Web-Based Survey. Int J Environ Res Public Health 2021;18:3248. [PMID: 33801074 DOI: 10.3390/ijerph18063248] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
434 Oganesyan A, Menzulin R, Surovoy Y, Nikiforchin A, Zykov K. Target Groups for a Short Dexamethasone Course among Critically Ill COVID-19 Patients. Crit Care Res Pract 2021;2021:5557302. [PMID: 34877019 DOI: 10.1155/2021/5557302] [Reference Citation Analysis]
435 Biscetti F, Rando MM, Nardella E, Cecchini AL, Bruno P, Landolfi R, Flex A. Cardiovascular Disease and SARS-CoV-2: the Role of Host Immune Response Versus Direct Viral Injury. Int J Mol Sci 2020;21:E8141. [PMID: 33143371 DOI: 10.3390/ijms21218141] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
436 Yu PJ, Cassiere H, Bocchieri K, DeRosa S, Yar S, Hartman A. Hypermetabolism in critically ill patients with COVID-19 and the effects of hypothermia: A case series. Metabol Open 2020;7:100046. [PMID: 32808941 DOI: 10.1016/j.metop.2020.100046] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
437 Li CX, Noreen S, Zhang LX, Saeed M, Wu PF, Ijaz M, Dai DF, Maqbool I, Madni A, Akram F, Naveed M, Li JH. A critical analysis of SARS-CoV-2 (COVID-19) complexities, emerging variants, and therapeutic interventions and vaccination strategies. Biomed Pharmacother 2021;146:112550. [PMID: 34959116 DOI: 10.1016/j.biopha.2021.112550] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
438 Tabatabai A, Ghneim MH, Kaczorowski DJ, Shah A, Dave S, Haase DJ, Vesselinov R, Deatrick KB, Rabin J, Rabinowitz RP, Galvagno S Jr, O'Connor JV, Menaker J, Herr DL, Gammie JS, Scalea TM, Madathil RJ. Mortality Risk Assessment in COVID-19 Venovenous Extracorporeal Membrane Oxygenation. Ann Thorac Surg 2021:S0003-4975(21)00104-1. [PMID: 33485917 DOI: 10.1016/j.athoracsur.2020.12.050] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
439 [DOI: 10.1101/2020.09.09.288704] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
440 Okamori S, Lee H, Kondo Y, Akiyama Y, Kabata H, Kaneko Y, Ishii M, Hasegawa N, Fukunaga K. Coronavirus disease 2019-associated rapidly progressive organizing pneumonia with fibrotic feature: Two case reports. Medicine (Baltimore) 2020;99:e21804. [PMID: 32871900 DOI: 10.1097/MD.0000000000021804] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
441 Lumlertgul N, Pirondini L, Cooney E, Kok W, Gregson J, Camporota L, Lane K, Leach R, Ostermann M. Acute kidney injury prevalence, progression and long-term outcomes in critically ill patients with COVID-19: a cohort study. Ann Intensive Care 2021;11:123. [PMID: 34357478 DOI: 10.1186/s13613-021-00914-5] [Reference Citation Analysis]
442 Prével R, Dupont A, Labrouche-Colomer S, Garcia G, Dewitte A, Rauch A, Goutay J, Caplan M, Jozefowicz E, Lanoix JP, Poissy J, Rivière E, Orieux A, Malvy D, Gruson D, Garçon L, Susen S, James C. Plasma Markers of Neutrophil Extracellular Trap Are Linked to Survival but Not to Pulmonary Embolism in COVID-19-Related ARDS Patients. Front Immunol 2022;13:851497. [PMID: 35371025 DOI: 10.3389/fimmu.2022.851497] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
443 Almazeedi S, Al-Youha S, Jamal MH, Al-Haddad M, Al-Muhaini A, Al-Ghimlas F, Al-Sabah S. Characteristics, risk factors and outcomes among the first consecutive 1096 patients diagnosed with COVID-19 in Kuwait. EClinicalMedicine 2020;24:100448. [PMID: 32766546 DOI: 10.1016/j.eclinm.2020.100448] [Cited by in Crossref: 51] [Cited by in F6Publishing: 54] [Article Influence: 25.5] [Reference Citation Analysis]
444 Tahaghoghi-Hajghorbani S, Zafari P, Masoumi E, Rajabinejad M, Jafari-Shakib R, Hasani B, Rafiei A. The role of dysregulated immune responses in COVID-19 pathogenesis. Virus Res 2020;290:198197. [PMID: 33069815 DOI: 10.1016/j.virusres.2020.198197] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
445 Baker SM, Leedy DJ, Klafter JA, Zhang Y, Secrest KM, Osborn TR, Cheng RK, Judson SD, Merel SE, Mikacenic C, Bhatraju PK, Liles WC. Clinical presentation, complications, and outcomes of hospitalized COVID-19 patients in an academic center with a centralized palliative care consult service. Health Sci Rep 2021;4:e423. [PMID: 34754946 DOI: 10.1002/hsr2.423] [Reference Citation Analysis]
446 Lohse A, Klopfenstein T, Balblanc JC, Royer PY, Bossert M, Gendrin V, Charpentier A, Bozgan AM, Badie J, Bourgoin C, Contreras R, Mazurier I, Conrozier T, Zayet S. Predictive factors of mortality in patients treated with tocilizumab for acute respiratory distress syndrome related to coronavirus disease 2019 (COVID-19). Microbes Infect 2020;22:500-3. [PMID: 32574789 DOI: 10.1016/j.micinf.2020.06.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
447 Karcıoğlu O, Yüksel A, Baha A, Er AB, Esendağlı D, Gülhan PY, Karaoğlanoğlu S, Erçelik M, Şerifoğlu İ, Yıldız E, Köktürk N. Covid-19: The Biggest Threat of the 21st Century: In Respectful Memory of the Warriors All Over the World. Turk Thorac J 2020;21:409-18. [PMID: 33352097 DOI: 10.5152/TurkThoracJ.2020.20069] [Reference Citation Analysis]
448 Azkur AK, Akdis M, Azkur D, Sokolowska M, van de Veen W, Brüggen MC, O'Mahony L, Gao Y, Nadeau K, Akdis CA. Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19. Allergy 2020;75:1564-81. [PMID: 32396996 DOI: 10.1111/all.14364] [Cited by in Crossref: 521] [Cited by in F6Publishing: 410] [Article Influence: 260.5] [Reference Citation Analysis]
449 Smith D, Montagne J, Raices M, Dietrich A, Bisso IC, Las Heras M, San Román JE, García Fornari G, Figari M. Tracheostomy in the intensive care unit: Guidelines during COVID-19 worldwide pandemic. Am J Otolaryngol 2020;41:102578. [PMID: 32505993 DOI: 10.1016/j.amjoto.2020.102578] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
450 Beloncle FM, Pavlovsky B, Desprez C, Fage N, Olivier PY, Asfar P, Richard JC, Mercat A. Recruitability and effect of PEEP in SARS-Cov-2-associated acute respiratory distress syndrome. Ann Intensive Care 2020;10:55. [PMID: 32399901 DOI: 10.1186/s13613-020-00675-7] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 20.5] [Reference Citation Analysis]
451 Elghoudi A, Aldhanhani H, Ghatasheh G, Sharif E, Narchi H. Covid-19 in Children and Young Adolescents in Al Ain, United Arab Emirates- a Retrospective Cross-Sectional Study. Front Pediatr 2020;8:603741. [PMID: 33537264 DOI: 10.3389/fped.2020.603741] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
452 Chang CL, McAleer M. Alternative Global Health Security Indexes for Risk Analysis of COVID-19. Int J Environ Res Public Health 2020;17:E3161. [PMID: 32370069 DOI: 10.3390/ijerph17093161] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
453 Bouza E, Pérez-Granda MJ, Escribano P, Fernández-Del-Rey R, Pastor I, Moure Z, Catalán P, Alonso R, Muñoz P, Guinea J; Senex-COVID-19 Study Group. Outbreak of COVID-19 in a nursing home in Madrid. J Infect 2020;81:647-79. [PMID: 32592704 DOI: 10.1016/j.jinf.2020.06.055] [Cited by in Crossref: 25] [Cited by in F6Publishing: 8] [Article Influence: 12.5] [Reference Citation Analysis]
454 Wiggill TM, Mayne ES, Vaughan JL, Louw S. Overview of the Haematological Effects of COVID-19 Infection. Adv Exp Med Biol 2021;1321:163-72. [PMID: 33656722 DOI: 10.1007/978-3-030-59261-5_14] [Reference Citation Analysis]
455 Lichter Y, Badelbayov T, Shalev I, Schvartz R, Szekely Y, Benisty D, Goldiner I, Kagarlyk M, Asraf K, Doolman R, Luttwak E, Kirgner I, Avivi I, Adi N, Katz BZ. Low FXIII activity levels in intensive care unit hospitalized COVID-19 patients. Thromb J 2021;19:79. [PMID: 34736472 DOI: 10.1186/s12959-021-00333-3] [Reference Citation Analysis]
456 Di Fiore F, Bouché O, Lepage C, Sefrioui D, Gangloff A, Schwarz L, Tuech JJ, Aparicio T, Lecomte T, Boulagnon-Rombi C, Lièvre A, Manfredi S, Phelip JM, Michel P; Thésaurus National de Cancérologie Digestive (TNCD)., Société Nationale Française de Gastroentérologie (SNFGE)., Fédération Francophone de Cancérologie Digestive (FFCD)., Groupe Coopérateur multidisciplinaire en Oncologie (GERCOR)., Fédération Nationale des Centres de Lutte Contre le Cancer (UNICANCER)., Société Française de Chirurgie Digestive (SFCD)., Société Française d'Endoscopie Digestive (SFED)., Société Française de Radiothérapie Oncologique (SFRO) and Société Française de Radiologie (SFR)., Association Chirurgie Hepato-Biliaire et Transplantation (ACHBT). COVID-19 epidemic: Proposed alternatives in the management of digestive cancers: A French intergroup clinical point of view (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR). Dig Liver Dis 2020;52:597-603. [PMID: 32418773 DOI: 10.1016/j.dld.2020.03.031] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 12.0] [Reference Citation Analysis]
457 Gonzalez-Ochoa AJ, Raffetto JD, Hernández AG, Zavala N, Gutiérrez O, Vargas A, Loustaunau J. Sulodexide in the Treatment of Patients with Early Stages of COVID-19: A Randomized Controlled Trial. Thromb Haemost 2021;121:944-54. [PMID: 33677827 DOI: 10.1055/a-1414-5216] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
458 Cook DC, Fraser RW, McKirdy SJ. A benefit-cost analysis of different response scenarios to COVID-19: A case study. Health Sci Rep 2021;4:e286. [PMID: 34136653 DOI: 10.1002/hsr2.286] [Reference Citation Analysis]
459 Recinella G, Marasco G, Serafini G, Maestri L, Bianchi G, Forti P, Zoli M. Prognostic role of nutritional status in elderly patients hospitalized for COVID-19: a monocentric study. Aging Clin Exp Res 2020;32:2695-701. [PMID: 33034016 DOI: 10.1007/s40520-020-01727-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 10.5] [Reference Citation Analysis]
460 Greenland JR, Michelow MD, Wang L, London MJ. COVID-19 Infection: Implications for Perioperative and Critical Care Physicians. Anesthesiology 2020;132:1346-61. [PMID: 32195698 DOI: 10.1097/ALN.0000000000003303] [Cited by in Crossref: 99] [Cited by in F6Publishing: 63] [Article Influence: 49.5] [Reference Citation Analysis]
461 Rehman SU, Tabish M. Alternative splicing of ACE2 possibly generates variants that may limit the entry of SARS-CoV-2: a potential therapeutic approach using SSOs. Clin Sci (Lond) 2020;134:1143-50. [PMID: 32442315 DOI: 10.1042/CS20200419] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
462 Zhao F, Zheng L, Shan F, Dai Y, Shen J, Yang S, Shi Y, Xue K, Zhang Z. Evaluation of pulmonary ventilation in COVID-19 patients using oxygen-enhanced three-dimensional ultrashort echo time MRI: a preliminary study. Clin Radiol 2021;76:391.e33-41. [PMID: 33712292 DOI: 10.1016/j.crad.2021.02.008] [Reference Citation Analysis]
463 Peron JPS, Nakaya H. Susceptibility of the Elderly to SARS-CoV-2 Infection: ACE-2 Overexpression, Shedding, and Antibody-dependent Enhancement (ADE). Clinics (Sao Paulo) 2020;75:e1912. [PMID: 32428113 DOI: 10.6061/clinics/2020/e1912] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 16.0] [Reference Citation Analysis]
464 Woods JA, Hutchinson NT, Powers SK, Roberts WO, Gomez-Cabrera MC, Radak Z, Berkes I, Boros A, Boldogh I, Leeuwenburgh C, Coelho-Júnior HJ, Marzetti E, Cheng Y, Liu J, Durstine JL, Sun J, Ji LL. The COVID-19 pandemic and physical activity. Sports Med Health Sci 2020;2:55-64. [PMID: 34189484 DOI: 10.1016/j.smhs.2020.05.006] [Cited by in Crossref: 90] [Cited by in F6Publishing: 42] [Article Influence: 45.0] [Reference Citation Analysis]
465 Batty GD, Deary IJ, Gale CR. Pre-pandemic cognitive function and COVID-19 mortality: prospective cohort study. Eur J Epidemiol 2021;36:559-64. [PMID: 33893922 DOI: 10.1007/s10654-021-00743-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
466 Bostanci Ceran B, Ozates S. Ocular manifestations of coronavirus disease 2019. Graefes Arch Clin Exp Ophthalmol 2020;258:1959-63. [PMID: 32504100 DOI: 10.1007/s00417-020-04777-7] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 10.5] [Reference Citation Analysis]
467 Peters MC, Sajuthi S, Deford P, Christenson S, Rios CL, Montgomery MT, Woodruff PG, Mauger DT, Erzurum SC, Johansson MW, Denlinger LC, Jarjour NN, Castro M, Hastie AT, Moore W, Ortega VE, Bleecker ER, Wenzel SE, Israel E, Levy BD, Seibold MA, Fahy JV. COVID-19-related Genes in Sputum Cells in Asthma. Relationship to Demographic Features and Corticosteroids. Am J Respir Crit Care Med 2020;202:83-90. [PMID: 32348692 DOI: 10.1164/rccm.202003-0821OC] [Cited by in Crossref: 183] [Cited by in F6Publishing: 107] [Article Influence: 91.5] [Reference Citation Analysis]
468 Huang I, Lim MA, Pranata R. Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia - A systematic review, meta-analysis, and meta-regression. Diabetes Metab Syndr. 2020;14:395-403. [PMID: 32334395 DOI: 10.1016/j.dsx.2020.04.018] [Cited by in Crossref: 317] [Cited by in F6Publishing: 291] [Article Influence: 158.5] [Reference Citation Analysis]
469 Fleming N, Sacks LJ, Pham CT, Neoh SL, Ekinci EI. An overview of COVID-19 in people with diabetes: Pathophysiology and considerations in the inpatient setting. Diabet Med 2021;38:e14509. [PMID: 33377213 DOI: 10.1111/dme.14509] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
470 Liu M, Jiang H, Li Y, Li C, Tan Z, Jin F, Zhang T, Nan Y. Independent Risk Factors for the Dynamic Development of COVID-19: A Retrospective Study. Int J Gen Med 2021;14:4349-67. [PMID: 34408476 DOI: 10.2147/IJGM.S325112] [Reference Citation Analysis]
471 Nikpouraghdam M, Jalali Farahani A, Alishiri G, Heydari S, Ebrahimnia M, Samadinia H, Sepandi M, Jafari NJ, Izadi M, Qazvini A, Dorostkar R, Tat M, Shahriary A, Farnoosh G, Hosseini Zijoud SR, Taghdir M, Alimohamadi Y, Abbaszadeh S, Gouvarchin Ghaleh HE, Bagheri M. Epidemiological characteristics of coronavirus disease 2019 (COVID-19) patients in IRAN: A single center study. J Clin Virol 2020;127:104378. [PMID: 32353762 DOI: 10.1016/j.jcv.2020.104378] [Cited by in Crossref: 134] [Cited by in F6Publishing: 120] [Article Influence: 67.0] [Reference Citation Analysis]
472 Elsayed HH, Hassaballa AS, Ahmed TA, Gumaa M, Sharkawy HY, Moharram AA. Variation in outcome of invasive mechanical ventilation between different countries for patients with severe COVID-19: A systematic review and meta-analysis. PLoS One 2021;16:e0252760. [PMID: 34086779 DOI: 10.1371/journal.pone.0252760] [Reference Citation Analysis]
473 Galassi G, Marchioni A. Myasthenia gravis at the crossroad of COVID-19: focus on immunological and respiratory interplay. Acta Neurol Belg 2021;121:633-42. [PMID: 33811309 DOI: 10.1007/s13760-021-01612-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
474 Shi K, Liu Y, Zhang Q, Ran CP, Hou J, Zhang Y, Wang XB. Severe Type of COVID-19: Pathogenesis, Warning Indicators and Treatment. Chin J Integr Med 2022;28:3-11. [PMID: 34962616 DOI: 10.1007/s11655-021-3313-x] [Reference Citation Analysis]
475 Preciado P, Tapia Silva LM, Ye X, Zhang H, Wang Y, Waguespack P, Kooman JP, Kotanko P. Arterial oxygen saturation and hypoxemia in hemodialysis patients with COVID-19. Clin Kidney J 2021;14:1222-8. [PMID: 34094520 DOI: 10.1093/ckj/sfab019] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
476 Águila Gordo D, Martínez Del Rio J, Piqueras Flores J. Changes in antihypertensive treatment in surviving patients SARS-CoV-2 respiratory infection and its cardiovascular impact after one year of follow-up. Med Clin (Barc) 2021:S0025-7753(21)00321-3. [PMID: 34218944 DOI: 10.1016/j.medcli.2021.06.001] [Reference Citation Analysis]
477 Chow RD, Majety M, Chen S. The aging transcriptome and cellular landscape of the human lung in relation to SARS-CoV-2. Nat Commun 2021;12:4. [PMID: 33397975 DOI: 10.1038/s41467-020-20323-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
478 Akkuş ÖÖ, Atalay BG, Parlak E. COVID 19 Pandemic: Changes in the emotions, body weights and nutrition habits of individuals during social intervention measures. MNM 2021. [DOI: 10.3233/mnm-210006] [Reference Citation Analysis]
479 Gao J, Huang X, Gu H, Lou L, Xu Z. Predictive criteria of severe cases in COVID-19 patients of early stage: A retrospective observational study. J Clin Lab Anal 2020;34:e23562. [PMID: 32893398 DOI: 10.1002/jcla.23562] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
480 Liauw J, Gundy S, Rochwerg B, Hutcheon JA. Antenatal corticosteroids and COVID-19: balancing benefits and harms. Am J Obstet Gynecol 2020;223:956-7. [PMID: 32858012 DOI: 10.1016/j.ajog.2020.08.062] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
481 Talebi-Taher M, Najafi MH, Behzad S. COVID-19 and RAAS inhibitors: is there a final conclusion? Iran J Microbiol 2021;13:728-36. [PMID: 35222849 DOI: 10.18502/ijm.v13i6.8071] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
482 Bychinin MV, Klypa TV, Mandel IA, Andreichenko SA, Baklaushev VP, Yusubalieva GM, Kolyshkina NA, Troitsky AV. Low Circulating Vitamin D in Intensive Care Unit-Admitted COVID-19 Patients as a Predictor of Negative Outcomes. J Nutr 2021;151:2199-205. [PMID: 33982128 DOI: 10.1093/jn/nxab107] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
483 Zeng HL, Lu QB, Yang Q, Wang X, Yue DY, Zhang LK, Li H, Liu W, Li HJ. Longitudinal Profile of Laboratory Parameters and Their Application in the Prediction for Fatal Outcome Among Patients Infected With SARS-CoV-2: A Retrospective Cohort Study. Clin Infect Dis 2021;72:626-33. [PMID: 33048116 DOI: 10.1093/cid/ciaa574] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
484 Al-Shamrani A, Al-Harbi AS, Alhaider SA, Alharbi S, Al-Harbi NS, Alanazi A, Al Ahmadi TS. Approach to childhood asthma in the era of COVID-19: The official statement endorsed by the Saudi Pediatric Pulmonology Association (SPPA). Int J Pediatr Adolesc Med 2020;7:103-6. [PMID: 32838011 DOI: 10.1016/j.ijpam.2020.07.001] [Reference Citation Analysis]
485 El-Solh AA, Meduri UG, Lawson Y, Carter M, Mergenhagen KA. Clinical Course and Outcome of COVID-19 Acute Respiratory Distress Syndrome: Data From a National Repository.J Intensive Care Med. 2021;36:664-672. [PMID: 33685275 DOI: 10.1177/0885066621994476] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
486 Estrada E. Cascading from SARS-CoV-2 to Parkinson's Disease through Protein-Protein Interactions. Viruses 2021;13:897. [PMID: 34066091 DOI: 10.3390/v13050897] [Reference Citation Analysis]
487 Wells Mulherin D, Walker R, Holcombe B, Guenter P. ASPEN Report on Nutrition Support Practice Processes With COVID-19: The First Response. Nutr Clin Pract 2020;35:783-91. [PMID: 32671870 DOI: 10.1002/ncp.10553] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
488 Corse T, Dayan L, Kersten S, Battaglia F, Terlecky SR, Han Z. Clinical Outcomes of COVID-19 Patients with Pre-existing, Compromised Immune Systems: A Review of Case Reports. Int J Med Sci 2020;17:2974-86. [PMID: 33173418 DOI: 10.7150/ijms.50537] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
489 Zhong P, Wang Z, Du Z. Serum triglyceride levels and related factors as prognostic indicators in COVID-19 patients: A retrospective study. Immun Inflamm Dis 2021;9:1055-60. [PMID: 34236141 DOI: 10.1002/iid3.469] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
490 Gutman JR, Lucchi NW, Cantey PT, Steinhardt LC, Samuels AM, Kamb ML, Kapella BK, McElroy PD, Udhayakumar V, Lindblade KA. Malaria and Parasitic Neglected Tropical Diseases: Potential Syndemics with COVID-19? Am J Trop Med Hyg 2020;103:572-7. [PMID: 32484155 DOI: 10.4269/ajtmh.20-0516] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 11.0] [Reference Citation Analysis]
491 Rawson TM, Moore LSP, Zhu N, Ranganathan N, Skolimowska K, Gilchrist M, Satta G, Cooke G, Holmes A. Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing. Clin Infect Dis. 2020;71:2459-2468. [PMID: 32358954 DOI: 10.1093/cid/ciaa530] [Cited by in Crossref: 306] [Cited by in F6Publishing: 343] [Article Influence: 153.0] [Reference Citation Analysis]
492 Cihakova D, Streiff MB, Menez SP, Chen TK, Gilotra NA, Michos ED, Marr KA, Karaba AH, Robinson ML, Blair PW, Dioverti MV, Post WS, Cox AL, R Antar AA. High-value laboratory testing for hospitalized COVID-19 patients: a review. Future Virol 2021. [PMID: 34567235 DOI: 10.2217/fvl-2020-0316] [Reference Citation Analysis]
493 Aguilar-Bretones M, Westerhuis BM, Raadsen MP, de Bruin E, Chandler FD, Okba NM, Haagmans BL, Langerak T, Endeman H, van den Akker JP, Gommers DA, van Gorp EC, GeurtsvanKessel CH, de Vries RD, Fouchier RA, Rockx BH, Koopmans MP, van Nierop GP. Seasonal coronavirus-specific B cells with limited SARS-CoV-2 cross-reactivity dominate the IgG response in severe COVID-19. J Clin Invest 2021;131:e150613. [PMID: 34499051 DOI: 10.1172/JCI150613] [Reference Citation Analysis]
494 Zhang L, Xu J, Qi X, Tao Z, Yang Z, Chen W, Wang X, Pan T, Dai Y, Tian R, Chen Y, Tang B, Liu Z, Tan R, Qu H, Yu Y, Liu J. Development and Validation of a Nomogram for Predicting the Risk of Coronavirus-Associated Acute Respiratory Distress Syndrome: A Retrospective Cohort Study. IDR 2022;Volume 15:2371-81. [DOI: 10.2147/idr.s348278] [Reference Citation Analysis]
495 Ciaffi J, Meliconi R, Ruscitti P, Berardicurti O, Giacomelli R, Ursini F. Rheumatic manifestations of COVID-19: a systematic review and meta-analysis. BMC Rheumatol 2020;4:65. [PMID: 33123675 DOI: 10.1186/s41927-020-00165-0] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 12.5] [Reference Citation Analysis]
496 Mehanna O, El Askary A, Ali E, El Esawy B, FathAlla T, Gharib AF. Impact of Obesity and Its Associated Comorbid Conditions on COVID-19 Presentation. Diabetes Metab Syndr Obes 2021;14:409-15. [PMID: 33542640 DOI: 10.2147/DMSO.S287779] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
497 Burke H, Freeman A, O'Regan P, Wysocki O, Freitas A, Dushianthan A, Celinski M, Batchelor J, Phan H, Borca F, Sheard N, Williams S, Watson A, Fitzpatrick P, Landers D, Wilkinson T; REACT COVID group. Biomarker identification using dynamic time warping analysis: a longitudinal cohort study of patients with COVID-19 in a UK tertiary hospital. BMJ Open 2022;12:e050331. [PMID: 35168965 DOI: 10.1136/bmjopen-2021-050331] [Reference Citation Analysis]
498 Meini S, Fortini A, Andreini R, Sechi LA, Tascini C. The Paradox of the Low Prevalence of Current Smokers Among COVID-19 Patients Hospitalized in Nonintensive Care Wards: Results From an Italian Multicenter Case-Control Study. Nicotine Tob Res 2021;23:1436-40. [PMID: 32964233 DOI: 10.1093/ntr/ntaa188] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
499 Dixit SB, Zirpe KG, Kulkarni AP, Chaudhry D, Govil D, Mehta Y, Jog SA, Khatib KI, Pandit RA, Samavedam S, Rangappa P, Bandopadhyay S, Shrivastav O, Mhatre U. Current Approaches to COVID-19: Therapy and Prevention. Indian J Crit Care Med 2020;24:838-46. [PMID: 33132570 DOI: 10.5005/jp-journals-10071-23470] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
500 Loforte A, Di Mauro M, Pellegrini C, Monterosso C, Pelenghi S, Degani A, Rinaldi M, Cura Stura E, Sales G, Montrucchio G, Mangino D, Terrini A, Pacini D, Affronti A, Tarzia V, Bottio T, Pantaleo A, Donatelli F, Miceli A, Santini F, Salsano A, Colli A, Ravenni G, Montalto A, Musumeci F, Salvador L, Gerosa G, Parolari A, Picichè M; endorsed by the Italian Society for Cardiac Surgery (SICCH). Extracorporeal Membrane Oxygenation for COVID-19 Respiratory Distress Syndrome: An Italian Society for Cardiac Surgery Report. ASAIO J 2021;67:385-91. [PMID: 33470643 DOI: 10.1097/MAT.0000000000001399] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
501 Estella Á, Vidal-Cortés P, Rodríguez A, Andaluz Ojeda D, Martín-Loeches I, Díaz E, Suberviola B, Gracia Arnillas MP, Catalán González M, Álvarez-Lerma F, Ramírez P, Nuvials X, Borges M, Zaragoza R. Management of infectious complications associated with coronavirus infection in severe patients admitted to ICU. Med Intensiva (Engl Ed) 2021;45:485-500. [PMID: 34475008 DOI: 10.1016/j.medine.2021.08.013] [Reference Citation Analysis]
502 Węcławek-Tompol J, Zakrzewska Z, Gryniewicz-Kwiatkowska O, Pierlejewski F, Bień E, Zaucha-Prażmo A, Zając-Spychała O, Szmydki-Baran A, Mizia-Malarz A, Bal W, Sawicka-Żukowska M, Kruk A, Raciborska A, Książek A, Szczepański T, Peregud-Pogorzelski J, Krawczuk-Rybak M, Chaber R, Matysiak M, Wachowiak J, Młynarski W, Dembowska-Bagińska B, Balwierz W, Matkowska-Kocjan A, Kazanowska B, Styczyński J, Ussowicz M. COVID-19 in pediatric cancer patients is associated with treatment interruptions but not with short-term mortality: a Polish national study. J Hematol Oncol 2021;14:163. [PMID: 34635137 DOI: 10.1186/s13045-021-01181-4] [Reference Citation Analysis]
503 Lu Q, Wang Z, Yin Y, Zhao Y, Tao P, Zhong P. Association of Peripheral Lymphocyte and the Subset Levels With the Progression and Mortality of COVID-19: A Systematic Review and Meta-Analysis. Front Med (Lausanne) 2020;7:558545. [PMID: 33102499 DOI: 10.3389/fmed.2020.558545] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
504 Fumagalli C, Ungar A, Rozzini R, Vannini M, Coccia F, Cesaroni G, Mazzeo F, D'Ettore N, Zocchi C, Tassetti L, Bartoloni A, Lavorini F, Marcucci R, Olivotto I, Rasero L, Fattirolli F, Fumagalli S, Marchionni N. Predicting Mortality Risk in Older Hospitalized Persons With COVID-19: A Comparison of the COVID-19 Mortality Risk Score with Frailty and Disability. J Am Med Dir Assoc 2021;22:1588-1592.e1. [PMID: 34334160 DOI: 10.1016/j.jamda.2021.05.028] [Reference Citation Analysis]
505 Myint PK, Carter B, Barlow-Pay F, Short R, Einarsson AG, Bruce E, McCarthy K, Verduri A, Collins J, Hesford J, Rickard F, Mitchell E, Holloway M, McGovern A, Vilches-Moraga A, Braude P, Pearce L, Stechman M, Price A, Quinn TJ, Clini E, Moug S, Hewitt J. Routine use of immunosuppressants is associated with mortality in hospitalised patients with COVID-19. Ther Adv Drug Saf 2021;12:2042098620985690. [PMID: 33680426 DOI: 10.1177/2042098620985690] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
506 Adamo S, Chevrier S, Cervia C, Zurbuchen Y, Raeber ME, Yang L, Sivapatham S, Jacobs A, Baechli E, Rudiger A, Stüssi-Helbling M, Huber LC, Schaer DJ, Bodenmiller B, Boyman O, Nilsson J. Profound dysregulation of T cell homeostasis and function in patients with severe COVID-19. Allergy 2021;76:2866-81. [PMID: 33884644 DOI: 10.1111/all.14866] [Cited by in Crossref: 24] [Cited by in F6Publishing: 12] [Article Influence: 24.0] [Reference Citation Analysis]
507 Ittyachen AM. Covid-19 and leptospirosis: Cytokine storm and the use of steroids. Trop Doct 2021;51:128-30. [PMID: 33236692 DOI: 10.1177/0049475520971425] [Reference Citation Analysis]
508 Mustafa AK, Joshi DJ, Alexander PJ, Tabachnick DR, Cross CA, Jweied EE, Mody NS, Huh MH, Fasih S, Pappas PS, Tatooles AJ. Comparative Propensity Matched Outcomes in Severe COVID-19 Respiratory Failure-Extracorporeal Membrane Oxygenation or Maximum Ventilation Alone. Ann Surg 2021;274:e388-94. [PMID: 34617934 DOI: 10.1097/SLA.0000000000005187] [Reference Citation Analysis]
509 Iacob S, Iacob DG. SARS-CoV-2 Treatment Approaches: Numerous Options, No Certainty for a Versatile Virus. Front Pharmacol 2020;11:1224. [PMID: 32982720 DOI: 10.3389/fphar.2020.01224] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
510 Alam MT, Mehdi A, Timsaal Y, Rehan M, Kumar A, Shaikh IS, Yasmin F, Memon GM, Ahmed N, Asghar MS. The clinical course, biochemical markers, and clinical outcomes of COVID-19 positive patients from the third wave in Pakistan: A retrospective cohort study. Ann Med Surg (Lond) 2022;77:103599. [PMID: 35464609 DOI: 10.1016/j.amsu.2022.103599] [Reference Citation Analysis]
511 Turrini M, Gardellini A, Beretta L, Buzzi L, Ferrario S, Vasile S, Clerici R, Colzani A, Liparulo L, Scognamiglio G, Imperiali G, Corrado G, Strada A, Galletti M, Castiglione N, Zanon C. Clinical Course and Risk Factors for In-Hospital Mortality of 205 Patients with SARS-CoV-2 Pneumonia in Como, Lombardy Region, Italy. Vaccines (Basel) 2021;9:640. [PMID: 34208017 DOI: 10.3390/vaccines9060640] [Reference Citation Analysis]
512 Spinelli MA, Lynch KL, Yun C, Glidden DV, Peluso MJ, Henrich TJ, Gandhi M, Brown LB. SARS-CoV-2 seroprevalence, and IgG concentration and pseudovirus neutralising antibody titres after infection, compared by HIV status: a matched case-control observational study. Lancet HIV 2021;8:e334-41. [PMID: 33933189 DOI: 10.1016/S2352-3018(21)00072-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
513 Zhao M, Zhang J, Li H, Luo Z, Ye J, Xu Y, Wang Z, Ye D, Liu J, Li D, Wang M, Wan J. Recent progress of antiviral therapy for coronavirus disease 2019. Eur J Pharmacol. 2021;890:173646. [PMID: 33190802 DOI: 10.1016/j.ejphar.2020.173646] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
514 Magleby R, Westblade LF, Trzebucki A, Simon MS, Rajan M, Park J, Goyal P, Safford MM, Satlin MJ. Impact of SARS-CoV-2 Viral Load on Risk of Intubation and Mortality Among Hospitalized Patients with Coronavirus Disease 2019. Clin Infect Dis. 2020;. [PMID: 32603425 DOI: 10.1093/cid/ciaa851] [Cited by in Crossref: 135] [Cited by in F6Publishing: 127] [Article Influence: 67.5] [Reference Citation Analysis]
515 Berardis S, Verroken A, Vetillart A, Struyf C, Gilbert M, Gruson D, Gohy S. SARS-CoV-2 seroprevalence in a Belgian cohort of patients with cystic fibrosis. J Cyst Fibros 2020;19:872-4. [PMID: 32828701 DOI: 10.1016/j.jcf.2020.08.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
516 Chua PEY, Shah SU, Gui H, Koh J, Somani J, Pang J. Epidemiological and clinical characteristics of non-severe and severe pediatric and adult COVID-19 patients across different geographical regions in the early phase of pandemic: a systematic review and meta-analysis of observational studies. J Investig Med 2021:jim-2021-001858. [PMID: 34135068 DOI: 10.1136/jim-2021-001858] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
517 Emrani J, Ahmed M, Jeffers-Francis L, Teleha JC, Mowa N, Newman RH, Thomas MD. SARS-COV-2, infection, transmission, transcription, translation, proteins, and treatment: A review. Int J Biol Macromol 2021;193:1249-73. [PMID: 34756970 DOI: 10.1016/j.ijbiomac.2021.10.172] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
518 Betanzos-Robledo L, Téllez-Rojo MM, Lamadrid-Figueroa H, Roldan-Valadez E, Peterson KE, Jansen EC, Basu N, Cantoral A. Differential fat accumulation in early adulthood according to adolescent-BMI and heavy metal exposure. New Dir Child Adolesc Dev 2022. [PMID: 35583253 DOI: 10.1002/cad.20463] [Reference Citation Analysis]
519 Giollo A, Cioffi G, Rossini M, Viapiana O, De Simone G. Very low reporting rate of connective tissue diseases among coronavirus disease 2019 (Covid-19) patients and the renin-angiotensin system - An overlooked association? Eur J Intern Med 2020;80:106-7. [PMID: 32553588 DOI: 10.1016/j.ejim.2020.06.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
520 Barochiner J, Martínez R. Use of inhibitors of the renin-angiotensin system in hypertensive patients and COVID-19 severity: A systematic review and meta-analysis. J Clin Pharm Ther 2020;45:1244-52. [PMID: 32767823 DOI: 10.1111/jcpt.13246] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 10.5] [Reference Citation Analysis]
521 Gil-Etayo FJ, Garcinuño S, Lalueza A, Díaz-Simón R, García-Reyne A, Pleguezuelo DE, Cabrera-Marante O, Rodriguez-Frias EA, Perez-Rivilla A, Serrano M, Serrano A. Anti-Phospholipid Antibodies and COVID-19 Thrombosis: A Co-Star, Not a Supporting Actor. Biomedicines 2021;9:899. [PMID: 34440103 DOI: 10.3390/biomedicines9080899] [Reference Citation Analysis]
522 Mendoza-Pinto C, García-Carrasco M, Realpozo PM, Méndez-Martínez S. [Therapeutic options for the management of severe Covid-19: A rheumatology perspective]. Reumatol Clin (Engl Ed) 2020. [PMID: 32426002 DOI: 10.1016/j.reuma.2020.05.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
523 Suri JS, Agarwal S, Gupta SK, Puvvula A, Biswas M, Saba L, Bit A, Tandel GS, Agarwal M, Patrick A, Faa G, Singh IM, Oberleitner R, Turk M, Chadha PS, Johri AM, Miguel Sanches J, Khanna NN, Viskovic K, Mavrogeni S, Laird JR, Pareek G, Miner M, Sobel DW, Balestrieri A, Sfikakis PP, Tsoulfas G, Protogerou A, Misra DP, Agarwal V, Kitas GD, Ahluwalia P, Teji J, Al-Maini M, Dhanjil SK, Sockalingam M, Saxena A, Nicolaides A, Sharma A, Rathore V, Ajuluchukwu JNA, Fatemi M, Alizad A, Viswanathan V, Krishnan PK, Naidu S. A narrative review on characterization of acute respiratory distress syndrome in COVID-19-infected lungs using artificial intelligence. Comput Biol Med 2021;130:104210. [PMID: 33550068 DOI: 10.1016/j.compbiomed.2021.104210] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
524 Chakraborty T, Jamal RF, Battineni G, Teja KV, Marto CM, Spagnuolo G. A Review of Prolonged Post-COVID-19 Symptoms and Their Implications on Dental Management. Int J Environ Res Public Health 2021;18:5131. [PMID: 34066174 DOI: 10.3390/ijerph18105131] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
525 Pérez-calatayud AA, Enriquez-garcía R, Fareli-gonzález C, Barrett CD, Saldivar-rodea CA, Perulles-marin J, Reyes-caldelas MA, Rosenberg-contreras CI, Gómez-moreno JB, Guerrero-avendaño G, Serrano-loyola R, Carrillo-esper R, Moore EE. In Situ Pulmonary Thrombolysis and Perfusion Lung Angiography in Severe COVID-19 Respiratory Failure. Critical Care Explorations 2022;4:e0670. [DOI: 10.1097/cce.0000000000000670] [Reference Citation Analysis]
526 Press VG, Gershon AS, Sciurba FC, Blagev DP. Concerns About Coronavirus Disease-Related Collateral Damage for Patients With COPD. Chest 2020;158:866-8. [PMID: 32473947 DOI: 10.1016/j.chest.2020.05.549] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
527 Mukerji SS, Das S, Alabsi H, Brenner LN, Jain A, Magdamo C, Collens SI, Ye E, Keller K, Boutros CL, Leone MJ, Newhouse A, Foy B, Li MD, Lang M, Anahtar MN, Shao YP, Ge W, Sun H, Triant VA, Kalpathy-Cramer J, Higgins J, Rosand J, Robbins GK, Westover MB. Prolonged Intubation in Patients With Prior Cerebrovascular Disease and COVID-19. Front Neurol 2021;12:642912. [PMID: 33897598 DOI: 10.3389/fneur.2021.642912] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
528 Lim W, Suhail M, Diaz K. Diagnostic Challenges of Pneumocystis Pneumonia during the COVID-19 Pandemic: A Case of a Young Patient with Ground Glass Opacities and Pulmonary Embolism on Chest CT. Case Rep Infect Dis 2021;2021:5669543. [PMID: 34373796 DOI: 10.1155/2021/5669543] [Reference Citation Analysis]
529 Rastogi A, Lerma EV. Anemia management for home dialysis including the new US public policy initiative. Kidney Int Suppl (2011) 2021;11:59-69. [PMID: 33777496 DOI: 10.1016/j.kisu.2020.12.005] [Reference Citation Analysis]
530 De D, Pandhi D. Use of Immunosuppressants/Immunomodulators in Autoimmune/Inflammatory Dermatologic Diseases during COVID-19 Pandemic-General Recommendation Based on Available Evidence. Indian Dermatol Online J 2020;11:526-33. [PMID: 32832437 DOI: 10.4103/idoj.IDOJ_414_20] [Reference Citation Analysis]
531 Alberca RW, Teixeira FME, Beserra DR, de Oliveira EA, Andrade MMS, Pietrobon AJ, Sato MN. Perspective: The Potential Effects of Naringenin in COVID-19. Front Immunol. 2020;11:570919. [PMID: 33101291 DOI: 10.3389/fimmu.2020.570919] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
532 Jin S, Jin Y, Xu B, Hong J, Yang X. Prevalence and Impact of Coagulation Dysfunction in COVID-19 in China: A Meta-Analysis. Thromb Haemost 2020;120:1524-35. [PMID: 32679593 DOI: 10.1055/s-0040-1714369] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 9.5] [Reference Citation Analysis]
533 Keller KG, Reangsing C, Schneider JK. Clinical presentation and outcomes of hospitalized adults with COVID-19: A systematic review. J Adv Nurs 2020;76:3235-57. [PMID: 32881050 DOI: 10.1111/jan.14558] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
534 Higham A, Mathioudakis A, Vestbo J, Singh D. COVID-19 and COPD: a narrative review of the basic science and clinical outcomes. Eur Respir Rev 2020;29:200199. [PMID: 33153991 DOI: 10.1183/16000617.0199-2020] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 8.5] [Reference Citation Analysis]
535 Wahezi DM, Lo MS, Rubinstein TB, Ringold S, Ardoin SP, Downes KJ, Jones KB, Laxer RM, Pellet Madan R, Mudano AS, Turner AS, Karp DR, Mehta JJ. American College of Rheumatology Guidance for the Management of Pediatric Rheumatic Disease During the COVID-19 Pandemic: Version 2. Arthritis Rheumatol 2021;73:e46-59. [PMID: 34114365 DOI: 10.1002/art.41772] [Reference Citation Analysis]
536 Windham S, Hirsch K, Peterson R, Douin D, Chauhan L, Heery L, Fling C, Vukovic N, Holguin F, Zimmer S, Erlandson K. The Predictive Potential of Elevated Serum Inflammatory Markers in Determining the Need for Intubation in CoVID-19 Patients. The Journal of Critical Care Medicine 2021;0. [DOI: 10.2478/jccm-2021-0035] [Reference Citation Analysis]
537 Ocak M, Tascanov MB, Yurt NŞ, Yurt YC. A new predictor for indicating clinical severity and prognosis in COVID-19 patients: Frontal QRS-T angle. Am J Emerg Med 2021;50:631-5. [PMID: 34879478 DOI: 10.1016/j.ajem.2021.09.046] [Reference Citation Analysis]
538 Abduljalil JM, Abduljalil BM. Epidemiology, genome, and clinical features of the pandemic SARS-CoV-2: a recent view. New Microbes New Infect 2020;35:100672. [PMID: 32322400 DOI: 10.1016/j.nmni.2020.100672] [Cited by in Crossref: 53] [Cited by in F6Publishing: 43] [Article Influence: 26.5] [Reference Citation Analysis]
539 Aiello P, Johnson S, Ramos Mercado A, Hussein S. Pneumatosis intestinalis in a patient with COVID-19. BMJ Case Rep 2020;13:e237564. [PMID: 32900750 DOI: 10.1136/bcr-2020-237564] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
540 Khan H, Patel S, Majumdar A. Role of NRF2 and Sirtuin activators in COVID-19. Clin Immunol 2021;233:108879. [PMID: 34798239 DOI: 10.1016/j.clim.2021.108879] [Reference Citation Analysis]
541 Tan EH, Sena AG, Prats-Uribe A, You SC, Ahmed WU, Kostka K, Reich C, Duvall SL, Lynch KE, Matheny ME, Duarte-Salles T, Bertolin SF, Hripcsak G, Natarajan K, Falconer T, Spotnitz M, Ostropolets A, Blacketer C, Alshammari TM, Alghoul H, Alser O, Lane JCE, Dawoud DM, Shah K, Yang Y, Zhang L, Areia C, Golozar A, Relcade M, Casajust P, Jonnagaddala J, Subbian V, Vizcaya D, Lai LY, Nyberg F, Morales DR, Posada JD, Shah NH, Gong M, Vivekanantham A, Abend A, Minty EP, Suchard M, Rijnbeek P, Ryan PB, Prieto-Alhambra D. Characteristics, outcomes, and mortality amongst 133,589 patients with prevalent autoimmune diseases diagnosed with, and 48,418 hospitalised for COVID-19: a multinational distributed network cohort analysis. medRxiv 2020:2020. [PMID: 33269355 DOI: 10.1101/2020.11.24.20236802] [Reference Citation Analysis]
542 Nandy K, Salunke A, Pathak SK, Pandey A, Doctor C, Puj K, Sharma M, Jain A, Warikoo V. Coronavirus disease (COVID-19): A systematic review and meta-analysis to evaluate the impact of various comorbidities on serious events.Diabetes Metab Syndr. 2020;14:1017-1025. [PMID: 32634716 DOI: 10.1016/j.dsx.2020.06.064] [Cited by in Crossref: 51] [Cited by in F6Publishing: 41] [Article Influence: 25.5] [Reference Citation Analysis]
543 Yuan Q, Huang HY, Chen XL, Chen RH, Zhang Y, Pan XB, Chen JN, Liu N, Du H. Does pre-existent physical inactivity have a role in the severity of COVID-19? Ther Adv Respir Dis 2021;15:17534666211025221. [PMID: 34148444 DOI: 10.1177/17534666211025221] [Reference Citation Analysis]
544 Pinato DJ, Lee AJX, Biello F, Seguí E, Aguilar-Company J, Carbó A, Bruna R, Bower M, Rizzo G, Benafif S, Carmona C, Chopra N, Cruz CA, D'Avanzo F, Evans JS, Galazi M, Garcia-Fructuoso I, Dalla Pria A, Newsom-Davis T, Ottaviani D, Patriarca A, Reyes R, Sharkey R, Sng CCT, Wong YNS, Ferrante D, Scotti L, Avanzi GC, Bellan M, Castello LM, Marco-Hernández J, Mollà M, Pirisi M, Ruiz-Camps I, Sainaghi PP, Gaidano G, Brunet J, Tabernero J, Prat A, Gennari A. Presenting Features and Early Mortality from SARS-CoV-2 Infection in Cancer Patients during the Initial Stage of the COVID-19 Pandemic in Europe. Cancers (Basel) 2020;12:E1841. [PMID: 32650523 DOI: 10.3390/cancers12071841] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 13.5] [Reference Citation Analysis]
545 Wang YC, Lee YT, Yang T, Sun JR, Shen CF, Cheng CM. Current diagnostic tools for coronaviruses-From laboratory diagnosis to POC diagnosis for COVID-19. Bioeng Transl Med 2020;:e10177. [PMID: 32838038 DOI: 10.1002/btm2.10177] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
546 Smith MS, Bonomo J, Knight WA 4th, Prestigiacomo CJ, Richards CT, Ramser E, Adeoye O, Bertsch S, Shirani P, Vagal A, Fichtenbaum CJ, Housholder A, Khatri P, Kleindorfer DO, Broderick JP, Grossman AW. Endovascular Therapy for Patients With Acute Ischemic Stroke During the COVID-19 Pandemic: A Proposed Algorithm. Stroke 2020;51:1902-9. [PMID: 32352910 DOI: 10.1161/STROKEAHA.120.029863] [Cited by in Crossref: 31] [Cited by in F6Publishing: 15] [Article Influence: 15.5] [Reference Citation Analysis]
547 Chen C, Lin S, Shen C, Hsieh K, Cheng C. Biomarkers during COVID-19: Mechanisms of Change and Implications for Patient Outcomes. Diagnostics 2022;12:509. [DOI: 10.3390/diagnostics12020509] [Reference Citation Analysis]
548 Sarkar S, Khanna P, Singh AK. The Impact of Neutrophil-Lymphocyte Count Ratio in COVID-19: A Systematic Review and Meta-Analysis. J Intensive Care Med 2021;:8850666211045626. [PMID: 34672824 DOI: 10.1177/08850666211045626] [Reference Citation Analysis]
549 Turcotte JJ, Meisenberg BR, MacDonald JH, Menon N, Fowler MB, West M, Rhule J, Qureshi SS, MacDonald EB. Risk factors for severe illness in hospitalized Covid-19 patients at a regional hospital. PLoS One 2020;15:e0237558. [PMID: 32785285 DOI: 10.1371/journal.pone.0237558] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
550 Xu K, Wei Y, Giunta S, Zhou M, Xia S. Do inflammaging and coagul-aging play a role as conditions contributing to the co-occurrence of the severe hyper-inflammatory state and deadly coagulopathy during COVID-19 in older people? Exp Gerontol 2021;151:111423. [PMID: 34048906 DOI: 10.1016/j.exger.2021.111423] [Reference Citation Analysis]
551 Mistry P, Balwani M, Barbouth D, Burrow TA, Ginns EI, Goker-Alpan O, Grabowski GA, Kartha RV, Kishnani PS, Lau H, Lee CU, Lopez G, Maegawa G, Packman S, Prada C, Rosenbloom B, Lal TR, Schiffmann R, Weinreb N, Sidransky E. Gaucher disease and SARS-CoV-2 infection: Emerging management challenges. Mol Genet Metab 2020;130:164-9. [PMID: 32471800 DOI: 10.1016/j.ymgme.2020.05.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
552 Sandooja R, Vura NVRK, Morocco M. Heightened ACE Activity and Unfavorable Consequences in COVID-19 Diabetic Subjects. Int J Endocrinol 2020;2020:7847526. [PMID: 32724306 DOI: 10.1155/2020/7847526] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
553 Fattorutto M, Bouckaert Y, Brauner J, Franck S, Bouton F, Heuse D, Bouckaert C, Bruyneel A. Pragmatic study of a thromboprophylaxis algorithm in critically ill patients with SARS-COV-2 infection. J Thromb Thrombolysis 2021. [PMID: 34173169 DOI: 10.1007/s11239-021-02514-3] [Reference Citation Analysis]
554 Wu X, Liu L, Jiao J, Yang L, Zhu B, Li X. Characterisation of clinical, laboratory and imaging factors related to mild vs. severe covid-19 infection: a systematic review and meta-analysis. Ann Med 2020;52:334-44. [PMID: 32755287 DOI: 10.1080/07853890.2020.1802061] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
555 Liu Y, Mao B, Liang S, Yang JW, Lu HW, Chai YH, Wang L, Zhang L, Li QH, Zhao L, He Y, Gu XL, Ji XB, Li L, Jie ZJ, Li Q, Li XY, Lu HZ, Zhang WH, Song YL, Qu JM, Xu JF; Shanghai Clinical Treatment Experts Group for COVID-19. Association between age and clinical characteristics and outcomes of COVID-19. Eur Respir J 2020;55:2001112. [PMID: 32312864 DOI: 10.1183/13993003.01112-2020] [Cited by in Crossref: 113] [Cited by in F6Publishing: 105] [Article Influence: 56.5] [Reference Citation Analysis]
556 Hasan SS, Capstick T, Zaidi STR, Kow CS, Merchant HA. Use of corticosteroids in asthma and COPD patients with or without COVID-19. Respir Med 2020;170:106045. [PMID: 32843175 DOI: 10.1016/j.rmed.2020.106045] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
557 de Leeuw AJM, Oude Luttikhuis MAM, Wellen AC, Müller C, Calkhoven CF. Obesity and its impact on COVID-19. J Mol Med (Berl) 2021;99:899-915. [PMID: 33824998 DOI: 10.1007/s00109-021-02072-4] [Reference Citation Analysis]
558 Khan YA. Risk of mortality due to COVID-19 and air pollution in Pakistan. Environ Sci Pollut Res Int 2021. [PMID: 34363580 DOI: 10.1007/s11356-021-15654-z] [Reference Citation Analysis]
559 [DOI: 10.1101/2020.03.22.20040832] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
560 Tang CF, Ding H, Jiao RQ, Wu XX, Kong LD. Possibility of magnesium supplementation for supportive treatment in patients with COVID-19. Eur J Pharmacol 2020;886:173546. [PMID: 32931782 DOI: 10.1016/j.ejphar.2020.173546] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
561 Forero-Peña DA, Carrión-Nessi FS, Mendoza-Millán DL, Omaña-Ávila ÓD, Mejía-Bernard MD, Camejo-Ávila NA, Flora-Noda DM, Velásquez VL, Chacón-Labrador FR, Doval-Fernández JM, Maricuto AL, Grillet ME, Hernández-Villena JV, Vincenti-González MF, Paniz-Mondolfi AE, Orejas J, Rodríguez VI, Contreras MB, Guevara RN, Carballo M, Caldera J, Redondo MC, Landaeta ME. First wave of COVID-19 in Venezuela: Epidemiological, clinical, and paraclinical characteristics of first cases. J Med Virol 2021. [PMID: 34761824 DOI: 10.1002/jmv.27449] [Reference Citation Analysis]
562 Desterke C, Turhan AG, Bennaceur-Griscelli A, Griscelli F. PPARγ Cistrome Repression during Activation of Lung Monocyte-Macrophages in Severe COVID-19. iScience 2020;23:101611. [PMID: 33015591 DOI: 10.1016/j.isci.2020.101611] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
563 Haward MF, Janvier A, Moore GP, Laventhal N, Fry JT, Lantos J. Should Extremely Premature Babies Get Ventilators During the COVID-19 Crisis? Am J Bioeth 2020;20:37-43. [PMID: 32400291 DOI: 10.1080/15265161.2020.1764134] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
564 Sahar Kostis YO, Rinsky-Halivni L, Cohen C, Zack O, Dekel R, Moshe S. Fitness for work during the COVID-19 disease: principles and suggested assistive tool for protecting workers during the pandemic era. Int Arch Occup Environ Health 2021;94:1233-8. [PMID: 34075453 DOI: 10.1007/s00420-021-01722-x] [Reference Citation Analysis]
565 Yu J, Chai P, Ge S, Fan X. Recent Understandings Toward Coronavirus Disease 2019 (COVID-19): From Bench to Bedside. Front Cell Dev Biol 2020;8:476. [PMID: 32582719 DOI: 10.3389/fcell.2020.00476] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
566 Kichloo A, Dettloff K, Aljadah M, Albosta M, Jamal S, Singh J, Wani F, Kumar A, Vallabhaneni S, Khan MZ. COVID-19 and Hypercoagulability: A Review. Clin Appl Thromb Hemost 2020;26:1076029620962853. [PMID: 33074732 DOI: 10.1177/1076029620962853] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
567 Rocha ASCD, Volschan A, Campos LAA, Coelho RPDS, Thielmann DCDA, Ferreira CALC, Colafranceschi AS. Predictive Value of Myocardial injury in Patients with COVID-19 Admitted to a Quaternary Hospital in the City of Rio de Janeiro. International Journal of Cardiovascular Sciences 2021. [DOI: 10.36660/ijcs.20200352] [Reference Citation Analysis]
568 Sha J, Qie G, Yao Q, Sun W, Wang C, Zhang Z, Wang X, Wang P, Jiang J, Bai X, Chu Y, Meng M. Sex Differences on Clinical Characteristics, Severity, and Mortality in Adult Patients With COVID-19: A Multicentre Retrospective Study. Front Med (Lausanne) 2021;8:607059. [PMID: 33644092 DOI: 10.3389/fmed.2021.607059] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
569 Fabre JB, Grelot L, Vanbiervielt W, Mazerie J, Manca R, Martin V. Managing the combined consequences of COVID-19 infection and lock-down policies on athletes: narrative review and guidelines proposal for a safe return to sport. BMJ Open Sport Exerc Med 2020;6:e000849. [PMID: 33194223 DOI: 10.1136/bmjsem-2020-000849] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
570 Sever N, Miličić G, Bodnar NO, Wu X, Rapoport TA. Mechanism of Lamellar Body Formation by Lung Surfactant Protein B. Mol Cell 2021;81:49-66.e8. [PMID: 33242393 DOI: 10.1016/j.molcel.2020.10.042] [Reference Citation Analysis]
571 Dastan F, Saffaei A, Haseli S, Marjani M, Moniri A, Abtahian Z, Abedini A, Kiani A, Seifi S, Jammati H, Hashemian SMR, Pourabdollah Toutkaboni M, Eslaminejad A, Heshmatnia J, Sadeghi M, Nadji SA, Dastan A, Baghaei P, Varahram M, Yousefian S, Salamzadeh J, Tabarsi P. Promising effects of tocilizumab in COVID-19: A non-controlled, prospective clinical trial. Int Immunopharmacol 2020;88:106869. [PMID: 32889241 DOI: 10.1016/j.intimp.2020.106869] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
572 Piedade J, Pereira G. COVID-19 in liver transplant recipients. Journal of Liver Transplantation 2021;3:100026. [DOI: 10.1016/j.liver.2021.100026] [Reference Citation Analysis]
573 Masumoto A, Kitai T, Matsumoto S, Kuroda S, Kohsaka S, Tachikawa R, Seo R, Doi A, Tomii K, Yonetsu T, Torii S, Komuro I, Hirata KI, Node K, Matsue Y, Furukawa Y. Impact of serum lactate dehydrogenase on the short-term prognosis of COVID-19 with pre-existing cardiovascular diseases. J Cardiol 2021:S0914-5087(21)00377-4. [PMID: 35000825 DOI: 10.1016/j.jjcc.2021.12.014] [Reference Citation Analysis]
574 Zinellu A, Sotgia S, Fois AG, Mangoni AA. Serum CK-MB, COVID-19 severity and mortality: An updated systematic review and meta-analysis with meta-regression. Adv Med Sci 2021;66:304-14. [PMID: 34256241 DOI: 10.1016/j.advms.2021.07.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
575 Balanchivadze N, Kudirka AA, Askar S, Almadhoun K, Kuriakose P, Fadel R, Dabak V. Impact of COVID-19 Infection on 24 Patients with Sickle Cell Disease. One Center Urban Experience, Detroit, MI, USA. Hemoglobin 2020;44:284-9. [PMID: 32722950 DOI: 10.1080/03630269.2020.1797775] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
576 Nouh FA, Othman H, Gwarsha EK, Elbadry AA, Alabdali A, Barassi IF, Elamary S, Elbadry AA, Elshaari FA. Apparent Association of Insulin With Interleukin-6 (IL-6) in Severe COVID-19 Patients Having Chronic Disease Comorbidities. Cureus. [DOI: 10.7759/cureus.23790] [Reference Citation Analysis]
577 Abutaleb A, Nathan S. COVID-19 infection-associated coagulopathy: Pathophysiology and clinical implications. Interv Neuroradiol 2021;27:6-12. [PMID: 34747644 DOI: 10.1177/15910199211035894] [Reference Citation Analysis]
578 Erdem HA, Korkma PE, Çağlayan D, Işıkgöz Taşbakan M, Yamazhan T, Taşbakan MS, Sayıner A, Gökengin D. Treatment of SARS-CoV-2 pneumonia with favipiravir: early results from the Ege University cohort, Turkey. Turk J Med Sci 2021;51:912-20. [PMID: 33237663 DOI: 10.3906/sag-2008-33] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
579 Gao S, Jiang F, Jin W, Shi Y, Yang L, Xia Y, Jia L, Wang B, Lin H, Cai Y, Xia Z, Peng J. Risk factors influencing the prognosis of elderly patients infected with COVID-19: a clinical retrospective study in Wuhan, China. Aging (Albany NY) 2020;12:12504-16. [PMID: 32651993 DOI: 10.18632/aging.103631] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
580 Oliveira E, Parikh A, Lopez-Ruiz A, Carrilo M, Goldberg J, Cearras M, Fernainy K, Andersen S, Mercado L, Guan J, Zafar H, Louzon P, Carr A, Baloch N, Pratley R, Silverstry S, Hsu V, Sniffen J, Herrera V, Finkler N. ICU outcomes and survival in patients with severe COVID-19 in the largest health care system in central Florida. PLoS One 2021;16:e0249038. [PMID: 33765049 DOI: 10.1371/journal.pone.0249038] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
581 Mehta P, Sahni S, Siddiqui S, Mishra N, Sharma P, Sharma S, Tyagi A, Chattopadhyay P, Vivekanand A, Devi P, Khan A, Waghdhare S, Budhiraja S, Uppili B, Maurya R, Nangia V, Shamim U, Hazarika PP, Wadhwa S, Tyagi N, Dewan A, Tarai B, Das P, Faruq M, Agrawal A, Jha S, Pandey R. Respiratory Co-Infections: Modulators of SARS-CoV-2 Patients' Clinical Sub-Phenotype. Front Microbiol 2021;12:653399. [PMID: 34122366 DOI: 10.3389/fmicb.2021.653399] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
582 Ferrari F, Martins VM, Fuchs FD, Stein R. Renin-Angiotensin-Aldosterone System Inhibitors in COVID-19: A Review. Clinics (Sao Paulo) 2021;76:e2342. [PMID: 33852652 DOI: 10.6061/clinics/2021/e2342] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
583 Gebretsadik D, Ahmed N, Kebede E, Gebremicheal S, Belete MA, Adane M. Knowledge, attitude, practice towards COVID-19 pandemic and its prevalence among hospital visitors at Ataye district hospital, Northeast Ethiopia. PLoS One 2021;16:e0246154. [PMID: 33606678 DOI: 10.1371/journal.pone.0246154] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
584 Tan CCS, Owen CJ, Tham CYL, Bertoletti A, van Dorp L, Balloux F. Pre-existing T cell-mediated cross-reactivity to SARS-CoV-2 cannot solely be explained by prior exposure to endemic human coronaviruses. Infect Genet Evol 2021;95:105075. [PMID: 34509646 DOI: 10.1016/j.meegid.2021.105075] [Reference Citation Analysis]
585 Moscatelli F, Sessa F, Valenzano A, Polito R, Monda V, Cibelli G, Villano I, Pisanelli D, Perrella M, Daniele A, Monda M, Messina G, Messina A. COVID-19: Role of Nutrition and Supplementation. Nutrients 2021;13:976. [PMID: 33803015 DOI: 10.3390/nu13030976] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
586 Kostova D, Richter P, Van Vliet G, Mahar M, Moolenaar RL. The Role of Noncommunicable Diseases in the Pursuit of Global Health Security. Health Secur 2021;19:288-301. [PMID: 33961498 DOI: 10.1089/hs.2020.0121] [Reference Citation Analysis]
587 Stefan G, Mehedinti AM, Andreiana I, Zugravu AD, Cinca S, Busuioc R, Miler I, Stancu S, Petrescu L, Dimitriu I, Moldovanu E, Crasnaru DE, Gugonea G, Georgescu V, Strambu VD, Capusa C. Clinical features and outcome of maintenance hemodialysis patients with COVID-19 from a tertiary nephrology care center in Romania. Ren Fail 2021;43:49-57. [PMID: 33307933 DOI: 10.1080/0886022X.2020.1853571] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
588 Kwee TC, Kwee RM. Chest CT in COVID-19: What the Radiologist Needs to Know. Radiographics. 2020;40:1848-1865. [PMID: 33095680 DOI: 10.1148/rg.2020200159] [Cited by in Crossref: 59] [Cited by in F6Publishing: 39] [Article Influence: 29.5] [Reference Citation Analysis]
589 Aslan A, Aslan C, Zolbanin NM, Jafari R. Acute respiratory distress syndrome in COVID-19: possible mechanisms and therapeutic management. Pneumonia (Nathan) 2021;13:14. [PMID: 34872623 DOI: 10.1186/s41479-021-00092-9] [Reference Citation Analysis]
590 Senapati S, Kumar S, Singh AK, Banerjee P, Bhagavatula S. Assessment of risk conferred by coding and regulatory variations of TMPRSS2 and CD26 in susceptibility to SARS-CoV-2 infection in human. J Genet 2020;99:53. [PMID: 32661206 [PMID: 32661206 DOI: 10.1007/s12041-020-01217-7] [Cited by in Crossref: 24] [Cited by in F6Publishing: 5] [Article Influence: 12.0] [Reference Citation Analysis]
591 Esteban Ronda V, Ruiz Alcaraz S, Ruiz Torregrosa P, Giménez Suau M, Nofuentes Pérez E, León Ramírez JM, Andrés M, Moreno-Pérez Ó, Candela Blanes A, Gil Carbonell J, Merino de Lucas E. Application of validated severity scores for pneumonia caused by SARS-CoV-2. Med Clin (Engl Ed) 2021;157:99-105. [PMID: 34226877 DOI: 10.1016/j.medcle.2021.01.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
592 Iacovoni A, Boffini M, Pidello S, Simonato E, Barbero C, Sebastiani R, Vittori C, Fontana A, Terzi A, De Ferrari GM, Rinaldi M. A case series of novel coronavirus infection in heart transplantation from 2 centers in the pandemic area in the North of Italy. J Heart Lung Transplant 2020;39:1081-8. [PMID: 32709482 DOI: 10.1016/j.healun.2020.06.016] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
593 Paliogiannis P, Mangoni AA, Dettori P, Nasrallah GK, Pintus G, Zinellu A. D-Dimer Concentrations and COVID-19 Severity: A Systematic Review and Meta-Analysis. Front Public Health 2020;8:432. [PMID: 32903841 DOI: 10.3389/fpubh.2020.00432] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 11.0] [Reference Citation Analysis]
594 Kiselevskiy M, Shubina I, Chikileva I, Sitdikova S, Samoylenko I, Anisimova N, Kirgizov K, Suleimanova A, Gorbunova T, Varfolomeeva S. Immune Pathogenesis of COVID-19 Intoxication: Storm or Silence? Pharmaceuticals (Basel) 2020;13:E166. [PMID: 32722596 DOI: 10.3390/ph13080166] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
595 Gadotti AC, de Castro Deus M, Telles JP, Wind R, Goes M, Garcia Charello Ossoski R, de Padua AM, de Noronha L, Moreno-Amaral A, Baena CP, Tuon FF. IFN-γ is an independent risk factor associated with mortality in patients with moderate and severe COVID-19 infection. Virus Res 2020;289:198171. [PMID: 32979474 DOI: 10.1016/j.virusres.2020.198171] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 9.5] [Reference Citation Analysis]
596 Rai DK, Sharma P, Kumar R. Post covid 19 pulmonary fibrosis. Is it real threat? Indian J Tuberc 2021;68:330-3. [PMID: 34099197 DOI: 10.1016/j.ijtb.2020.11.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
597 Sokolski M, Reszka K, Suchocki T, Adamik B, Doroszko A, Drobnik J, Gorka-Dynysiewicz J, Jedrzejczyk M, Kaliszewski K, Kilis-Pstrusinska K, Konopska B, Kopec A, Larysz A, Lis W, Matera-Witkiewicz A, Pawlik-Sobecka L, Rosiek-Biegus M, Sokolska JM, Sokolowski J, Zapolska-Tomasiewicz A, Protasiewicz M, Madziarska K, Jankowska EA. History of Heart Failure in Patients Hospitalized Due to COVID-19: Relevant Factor of In-Hospital Complications and All-Cause Mortality up to Six Months. J Clin Med 2022;11:241. [PMID: 35011982 DOI: 10.3390/jcm11010241] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
598 Zhang N, Zhang H, Tang Y, Zhang H, Ma A, Xu F, Sun Y, Jiang L, Shan F. Risk factors for illness severity in patients with COVID-19 pneumonia: a prospective cohort study. Int J Med Sci 2021;18:921-8. [PMID: 33456349 DOI: 10.7150/ijms.51205] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
599 Filgueira TO, Castoldi A, Santos LER, de Amorim GJ, de Sousa Fernandes MS, Anastácio WLDN, Campos EZ, Santos TM, Souto FO. The Relevance of a Physical Active Lifestyle and Physical Fitness on Immune Defense: Mitigating Disease Burden, With Focus on COVID-19 Consequences. Front Immunol 2021;12:587146. [PMID: 33613573 DOI: 10.3389/fimmu.2021.587146] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 13.0] [Reference Citation Analysis]
600 Cadegiani FA, Goren A, Wambier CG. Spironolactone may provide protection from SARS-CoV-2: Targeting androgens, angiotensin converting enzyme 2 (ACE2), and renin-angiotensin-aldosterone system (RAAS). Med Hypotheses 2020;143:110112. [PMID: 32721806 DOI: 10.1016/j.mehy.2020.110112] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 10.5] [Reference Citation Analysis]
601 John AE, Joseph C, Jenkins G, Tatler AL. COVID-19 and pulmonary fibrosis: A potential role for lung epithelial cells and fibroblasts. Immunol Rev 2021;302:228-40. [PMID: 34028807 DOI: 10.1111/imr.12977] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
602 Schrijver B, Assmann JLJC, van Gammeren AJ, Vermeulen RCH, Portengen L, Heukels P, Langerak AW, Dik WA, van der Velden VHJ, Ermens TAAM. Extensive longitudinal immune profiling reveals sustained innate immune activation in COVID-19 patients with unfavorable outcome. Eur Cytokine Netw 2020;31:154-67. [PMID: 33648924 DOI: 10.1684/ecn.2020.0456] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
603 Li G, Zhou CL, Ba YM, Wang YM, Song B, Cheng XB, Dong QF, Wang LL, You SS. Nutritional risk and therapy for severe and critical COVID-19 patients: A multicenter retrospective observational study. Clin Nutr 2021;40:2154-61. [PMID: 33077274 DOI: 10.1016/j.clnu.2020.09.040] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
604 James PT, Ali Z, Armitage AE, Bonell A, Cerami C, Drakesmith H, Jobe M, Jones KS, Liew Z, Moore SE, Morales-Berstein F, Nabwera HM, Nadjm B, Pasricha SR, Scheelbeek P, Silver MJ, Teh MR, Prentice AM. The Role of Nutrition in COVID-19 Susceptibility and Severity of Disease: A Systematic Review. J Nutr 2021;151:1854-78. [PMID: 33982105 DOI: 10.1093/jn/nxab059] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
605 Generoso JS, Barichello de Quevedo JL, Cattani M, Lodetti BF, Sousa L, Collodel A, Diaz AP, Dal-Pizzol F. Neurobiology of COVID-19: how can the virus affect the brain? Braz J Psychiatry 2021:S1516-44462021005003203. [PMID: 33605367 DOI: 10.1590/1516-4446-2020-1488] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
606 Lim JH, Cho JH, Jeon Y, Kim JH, Lee GY, Jeon S, Noh HW, Lee YH, Lee J, Chang HH, Jung HY, Choi JY, Park SH, Kim CD, Kim YL, Kim SW. Adverse impact of renin-angiotensin system blockade on the clinical course in hospitalized patients with severe COVID-19: a retrospective cohort study. Sci Rep 2020;10:20250. [PMID: 33219294 DOI: 10.1038/s41598-020-76915-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
607 Li Z, Wu J, Zhou J, Yuan B, Chen J, Wu W, Mo L, Qu Z, Zhou F, Dong Y, Huang K, Liu Z, Wang T, Symmes D, Gu J, Sho E, Zhang J, Chen R, Xu Y. A Vimentin-Targeting Oral Compound with Host-Directed Antiviral and Anti-Inflammatory Actions Addresses Multiple Features of COVID-19 and Related Diseases. mBio 2021;12:e0254221. [PMID: 34634931 DOI: 10.1128/mBio.02542-21] [Reference Citation Analysis]
608 Cavanna L, Proietto M, Citterio C, Anselmi E, Zaffignani E, Stroppa EM, Borsotti MT, Contini A, Di Girolamo G, Quitadamo VM, Bacchetta N, Muroni M, Brescia MG, Delledonne M. COVID-19 Vaccination in Cancer Patients Older Than 70 Years Undergoing Active Treatment. Seroconversion Rate and Safety. Vaccines 2022;10:164. [DOI: 10.3390/vaccines10020164] [Reference Citation Analysis]
609 Fang S, Wang H, Lu L, Jia Y, Xia Z. Decreased complement C3 levels are associated with poor prognosis in patients with COVID-19: A retrospective cohort study. Int Immunopharmacol 2020;89:107070. [PMID: 33039965 DOI: 10.1016/j.intimp.2020.107070] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
610 Brosnahan SB, Jonkman AH, Kugler MC, Munger JS, Kaufman DA. COVID-19 and Respiratory System Disorders: Current Knowledge, Future Clinical and Translational Research Questions. Arterioscler Thromb Vasc Biol 2020;40:2586-97. [PMID: 32960072 DOI: 10.1161/ATVBAHA.120.314515] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
611 Yue J, Xu H, Zhou Y, Liu W, Han X, Mao Q, Li S, Tam LS, Ma J, Liu W. Dyslipidemia Is Related to Mortality in Critical Patients With Coronavirus Disease 2019: A Retrospective Study. Front Endocrinol (Lausanne) 2021;12:611526. [PMID: 34248834 DOI: 10.3389/fendo.2021.611526] [Reference Citation Analysis]
612 Hong W, Chen Q, Qian S, Basharat Z, Zimmer V, Wang Y, Zippi M, Pan J. Critically Ill vs. Non-Critically Ill Patients With COVID-19 Pneumonia: Clinical Features, Laboratory Findings, and Prediction. Front Cell Infect Microbiol 2021;11:550456. [PMID: 34327146 DOI: 10.3389/fcimb.2021.550456] [Reference Citation Analysis]
613 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
614 Yue T, Zhou W, He J, Wang H, Liu Y, Wang B, Zhu Q, Xia H, Hu H. Combined clinical and imaging features better predict the critical outcomes of patients with SARS-COV-2. Medicine (Baltimore) 2021;100:e25083. [PMID: 33761668 DOI: 10.1097/MD.0000000000025083] [Reference Citation Analysis]
615 Giorgi M, Cardarelli S, Ragusa F, Saliola M, Biagioni S, Poiana G, Naro F, Massimi M. Phosphodiesterase Inhibitors: Could They Be Beneficial for the Treatment of COVID-19? Int J Mol Sci 2020;21:E5338. [PMID: 32727145 DOI: 10.3390/ijms21155338] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
616 Halpin-Veszeleiova K, Hatfield SM. Therapeutic Targeting of Hypoxia-A2-Adenosinergic Pathway in COVID-19 Patients. Physiology (Bethesda) 2022;37:46-52. [PMID: 34486395 DOI: 10.1152/physiol.00010.2021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
617 Mendoza-Pinto C, García-Carrasco M, Munguía Realpozo P, Méndez-Martínez S. Therapeutic options for the management of severe COVID-19: A rheumatology perspective. Reumatol Clin (Engl Ed) 2021;17:431-6. [PMID: 34625144 DOI: 10.1016/j.reumae.2020.05.002] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
618 Mazzaccaro D, Giacomazzi F, Giannetta M, Varriale A, Scaramuzzo R, Modafferi A, Malacrida G, Righini P, Marrocco-Trischitta MM, Nano G. Non-Overt Coagulopathy in Non-ICU Patients with Mild to Moderate COVID-19 Pneumonia. J Clin Med 2020;9:E1781. [PMID: 32521707 DOI: 10.3390/jcm9061781] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
619 Huang CG, Dutta A, Huang CT, Chang PY, Hsiao MJ, Hsieh YC, Lin SM, Shih SR, Tsao KC, Yang CT. Relative COVID-19 Viral Persistence and Antibody Kinetics. Pathogens 2021;10:752. [PMID: 34199240 DOI: 10.3390/pathogens10060752] [Reference Citation Analysis]
620 Boyuk B, Akin S, Aladag N, Isik A, Erman H, Ozgur Y, Topal M, Karademir N, Tomar Uysal B, Ozbilgehan B, Kabaca D, Kalmaz C, Arslan S, Keskin O. COVID-19 pneumonia in patients with impaired fasting glucose, newly diagnosed diabetes and pre-existing diabetes: a tertiary center experience. J Investig Med 2022:jim-2022-002363. [PMID: 35654475 DOI: 10.1136/jim-2022-002363] [Reference Citation Analysis]
621 Wang Q, Yao Y, Huang Z, Cao J, Zhu C, Yu K, Pan J, Hu B. Low CD4 T cell count predicts radiological progression in severe and critically ill COVID-19 patients: a case control study. J Thorac Dis 2021;13:4723-30. [PMID: 34527313 DOI: 10.21037/jtd-20-1848] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
622 Bai Z, Li P, Wen J, Han Y, Cui Y, Zhou Y, Shi Z, Chen S, Li Q, Zhao X, Wang Z, Li R, Guo Y, Zhan X, Xu G, Ding K, Wang J, Xiao X. Inhibitory effects and mechanisms of the anti-covid-19 traditional Chinese prescription, Keguan-1, on acute lung injury. J Ethnopharmacol 2021;285:114838. [PMID: 34788645 DOI: 10.1016/j.jep.2021.114838] [Reference Citation Analysis]
623 Lee RJ, Wysocki O, Bhogal T, Shotton R, Tivey A, Angelakas A, Aung T, Banfill K, Baxter M, Boyce H, Brearton G, Copson E, Dickens E, Eastlake L, Gomes F, Hague C, Harrison M, Horsley L, Huddar P, Hudson Z, Khan S, Khan UT, Maynard A, McKenzie H, Palmer D, Robinson T, Rowe M, Thomas A, Tweedy J, Sheehan R, Stockdale A, Weaver J, Williams S, Wilson C, Zhou C, Dive C, Cooksley T, Palmieri C, Freitas A, Armstrong AC. Longitudinal characterisation of haematological and biochemical parameters in cancer patients prior to and during COVID-19 reveals features associated with outcome. ESMO Open 2021;6:100005. [PMID: 33399072 DOI: 10.1016/j.esmoop.2020.100005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
624 Saleki K, Banazadeh M, Miri NS, Azadmehr A. Triangle of cytokine storm, central nervous system involvement, and viral infection in COVID-19: the role of sFasL and neuropilin-1. Rev Neurosci 2021. [PMID: 34225390 DOI: 10.1515/revneuro-2021-0047] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
625 Fernández-Fernández FJ. COVID-19, hypertension and angiotensin receptor-blocking drugs. J Hypertens 2020;38:1191. [PMID: 32371812 DOI: 10.1097/HJH.0000000000002468] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
626 Strauss AT, Boyarsky BJ, Garonzik-Wang JM, Werbel W, Durand CM, Avery RK, Jackson KR, Kernodle AB, Baker T, Snyder J, Segev DL, Massie AB. Liver transplantation in the United States during the COVID-19 pandemic: National and center-level responses. Am J Transplant 2021;21:1838-47. [PMID: 33107180 DOI: 10.1111/ajt.16373] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 9.5] [Reference Citation Analysis]
627 Bein B, Bachmann M, Huggett S, Wegermann P. SARS-CoV-2/COVID-19: Evidence-Based Recommendations on Diagnosis and Therapy. Geburtshilfe Frauenheilkd 2020;80:491-8. [PMID: 32435065 DOI: 10.1055/a-1156-3991] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
628 Mazzitelli I, Bleichmar L, Ludueña MG, Pisarevsky A, Labato M, Chiaradia V, Finocchieto P, Paulin F, Hormanstorfer M, Baretto MC, Adanza SP, Parodi MN, Ragusa M, Melucci C, Díaz FE, Paletta A, Di Diego F, Ceballos A, Geffner J. Immunoglobulin G Immune Complexes May Contribute to Neutrophil Activation in the Course of Severe Coronavirus Disease 2019. J Infect Dis 2021;224:575-85. [PMID: 34398243 DOI: 10.1093/infdis/jiab174] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
629 Wei F, Kong D, Li T, Li A, Tan Y, Fang J, Zhuang X, Lai C, Xu W, Dong H, Ma C, Hong K, Cui Y, Tang S, Yu F, Zheng C. Efficacy and safety of umbilical cord mesenchymal stem cells for the treatment of patients with COVID-19. Clinics (Sao Paulo) 2021;76:e2604. [PMID: 34008772 DOI: 10.6061/clinics/2021/e2604] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
630 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
631 Pomara C, Li Volti G, Cappello F. The Post-Lockdown Era: What Is Next in Italy? Front Pharmacol 2020;11:1074. [PMID: 32760280 DOI: 10.3389/fphar.2020.01074] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
632 Martinez-Guerra BA, Gonzalez-Lara MF, Roman-Montes CM, Tamez-Torres KM, Dardón-Fierro FE, Rajme-Lopez S, Medrano-Borromeo C, Martínez-Valenzuela A, Ortiz-Brizuela E, Sifuentes-Osornio J, Ponce-de-Leon A. Outcomes of patients with severe and critical COVID-19 treated with dexamethasone: a prospective cohort study. Emerg Microbes Infect 2022;11:50-9. [PMID: 34839785 DOI: 10.1080/22221751.2021.2011619] [Reference Citation Analysis]
633 Lorente L, Martín MM, González-Rivero AF, Pérez-Cejas A, Cáceres JJ, Perez A, Ramos-Gómez L, Solé-Violán J, Marcos Y Ramos JA, Ojeda N, Jiménez A. DNA and RNA Oxidative Damage and Mortality of Patients With COVID-19. Am J Med Sci 2021;361:585-90. [PMID: 33600784 DOI: 10.1016/j.amjms.2021.02.012] [Reference Citation Analysis]
634 Tung ML, Tan B, Cherian R, Chandra B. Anti-phospholipid syndrome and COVID-19 thrombosis: connecting the dots. Rheumatol Adv Pract 2021;5:rkaa081. [PMID: 33615129 DOI: 10.1093/rap/rkaa081] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
635 [DOI: 10.1101/2020.03.27.20043661] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
636 Chamata Y, Jackson KG, Watson KA, Jauregi P. Whey-Derived Peptides at the Heart of the COVID-19 Pandemic. Int J Mol Sci 2021;22:11662. [PMID: 34769093 DOI: 10.3390/ijms222111662] [Reference Citation Analysis]
637 Maeda T, Obata R, Rizk DO D, Kuno T. The association of interleukin-6 value, interleukin inhibitors, and outcomes of patients with COVID-19 in New York City. J Med Virol 2021;93:463-71. [PMID: 32720702 DOI: 10.1002/jmv.26365] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
638 Petrakis D, Margină D, Tsarouhas K, Tekos F, Stan M, Nikitovic D, Kouretas D, Spandidos DA, Tsatsakis A. Obesity ‑ a risk factor for increased COVID‑19 prevalence, severity and lethality (Review). Mol Med Rep 2020;22:9-19. [PMID: 32377709 DOI: 10.3892/mmr.2020.11127] [Cited by in Crossref: 122] [Cited by in F6Publishing: 109] [Article Influence: 61.0] [Reference Citation Analysis]
639 Al-Mulla F, Mohammad A, Al Madhoun A, Haddad D, Ali H, Eaaswarkhanth M, John SE, Nizam R, Channanath A, Abu-Farha M, Ahmad R, Abubaker J, Thanaraj TA. ACE2 and FURIN variants are potential predictors of SARS-CoV-2 outcome: A time to implement precision medicine against COVID-19. Heliyon 2021;7:e06133. [PMID: 33532652 DOI: 10.1016/j.heliyon.2021.e06133] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
640 Lanzoni G, Linetsky E, Correa D, Alvarez RA, Marttos A, Hirani K, Cayetano SM, Castro JG, Paidas MJ, Efantis Potter J, Xu X, Glassberg M, Tan J, Patel AN, Goldstein B, Kenyon NS, Baidal D, Alejandro R, Vianna R, Ruiz P, Caplan AI, Ricordi C. Umbilical Cord-derived Mesenchymal Stem Cells for COVID-19 Patients with Acute Respiratory Distress Syndrome (ARDS). CellR4 Repair Replace Regen Reprogram 2020;8:e2839. [PMID: 34164564 DOI: 10.32113/cellr4_20204_2839] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
641 Tsai CC, Wang YC, Chiang TT, Chen IA, Chiu CH, Yang YS, Yeh KM, Chang FY. Successful treatment of 28 patients with coronavirus disease 2019 at a medical center in Taiwan. J Formos Med Assoc 2021;120:713-9. [PMID: 32773262 DOI: 10.1016/j.jfma.2020.07.033] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
642 Danladi J, Sabir H. Innate immunity, inflammation activation and heat-shock protein in COVID-19 pathogenesis. J Neuroimmunol 2021;358:577632. [PMID: 34186336 DOI: 10.1016/j.jneuroim.2021.577632] [Reference Citation Analysis]
643 Husain W, Ashkanani F. Does COVID-19 change dietary habits and lifestyle behaviours in Kuwait: a community-based cross-sectional study. Environ Health Prev Med 2020;25:61. [PMID: 33045996 DOI: 10.1186/s12199-020-00901-5] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 16.0] [Reference Citation Analysis]
644 Petersen MW, Meyhoff TS, Helleberg M, Kjaer MN, Granholm A, Hjortsø CJS, Jensen TS, Møller MH, Hjortrup PB, Wetterslev M, Vesterlund GK, Russell L, Jørgensen VL, Tjelle K, Benfield T, Ulrik CS, Andreasen AS, Mohr T, Bestle MH, Poulsen LM, Hitz MF, Hildebrandt T, Knudsen LS, Møller A, Sølling CG, Brøchner AC, Rasmussen BS, Nielsen H, Christensen S, Strøm T, Cronhjort M, Wahlin RR, Jakob S, Cioccari L, Venkatesh B, Hammond N, Jha V, Myatra SN, Gluud C, Lange T, Perner A. Low-dose hydrocortisone in patients with COVID-19 and severe hypoxia (COVID STEROID) trial-Protocol and statistical analysis plan. Acta Anaesthesiol Scand 2020;64:1365-75. [PMID: 32779728 DOI: 10.1111/aas.13673] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 9.5] [Reference Citation Analysis]
645 Feketea GM, Vlacha V. The Diagnostic Significance of Usual Biochemical Parameters in Coronavirus Disease 19 (COVID-19): Albumin to Globulin Ratio and CRP to Albumin Ratio. Front Med (Lausanne) 2020;7:566591. [PMID: 33224959 DOI: 10.3389/fmed.2020.566591] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
646 Wang Y, Shi L, Wang Y, Duan G, Yang H. Albumin and total bilirubin for severity and mortality in coronavirus disease 2019 patients. J Clin Lab Anal 2020;34:e23412. [PMID: 32745325 DOI: 10.1002/jcla.23412] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
647 Orioli L, Servais T, Belkhir L, Laterre PF, Thissen JP, Vandeleene B, Maiter D, Yombi JC, Hermans MP. Clinical characteristics and short-term prognosis of in-patients with diabetes and COVID-19: A retrospective study from an academic center in Belgium. Diabetes Metab Syndr 2021;15:149-57. [PMID: 33352454 DOI: 10.1016/j.dsx.2020.12.020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
648 Wahezi DM, Lo MS, Rubinstein TB, Ringold S, Ardoin SP, Downes KJ, Jones KB, Laxer RM, Pellet Madan R, Mudano AS, Turner AS, Karp DR, Mehta JJ. American College of Rheumatology Guidance for the Management of Pediatric Rheumatic Disease During the COVID-19 Pandemic: Version 1. Arthritis Rheumatol 2020;72:1809-19. [PMID: 32705780 DOI: 10.1002/art.41455] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
649 Rastad H, Karim H, Ejtahed HS, Tajbakhsh R, Noorisepehr M, Babaei M, Azimzadeh M, Soleimani A, Inanloo SH, Shafiabadi Hassani N, Rasanezhad F, Shahrestanaki E, Khodaparast Z, Golami H, Qorbani M. Risk and predictors of in-hospital mortality from COVID-19 in patients with diabetes and cardiovascular disease. Diabetol Metab Syndr 2020;12:57. [PMID: 32641974 DOI: 10.1186/s13098-020-00565-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 11.0] [Reference Citation Analysis]
650 Hussain A, Rao D, Buttle T, Linkson L, Owen W, Hadley E, El-hasani S. Risk Factors for Severe Coronavirus Disease (COVID-19). EMJ Respir. [DOI: 10.33590/emjrespir/20-00151] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
651 Mahamat-Saleh Y, Fiolet T, Rebeaud ME, Mulot M, Guihur A, El Fatouhi D, Laouali N, Peiffer-Smadja N, Aune D, Severi G. Diabetes, hypertension, body mass index, smoking and COVID-19-related mortality: a systematic review and meta-analysis of observational studies. BMJ Open 2021;11:e052777. [PMID: 34697120 DOI: 10.1136/bmjopen-2021-052777] [Reference Citation Analysis]
652 Favilli A, Mattei Gentili M, Raspa F, Giardina I, Parazzini F, Vitagliano A, Borisova AV, Gerli S. Effectiveness and safety of available treatments for COVID-19 during pregnancy: a critical review. J Matern Fetal Neonatal Med 2020;:1-14. [PMID: 32508168 DOI: 10.1080/14767058.2020.1774875] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
653 Bonny V, Maillard A, Mousseaux C, Plaçais L, Richier Q. [COVID-19: Pathogenesis of a multi-faceted disease]. Rev Med Interne 2020;41:375-89. [PMID: 32507520 DOI: 10.1016/j.revmed.2020.05.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
654 Donoso-Navarro E, Arribas Gómez I, Bernabeu-Andreu FA. IL-6 and Other Biomarkers associated with Poor Prognosis in a Cohort of Hospitalized Patients with COVID-19 in Madrid. Biomark Insights 2021;16:11772719211013363. [PMID: 34103886 DOI: 10.1177/11772719211013363] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
655 Ran J, Song Y, Zhuang Z, Han L, Zhao S, Cao P, Geng Y, Xu L, Qin J, He D, Wu F, Yang L. Blood pressure control and adverse outcomes of COVID-19 infection in patients with concomitant hypertension in Wuhan, China. Hypertens Res 2020;43:1267-76. [PMID: 32855527 DOI: 10.1038/s41440-020-00541-w] [Cited by in F6Publishing: 21] [Reference Citation Analysis]
656 Fakhri S, Nouri Z, Moradi SZ, Akkol EK, Piri S, Sobarzo-Sánchez E, Farzaei MH, Echeverría J. Targeting Multiple Signal Transduction Pathways of SARS-CoV-2: Approaches to COVID-19 Therapeutic Candidates. Molecules 2021;26:2917. [PMID: 34068970 DOI: 10.3390/molecules26102917] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
657 Du RH, Liu LM, Yin W, Wang W, Guan LL, Yuan ML, Li YL, Hu Y, Li XY, Sun B, Peng P, Shi HZ. Hospitalization and Critical Care of 109 Decedents with COVID-19 Pneumonia in Wuhan, China. Ann Am Thorac Soc. 2020;17:839-846. [PMID: 32255382 DOI: 10.1513/annalsats.202003-225oc] [Cited by in Crossref: 101] [Cited by in F6Publishing: 78] [Article Influence: 50.5] [Reference Citation Analysis]
658 Chen S, Sun H, Heng M, Tong X, Geldsetzer P, Wang Z, Wu P, Yang J, Hu Y, Wang C, Bärnighausen T. Factors Predicting Progression to Severe COVID-19: A Competing Risk Survival Analysis of 1753 Patients in Community Isolation in Wuhan, China. Engineering (Beijing) 2021. [PMID: 34721935 DOI: 10.1016/j.eng.2021.07.021] [Reference Citation Analysis]
659 Razmi M, Hashemi F, Gheytanchi E, Dehghan Manshadi M, Ghods R, Madjd Z. Immunomodulatory-based therapy as a potential promising treatment strategy against severe COVID-19 patients: A systematic review. Int Immunopharmacol 2020;88:106942. [PMID: 32896750 DOI: 10.1016/j.intimp.2020.106942] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
660 Wang B, Zhang L, Yin S, Deng W, Xie M. Risk factors associated with deep vein thrombosis in COVID-19 patients. MedComm (2020) 2021;2:288-91. [PMID: 34230922 DOI: 10.1002/mco2.52] [Reference Citation Analysis]
661 Shi C, Tingting W, Li JP, Sullivan MA, Wang C, Wang H, Deng B, Zhang Y. Comprehensive Landscape of Heparin Therapy for COVID-19. Carbohydr Polym 2021;254:117232. [PMID: 33357843 DOI: 10.1016/j.carbpol.2020.117232] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
662 Sayegh MJ, Larsen CG, Pinpin C, Intravia JM, Nellans KW. Ulnar Neuropathy After Intermittent Prone Positioning for COVID-19 Infection: A Preliminary Report of 3 Cases. JBJS Case Connect 2021;11. [PMID: 33739958 DOI: 10.2106/JBJS.CC.20.00729] [Reference Citation Analysis]
663 Suh YJ, Hong H, Ohana M, Bompard F, Revel MP, Valle C, Gervaise A, Poissy J, Susen S, Hékimian G, Artifoni M, Periard D, Contou D, Delaloye J, Sanchez B, Fang C, Garzillo G, Robbie H, Yoon SH. Pulmonary Embolism and Deep Vein Thrombosis in COVID-19: A Systematic Review and Meta-Analysis. Radiology 2021;298:E70-80. [PMID: 33320063 DOI: 10.1148/radiol.2020203557] [Cited by in Crossref: 30] [Cited by in F6Publishing: 40] [Article Influence: 15.0] [Reference Citation Analysis]
664 Zhang Y, Shi F, Wang Y, Meng Y, Zhang Q, Wang K, Zeng P, Diao H. Comparative Analysis of Long Non-Coding RNA Expression and Immune Response in Mild and Severe COVID-19. Front Mol Biosci 2022;9:835590. [DOI: 10.3389/fmolb.2022.835590] [Reference Citation Analysis]
665 Higgins V, Sohaei D, Diamandis EP, Prassas I. COVID-19: from an acute to chronic disease? Potential long-term health consequences. Crit Rev Clin Lab Sci 2021;58:297-310. [PMID: 33347790 DOI: 10.1080/10408363.2020.1860895] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
666 Yamada T, Wakabayashi M, Yamaji T, Chopra N, Mikami T, Miyashita H, Miyashita S. Value of leukocytosis and elevated C-reactive protein in predicting severe coronavirus 2019 (COVID-19): A systematic review and meta-analysis. Clin Chim Acta 2020;509:235-43. [PMID: 32533986 DOI: 10.1016/j.cca.2020.06.008] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 9.0] [Reference Citation Analysis]
667 Valeri AM, Robbins-Juarez SY, Stevens JS, Ahn W, Rao MK, Radhakrishnan J, Gharavi AG, Mohan S, Husain SA. Presentation and Outcomes of Patients with ESKD and COVID-19. J Am Soc Nephrol 2020;31:1409-15. [PMID: 32467113 DOI: 10.1681/ASN.2020040470] [Cited by in Crossref: 114] [Cited by in F6Publishing: 57] [Article Influence: 57.0] [Reference Citation Analysis]
668 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
669 Lamblin G, Golfier F, Peron J, Moret S, Chene G, Nohuz E, Lebon M, Dubernard G, Cortet M. [Impact of the COVID-19 Outbreak on the management of patients with gynecological cancers]. Gynecol Obstet Fertil Senol 2020;48:777-83. [PMID: 33010487 DOI: 10.1016/j.gofs.2020.09.011] [Reference Citation Analysis]
670 Celli B, Fabbri LM. Urgent need of a management plan for survivors of COVID-19. Eur Respir J 2020;55:2000764. [PMID: 32217657 DOI: 10.1183/13993003.00764-2020] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
671 Li X, Pan X, Li Y, An N, Xing Y, Yang F, Tian L, Sun J, Gao Y, Shang H, Xing Y. Cardiac injury associated with severe disease or ICU admission and death in hospitalized patients with COVID-19: a meta-analysis and systematic review. Crit Care. 2020;24:468. [PMID: 32723362 DOI: 10.1186/s13054-020-03183-z] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 10.0] [Reference Citation Analysis]
672 Parcha V, Malla G, Suri SS, Kalra R, Heindl B, Berra L, Fouad MN, Arora G, Arora P. Geographic Variation in Racial Disparities in Health and Coronavirus Disease-2019 (COVID-19) Mortality. Mayo Clin Proc Innov Qual Outcomes 2020;4:703-16. [PMID: 33043273 DOI: 10.1016/j.mayocpiqo.2020.09.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
673 Mahida RY, Chotalia M, Alderman J, Patel C, Hayden A, Desai R, Beesley E, Crowley LE, Soltan M, Bangash M, Parekh D, Patel J, Thickett DR. Characterisation and outcomes of ARDS secondary to pneumonia in patients with and without SARS-CoV-2: a single-centre experience. BMJ Open Respir Res 2020;7:e000731. [PMID: 33257441 DOI: 10.1136/bmjresp-2020-000731] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
674 Chekkal M, Deba T, Hadjali S, Lamara H, Oulaa H, Zouai K, Hariti G. Prevention and treatment of COVID-19-associated hypercoagulability: Recommendations of the Algerian society of transfusion and hemobiology. Transfus Clin Biol 2020;27:203-6. [PMID: 33022374 DOI: 10.1016/j.tracli.2020.09.004] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
675 de la Rica R, Borges M, Aranda M, Del Castillo A, Socias A, Payeras A, Rialp G, Socias L, Masmiquel L, Gonzalez-Freire M. Low Albumin Levels Are Associated with Poorer Outcomes in a Case Series of COVID-19 Patients in Spain: A Retrospective Cohort Study. Microorganisms. 2020;8. [PMID: 32722020 DOI: 10.3390/microorganisms8081106] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 12.5] [Reference Citation Analysis]
676 Addeo A, Friedlaender A. Cancer and COVID-19: Unmasking their ties. Cancer Treat Rev 2020;88:102041. [PMID: 32516704 DOI: 10.1016/j.ctrv.2020.102041] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 11.5] [Reference Citation Analysis]
677 Gleeson LE, Roche HM, Sheedy FJ. Obesity, COVID-19 and innate immunometabolism. Br J Nutr 2021;125:628-32. [PMID: 32892755 DOI: 10.1017/S0007114520003529] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
678 Vandael E, Latour K, Islamaj E, Panis LI, Callies M, Haarhuis F, Proesmans K, Devleesschauwer B, Rebolledo Gonzalez J, Hannecart A, Mahieu R, de Viron L, De Clercq E, Kongs A, Hammami N, François J, Dubourg D, Henz S, Catry B, Dequeker S. COVID-19 cases, hospitalizations and deaths in Belgian nursing homes: results of a surveillance conducted between April and December 2020. Arch Public Health 2022;80. [DOI: 10.1186/s13690-022-00794-6] [Reference Citation Analysis]
679 Kallel A, Rekik M, Khemakhem M. Hybrid-based framework for COVID-19 prediction via federated machine learning models. J Supercomput 2021;:1-28. [PMID: 34754141 DOI: 10.1007/s11227-021-04166-9] [Reference Citation Analysis]
680 van Eeden C, Khan L, Osman MS, Cohen Tervaert JW. Natural Killer Cell Dysfunction and Its Role in COVID-19. Int J Mol Sci 2020;21:E6351. [PMID: 32883007 DOI: 10.3390/ijms21176351] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 16.0] [Reference Citation Analysis]
681 Varikasuvu SR, Dutt N, Thangappazham B, Varshney S. Diabetes and COVID-19: A pooled analysis related to disease severity and mortality. Prim Care Diabetes 2021;15:24-7. [PMID: 32891525 DOI: 10.1016/j.pcd.2020.08.015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
682 Bhaskar LVKS, Roshan B, Nasri H. The Fuzzy Connection between SARS-CoV-2 Infection and Loss of Renal Function. Am J Nephrol 2020;51:572-3. [PMID: 32599598 DOI: 10.1159/000508087] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
683 Kerr C, O' Regan S, Creagh D, Hughes G, Geary U, Colgan MP, Canning C, Martin Z, Merry C, Noonan N, Bergin C. Acceptability of and symptom findings from an online symptom check-in tool for COVID-19 outpatient follow-up among a predominantly healthcare worker population. BMJ Open 2021;11:e050444. [PMID: 34588254 DOI: 10.1136/bmjopen-2021-050444] [Reference Citation Analysis]
684 Evangelista H, Amaral C, Porto LC, Gonçalves Junior SJ, Delfino Sodré E, Nogueira J, Dos Santos AMG, Cataldo M, Junger D. Modeling the initial phase of SARS-CoV-2 deposition in the respiratory tract mimicked by the 11C radionuclide. PLoS One 2021;16:e0245019. [PMID: 33444356 DOI: 10.1371/journal.pone.0245019] [Reference Citation Analysis]
685 Junqueira C, Crespo Â, Ranjbar S, de Lacerda LB, Lewandrowski M, Ingber J, Parry B, Ravid S, Clark S, Schrimpf MR, Ho F, Beakes C, Margolin J, Russell N, Kays K, Boucau J, Das Adhikari U, Vora SM, Leger V, Gehrke L, Henderson LA, Janssen E, Kwon D, Sander C, Abraham J, Goldberg MB, Wu H, Mehta G, Bell S, Goldfeld AE, Filbin MR, Lieberman J. FcγR-mediated SARS-CoV-2 infection of monocytes activates inflammation. Nature 2022. [PMID: 35385861 DOI: 10.1038/s41586-022-04702-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 15.0] [Reference Citation Analysis]
686 Alsudir SA, Almalik A, Alhasan AH. Catalogue of self-targeting nano-medical inventions to accelerate clinical trials. Biomater Sci 2021;9:3898-910. [PMID: 33912874 DOI: 10.1039/d1bm00235j] [Reference Citation Analysis]
687 Canna SW, Cron RQ. Highways to hell: Mechanism-based management of cytokine storm syndromes. J Allergy Clin Immunol 2020;146:949-59. [PMID: 33007328 DOI: 10.1016/j.jaci.2020.09.016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
688 Le Maréchal M, Morand P, Epaulard O, Némoz B. COVID-19 in clinical practice: A narrative synthesis. Med Mal Infect 2020;50:639-47. [PMID: 33007400 DOI: 10.1016/j.medmal.2020.09.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
689 Hosoki K, Chakraborty A, Sur S. Molecular mechanisms and epidemiology of COVID-19 from an allergist's perspective. J Allergy Clin Immunol 2020;146:285-99. [PMID: 32624257 DOI: 10.1016/j.jaci.2020.05.033] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 11.0] [Reference Citation Analysis]
690 Peddapalli A, Gehani M, Kalle AM, Peddapalli SR, Peter AE, Sharad S. Demystifying Excess Immune Response in COVID-19 to Reposition an Orphan Drug for Down-Regulation of NF-κB: A Systematic Review. Viruses 2021;13:378. [PMID: 33673529 DOI: 10.3390/v13030378] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
691 Li S, Han J, Zhang A, Han Y, Chen M, Liu Z, Shao M, Cao W. Exploring the Demographics and Clinical Characteristics Related to the Expression of Angiotensin-Converting Enzyme 2, a Receptor of SARS-CoV-2. Front Med (Lausanne) 2020;7:530. [PMID: 32974373 DOI: 10.3389/fmed.2020.00530] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
692 Ishigami J, Kou M, Ding N, Matsushita K. Cardiovascular Disease and Coronavirus Disease 2019: Epidemiology, Management, and Prevention. Curr Epidemiol Rep 2021;:1-8. [PMID: 33425654 DOI: 10.1007/s40471-020-00261-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
693 Mantero V, Abate L, Balgera R, Basilico P, Salmaggi A, Cordano C. Assessing the susceptibility to acute respiratory illness COVID-19-related in a cohort of multiple sclerosis patients. Mult Scler Relat Disord 2020;46:102453. [PMID: 32835900 DOI: 10.1016/j.msard.2020.102453] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
694 Hanlon P, Chadwick F, Shah A, Wood R, Minton J, McCartney G, Fischbacher C, Mair FS, Husmeier D, Matthiopoulos J, McAllister DA. COVID-19 - exploring the implications of long-term condition type and extent of multimorbidity on years of life lost: a modelling study. Wellcome Open Res 2020;5:75. [PMID: 33709037 DOI: 10.12688/wellcomeopenres.15849.3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
695 Said KB, Alsolami A, Khalifa AM, Khalil NA, Moursi S, Osman A, Fahad D, Rakha E, Rashidi M, Moussa S, Bashir AI, Alfouzan F, Hammam S, Taha TE, Al-Hazimi A, Al Jadani A, On Behalf Of The Ha'il Com Research Unit Group. A Multi-Point Surveillance for Antimicrobial Resistance Profiles among Clinical Isolates of Gram-Negative Bacteria Recovered from Major Ha'il Hospitals, Saudi Arabia. Microorganisms 2021;9:2024. [PMID: 34683344 DOI: 10.3390/microorganisms9102024] [Reference Citation Analysis]
696 Bach I, Surathi P, Montealegre N, Abu-Hadid O, Rubenstein S, Redko S, Gupta S, Hillen M, Patel P, Khandelwal P, Kamel A. Stroke in COVID-19: a single-centre initial experience in a hotspot of the pandemic. Stroke Vasc Neurol 2020;5:331-6. [PMID: 32973116 DOI: 10.1136/svn-2020-000525] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
697 Zhan Z, Yang X, Du H, Zhang C, Song Y, Ran X, Zhang A, Yang M. Early Improvement of Acute Respiratory Distress Syndrome in Patients With COVID-19 in the Intensive Care Unit: Retrospective Analysis. JMIR Public Health Surveill 2021;7:e24843. [PMID: 33630743 DOI: 10.2196/24843] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
698 Jones K, Mantey J, Washer L, Meddings J, Patel PK, Montoya A, Mills JP, Gibson K, Mody L. When planning meets reality: COVID-19 interpandemic survey of Michigan Nursing Homes. Am J Infect Control 2021;49:1343-9. [PMID: 33794312 DOI: 10.1016/j.ajic.2021.03.016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
699 Curtis JR, Johnson SR, Anthony DD, Arasaratnam RJ, Baden LR, Bass AR, Calabrese C, Gravallese EM, Harpaz R, Sadun RE, Turner AS, Williams EA, Mikuls TR. American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 1. Arthritis Rheumatol 2021;73:1093-107. [PMID: 33728796 DOI: 10.1002/art.41734] [Cited by in Crossref: 35] [Cited by in F6Publishing: 21] [Article Influence: 35.0] [Reference Citation Analysis]
700 Raad M, Gorgis S, Dabbagh M, Chehab O, Parikh S, Singh G. Right Heart Strain on Presenting 12-Lead Electrocardiogram Predicts Critical Illness in COVID-19. JACC Clin Electrophysiol 2021;7:485-93. [PMID: 33358667 DOI: 10.1016/j.jacep.2020.09.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
701 Zhang Y, He L, Chen H, Lu S, Xiong Y, Liu J, Zheng Y, Wang S, Liu L. Manifestations of blood coagulation and its relation to clinical outcomes in severe COVID-19 patients: Retrospective analysis. Int J Lab Hematol 2020;42:766-72. [PMID: 32592539 DOI: 10.1111/ijlh.13273] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
702 Lin S, Lau LH, Chanchlani N, Kennedy NA, Ng SC. Recent advances in clinical practice: management of inflammatory bowel disease during the COVID-19 pandemic. Gut 2022;71:1426-39. [PMID: 35477864 DOI: 10.1136/gutjnl-2021-326784] [Reference Citation Analysis]
703 Valdez-Cruz NA, García-Hernández E, Espitia C, Cobos-Marín L, Altamirano C, Bando-Campos CG, Cofas-Vargas LF, Coronado-Aceves EW, González-Hernández RA, Hernández-Peralta P, Juárez-López D, Ortega-Portilla PA, Restrepo-Pineda S, Zelada-Cordero P, Trujillo-Roldán MA. Integrative overview of antibodies against SARS-CoV-2 and their possible applications in COVID-19 prophylaxis and treatment. Microb Cell Fact 2021;20:88. [PMID: 33888152 DOI: 10.1186/s12934-021-01576-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
704 Zrzavy T, Wimmer I, Rommer PS, Berger T. Immunology of COVID-19 and disease-modifying therapies: The good, the bad and the unknown. Eur J Neurol 2020. [PMID: 33090599 DOI: 10.1111/ene.14578] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
705 Ng JH, Zaidan M, Jhaveri KD, Izzedine H. Acute tubulointerstitial nephritis and COVID-19. Clin Kidney J 2021;14:2151-7. [PMID: 34603692 DOI: 10.1093/ckj/sfab107] [Reference Citation Analysis]
706 Kotnala RK, Tempe DK, Mishra P, Ramji S, Patil AP. Clinical Triage in a Large 2000-Bed COVID-19 Care Facility: Role of the Anesthesiologist. J Cardiothorac Vasc Anesth 2021;35:2827-30. [PMID: 33602636 DOI: 10.1053/j.jvca.2021.01.047] [Reference Citation Analysis]
707 Izadi M, Cegolon L, Javanbakht M, Sarafzadeh A, Abolghasemi H, Alishiri G, Zhao S, Einollahi B, Kashaki M, Jonaidi-Jafari N, Asadi M, Jafari R, Fathi S, Nikoueinejad H, Ebrahimi M, Imanizadeh S, Ghazale AH. Ozone therapy for the treatment of COVID-19 pneumonia: A scoping review. Int Immunopharmacol 2021;92:107307. [PMID: 33476982 DOI: 10.1016/j.intimp.2020.107307] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
708 Gustine JN, Jones D. Immunopathology of Hyperinflammation in COVID-19. Am J Pathol 2021;191:4-17. [PMID: 32919977 DOI: 10.1016/j.ajpath.2020.08.009] [Cited by in Crossref: 54] [Cited by in F6Publishing: 58] [Article Influence: 27.0] [Reference Citation Analysis]
709 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
710 Dreier E, Malfertheiner MV, Dienemann T, Fisser C, Foltan M, Geismann F, Graf B, Lunz D, Maier LS, Müller T, Offner R, Peterhoff D, Philipp A, Salzberger B, Schmidt B, Sinner B, Lubnow M. ECMO in COVID-19-prolonged therapy needed? A retrospective analysis of outcome and prognostic factors. Perfusion 2021;36:582-91. [PMID: 33612020 DOI: 10.1177/0267659121995997] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
711 Shinde T, Hansbro PM, Sohal SS, Dingle P, Eri R, Stanley R. Microbiota Modulating Nutritional Approaches to Countering the Effects of Viral Respiratory Infections Including SARS-CoV-2 through Promoting Metabolic and Immune Fitness with Probiotics and Plant Bioactives. Microorganisms 2020;8:E921. [PMID: 32570850 DOI: 10.3390/microorganisms8060921] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 11.0] [Reference Citation Analysis]
712 Elbeddini A, Gerochi R, Elshahawi A. Evaluation of the prophylaxis and treatment of COVID-associated coagulopathy. J Pharm Policy Pract 2020;13:73. [PMID: 33117545 DOI: 10.1186/s40545-020-00274-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
713 Lampasona V, Secchi M, Scavini M, Bazzigaluppi E, Brigatti C, Marzinotto I, Davalli A, Caretto A, Laurenzi A, Martinenghi S, Molinari C, Vitali G, Di Filippo L, Mercalli A, Melzi R, Tresoldi C, Rovere-Querini P, Landoni G, Ciceri F, Bosi E, Piemonti L. Antibody response to multiple antigens of SARS-CoV-2 in patients with diabetes: an observational cohort study. Diabetologia 2020;63:2548-58. [PMID: 33029657 DOI: 10.1007/s00125-020-05284-4] [Cited by in Crossref: 38] [Cited by in F6Publishing: 1] [Article Influence: 19.0] [Reference Citation Analysis]
714 Rossi D, Shadman M, Condoluci A, Brown JR, Byrd JC, Gaidano G, Hallek M, Hillmen P, Mato A, Montserrat E, Ghia P. How We Manage Patients With Chronic Lymphocytic Leukemia During the SARS-CoV-2 Pandemic. Hemasphere 2020;4:e432. [PMID: 32803132 DOI: 10.1097/HS9.0000000000000432] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 5.5] [Reference Citation Analysis]
715 Kavianpour M, Saleh M, Verdi J. The role of mesenchymal stromal cells in immune modulation of COVID-19: focus on cytokine storm. Stem Cell Res Ther 2020;11:404. [PMID: 32948252 DOI: 10.1186/s13287-020-01849-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
716 Ladani AP, Loganathan M, Danve A. Managing rheumatic diseases during COVID-19. Clin Rheumatol 2020;39:3245-54. [PMID: 32895747 DOI: 10.1007/s10067-020-05387-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
717 Leeming DJ, Genovese F, Sand JMB, Rasmussen DGK, Christiansen C, Jenkins G, Maher TM, Vestbo J, Karsdal MA. Can biomarkers of extracellular matrix remodelling and wound healing be used to identify high risk patients infected with SARS-CoV-2?: lessons learned from pulmonary fibrosis. Respir Res 2021;22:38. [PMID: 33546680 DOI: 10.1186/s12931-020-01590-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
718 [DOI: 10.1101/2020.03.25.20043703] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
719 Rubin SJS, Falkson SR, Degner NR, Blish C. Clinical characteristics associated with COVID-19 severity in California. J Clin Transl Sci 2020;5:e3. [PMID: 34192044 DOI: 10.1017/cts.2020.40] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
720 Zhang K, Zhang X, Ding W, Xuan N, Tian B, Huang T, Zhang Z, Cui W, Huang H,